<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="ame270028" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Animal Model Exp Med</journal-id><journal-id journal-id-type="iso-abbrev">Animal Model Exp Med</journal-id><journal-id journal-id-type="pmc-domain-id">3615</journal-id><journal-id journal-id-type="pmc-domain">animalmod</journal-id><journal-id journal-id-type="publisher-id">AME2</journal-id><journal-title-group><journal-title>Animal Models and Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">2096-5451</issn><issn pub-type="epub">2576-2095</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12431601</article-id><article-id pub-id-type="pmcid-ver">PMC12431601.1</article-id><article-id pub-id-type="pmcaid">12431601</article-id><article-id pub-id-type="pmcaiid">12431601</article-id><article-id pub-id-type="pmid">40387186</article-id><article-id pub-id-type="doi">10.1002/ame2.70028</article-id><article-id pub-id-type="publisher-id">AME270028</article-id><article-id pub-id-type="other">AMEM-2025-0017.R2</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Regular Article</subject><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Animal models of lung cancer: Phenotypic comparison of different animal models of lung cancer and their application in the study of mechanisms</article-title><alt-title alt-title-type="left-running-head">Yang et&#160;al.</alt-title></title-group><contrib-group><contrib id="ame270028-cr-0001" contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="Z">Zixuan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0000-2307-3630</contrib-id><xref rid="ame270028-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame270028-cr-0002" contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="X">Xianbin</given-names></name><xref rid="ame270028-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame270028-cr-0003" contrib-type="author"><name name-style="western"><surname>Tan</surname><given-names initials="L">Lili</given-names></name><xref rid="ame270028-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270028-cr-0004" contrib-type="author"><name name-style="western"><surname>Que</surname><given-names initials="P">Pingxinyi</given-names></name><xref rid="ame270028-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270028-cr-0005" contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="T">Tong</given-names></name><xref rid="ame270028-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame270028-cr-0006" contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="W">Wei</given-names></name><xref rid="ame270028-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="ame270028-cr-0007" contrib-type="author" corresp="yes"><name name-style="western"><surname>Yao</surname><given-names initials="D">Dejiao</given-names></name><xref rid="ame270028-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><address><email>dejiaoy@163.com</email></address></contrib><contrib id="ame270028-cr-0008" contrib-type="author" corresp="yes"><name name-style="western"><surname>Tang</surname><given-names initials="S">Songqi</given-names></name><xref rid="ame270028-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>tangsongqi@muhn.edu.cn</email></address></contrib></contrib-group><aff id="ame270028-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">School of Traditional Chinese Medicine</named-content>
<institution>Hainan Medical University</institution>
<city>Haikou</city>
<country country="CN">China</country>
</aff><aff id="ame270028-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">School of Pharmacy</named-content>
<institution>Chengdu University of Traditional Chinese Medicine</institution>
<city>Chengdu</city>
<country country="CN">China</country>
</aff><aff id="ame270028-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">School of Basic Medical Sciences</named-content>
<institution>Chengdu University of Traditional Chinese Medicine</institution>
<city>Chengdu</city>
<country country="CN">China</country>
</aff><aff id="ame270028-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Oncology Department II</named-content>
<institution>Hospital of Chengdu University of Traditional Chinese Medicine</institution>
<city>Chengdu</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Songqi Tang, School of Traditional Chinese Medicine, Hainan Medical University, Haikou, China.<break/>
Email: <email>tangsongqi@muhn.edu.cn</email><break/>
Dejiao Yao, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.<break/>
Email: <email>dejiaoy@163.com</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2025</year></pub-date><volume>8</volume><issue seq="90">7</issue><issue-id pub-id-type="pmc-issue-id">496817</issue-id><issue-id pub-id-type="doi">10.1002/ame2.v8.7</issue-id><issue-title content-type="special-issue-title">Themed Issue: Mechanism Verification of Plant Bioactive Components</issue-title><fpage>1229</fpage><lpage>1252</lpage><history><date date-type="received"><day>16</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>4</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Animal Models and Experimental Medicine</italic> published by John Wiley &amp; Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="AME2-8-1229.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:AME2-8-1229.pdf"/><abstract><title>Abstract</title><p>Lung cancer has one of the highest rates of incidence and mortality worldwide, making research on its mechanisms and treatments crucial. Animal models are essential in lung cancer research as they accurately replicate the biological characteristics and treatment outcomes seen in human diseases. Currently, various lung cancer models have been established, including chemical induction models, orthotopic transplantation models, ectopic transplantation models, metastasis models, and gene editing mouse models. Additionally, lung cancer grafts can be categorized into two types: tissue&#8208;based and cell&#8208;based grafts. This paper summarizes the phenotypes, advantages, and disadvantages of various induction methods based on their modeling techniques. The goal is to enhance the simulation of clinical lung cancer characteristics and to establish a solid foundation for future clinical research.</p></abstract><abstract abstract-type="graphical"><p>Grafts used to construct lung cancer animal models come from various sources, primarily cell lines, patient&#8208;derived tumor tissues, and circulating tumor cells. Based on the sources of grafts and research objectives, lung cancer animal models can be categorized into several types: chemical&#8208;induced models, orthotopic transplantation models, heterotopic transplantation models, metastasis models, and gene&#8208;edited models. These models are crucial for lung cancer research, as they can simulate various disease phenotypes, including cell proliferation, invasion and metastasis, epithelial&#8208;mesenchymal transition (EMT), cell cycle regulation, gene mutations, apoptosis, and immune infiltration. These models serve as powerful tools for exploring the pathogenesis of lung cancer, identifying new therapeutic targets, and evaluating drug efficacy.<boxed-text position="anchor" content-type="graphic" id="ame270028-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="AME2-8-1229-g001.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ame270028-kwd-0001">animal models of lung cancer</kwd><kwd id="ame270028-kwd-0002">chemical induction methods</kwd><kwd id="ame270028-kwd-0003">gene editing mouse models</kwd><kwd id="ame270028-kwd-0004">lung cancer grafts</kwd><kwd id="ame270028-kwd-0005">transplantation models</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Sichuan Provincial Administration of Traditional Chinese Medicine</institution><institution-id institution-id-type="doi">10.13039/501100016350</institution-id></institution-wrap></funding-source><award-id>2023MS564</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82474436</award-id></award-group></funding-group><counts><fig-count count="9"/><table-count count="2"/><page-count count="24"/><word-count count="17300"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:12.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="AME270028-cit-2001"><string-name name-style="western"><surname>Yang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>L</given-names></string-name>, et al. <article-title>Animal models of lung cancer: Phenotypic comparison of different animal models of lung cancer and their application in the study of mechanisms</article-title>. <source>Anim Models Exp Med</source>. <year>2025</year>;<volume>8</volume>:<fpage>1229</fpage>&#8208;<lpage>1252</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ame2.70028</pub-id><pub-id pub-id-type="pmcid">PMC12431601</pub-id><pub-id pub-id-type="pmid">40387186</pub-id></mixed-citation>
</p><fn-group id="ame270028-ntgp-0001"><fn fn-type="equal" id="ame270028-note-0001"><p>Zixuan Yang and Xianbin Zhao contributed equally to this work as co&#8208;first authors.</p></fn></fn-group></notes></front><body id="ame270028-body-0001"><sec id="ame270028-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Lung cancer is one of the most common malignant tumors worldwide, affecting the bronchus, alveoli, and other lung tissues.<xref rid="ame270028-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> In 2022, nearly 2.5 million new cases of lung cancer were diagnosed, with over 1.8 million deaths worldwide, making it the most prevalent cancer in terms of both morbidity and mortality.<xref rid="ame270028-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Factors such as smoking, environmental pollution, and occupational exposure substantially elevate the risk of developing lung cancer.<xref rid="ame270028-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="ame270028-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="ame270028-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> The emergence of lung cancer is characterized by genetic harm, mutations, and a decline in cellular functionality, reflecting a complex and multi&#8208;stage journey. Currently, lung cancer treatment primarily involves surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy, among other approaches. In this paper, the animal models of lung cancer &#8211; chemical induction, transplantation models, and gene editing mouse models &#8211; are summarized, and the advantages and disadvantages of different modeling methods are discussed (Table&#160;<xref rid="ame270028-tbl-0001" ref-type="table">1</xref>). Lung cancer transplantation models are categorized based on the inoculation site into orthotopic, ectopic, and metastasis models. Additionally, lung cancer grafts are classified into two categories: tissue grafts and cellular grafts. This aims to guide future animal experiments in lung cancer research, enhance the simulation of clinical lung cancer manifestations, and establish a foundation for subsequent clinical studies.</p><table-wrap position="float" id="ame270028-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Phenotypic comparison in animal models of lung cancer.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Strain</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mouse age</th><th align="left" valign="bottom" rowspan="1" colspan="1">Reagent</th><th align="left" valign="bottom" rowspan="1" colspan="1">Methods</th><th align="left" valign="bottom" rowspan="1" colspan="1">Phenotypes</th><th align="left" valign="bottom" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="7" valign="top" rowspan="1">Chemical induction</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Smoke&#8208;induced lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">Adult mice</td><td align="left" valign="top" rowspan="1" colspan="1">8&#8211;12&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">Cigarette smoke</td><td align="left" valign="top" rowspan="1" colspan="1">Exposed to cigarette smoke for 2&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8211;5</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0006" ref-type="bibr">6</xref>, <xref rid="ame270028-bib-0007" ref-type="bibr">7</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">NNK&#8208;induced lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">Albino Sprague Dawley</td><td align="left" valign="top" rowspan="1" colspan="1">10&#8201;weeks</td><td align="left" rowspan="2" valign="top" colspan="1">NNK</td><td align="left" valign="top" rowspan="1" colspan="1">1.5&#8201;mg/kg three times weekly for 20&#8201;weeks, s.c.</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8211;3, and 6</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0008" ref-type="bibr">8</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A/J mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8211;6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">50&#8201;mg/kg for 4&#8201;weeks, i.p.</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8211;3, and 6</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0009" ref-type="bibr">9</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">Urethane&#8208;induced lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">Albino Wistar</td><td align="left" valign="top" rowspan="1" colspan="1">6&#8201;weeks</td><td align="left" rowspan="2" valign="top" colspan="1">Urethane</td><td align="left" valign="top" rowspan="1" colspan="1">1000&#8201;mg/kg, three consecutive i.p. injections separated by 48&#8201;h each week for 12&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">1, 3, 4, and 6</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0010" ref-type="bibr">10</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6</td><td align="left" valign="top" rowspan="1" colspan="1">6&#8211;8&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;g/kg in 200&#8201;&#956;L PBS, i.p.</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 5</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0011" ref-type="bibr">11</xref>, <xref rid="ame270028-bib-0012" ref-type="bibr">12</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">Bap&#8208;induced lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">A/J mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8211;6&#8201;weeks</td><td align="left" rowspan="2" valign="top" colspan="1">Bap</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;mg /7&#8201;days for 4&#8201;weeks, i.p.</td><td align="left" valign="top" rowspan="1" colspan="1">1, 3, and 7</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0009" ref-type="bibr">9</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Swiss albino mice</td><td align="left" valign="top" rowspan="1" colspan="1">7&#8211;8&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">50&#8201;mg/kg, twice weekly for four consecutive weeks, orally</td><td align="left" valign="top" rowspan="1" colspan="1">1, 8, and 9</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0013" ref-type="bibr">13</xref>, <xref rid="ame270028-bib-0014" ref-type="bibr">14</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">MNU&#8208;induced lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">KrasLSL&#8208;G12D mice and wild&#8208;type mice</td><td align="left" valign="top" rowspan="1" colspan="1">7&#8211;12&#8201;weeks</td><td align="left" rowspan="2" valign="top" colspan="1">MNU</td><td align="left" valign="top" rowspan="1" colspan="1">50&#8201;mg/kg for 20&#8201;weeks, i.p.</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 8</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0015" ref-type="bibr">15</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FVB&#8208;Trp53+/&#8722; mice and wild&#8208;type mice</td><td align="left" valign="top" rowspan="1" colspan="1">6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">50&#8201;mg/kg for 26&#8201;weeks, i.p.</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 8</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0016" ref-type="bibr">16</xref>]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">TT&#8208;DDE&#8208;induced lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">ICR mice</td><td align="left" valign="top" rowspan="1" colspan="1">6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">TT&#8208;DDE</td><td align="left" valign="top" rowspan="1" colspan="1">24&#8201;mg/kg for 8&#8201;weeks, ITLI.</td><td align="left" valign="top" rowspan="1" colspan="1">1, 3, and 6</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0017" ref-type="bibr">17</xref>]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MCA/DEN&#8208;induced lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">Wistar rat</td><td align="left" valign="top" rowspan="1" colspan="1">6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">MCA and DEN</td><td align="left" valign="top" rowspan="1" colspan="1">10&#8201;mg MCA and 10&#8201;&#956;L DEN instilled into the left lobe at the 15, 35, 55, 65, and 75&#8201;days</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 8</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0018" ref-type="bibr">18</xref>, <xref rid="ame270028-bib-0019" ref-type="bibr">19</xref>, <xref rid="ame270028-bib-0020" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">LPS&#8208;induced lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">A/J mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8211;6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">LPS AND NNK</td><td align="left" valign="top" rowspan="1" colspan="1">3&#8201;mg NNK and 5&#8201;&#956;g LPS for 10&#8201;weeks, i.p.</td><td align="left" valign="top" rowspan="1" colspan="1">1, 4, and 5</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0021" ref-type="bibr">21</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">LPS AND Bap</td><td align="left" valign="top" rowspan="1" colspan="1">150&#8201;mg/kg NNK (i.p, biweekly for 4&#8201;weeks) and 0.25&#8201;mg/kg LPS (IN, weekly for 12&#8201;weeks)</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 4</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0022" ref-type="bibr">22</xref>]</td></tr><tr><td align="left" colspan="7" valign="top" rowspan="1">Orthotopic transplantation</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">Intrapulmonary injection</td><td align="left" valign="top" rowspan="1" colspan="1">SD rats</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">3,4&#8208;benzopyrene</td><td align="left" valign="top" rowspan="1" colspan="1">Treated twice at a 2&#8208;week intervals with 2&#8201;mg 3,4&#8208;benzopyrene (dissolved in 0.2&#8201;mL corn oil) through intrapulmonary injection</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 6</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0023" ref-type="bibr">23</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">4&#8211;6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">LLC&#8208;luc</td><td align="left" valign="top" rowspan="1" colspan="1">1.2&#8201;&#215;&#8201;10<sup>6</sup> cells/mL in a 1:1 ratio of PBS mixed with Matrige, Inject into the lung</td><td align="left" valign="top" rowspan="1" colspan="1">1, 5&#8211;7</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0024" ref-type="bibr">24</xref>]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Intranasal injection</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 and BALB/c nude mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8211;8&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">LLC and NCI&#8208;H460</td><td align="left" valign="top" rowspan="1" colspan="1">LLC (1&#8201;&#215;&#8201;10<sup>5</sup> to 1&#8201;&#215;&#8201;10<sup>7</sup> cells) or NCI&#8208;H460 (5&#8201;&#215;&#8201;10<sup>6</sup>) in 100&#8201;&#956;L PBS, pntranasal injection</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 5</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0025" ref-type="bibr">25</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">Intratracheal injection</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">7&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">LLC&#8208;luc and Particulate matter</td><td align="left" valign="top" rowspan="1" colspan="1">LLC&#8208;luc cells (2&#8201;&#215;&#8201;10<sup>6</sup> cells/mL) were injected intravenously and particulate matter (200&#8201;&#956;g) were injected into lung</td><td align="left" valign="top" rowspan="1" colspan="1">1, 2, and 10</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0026" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BALB/c mice</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">LLC</td><td align="left" valign="top" rowspan="1" colspan="1">3&#8201;&#215;&#8201;10<sup>5</sup> cells/mouse, pnjected cell into the trachea</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 2</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0027" ref-type="bibr">27</xref>]</td></tr><tr><td align="left" colspan="7" valign="top" rowspan="1">Heterotopic transplantation</td></tr><tr><td align="left" style="padding-left:10%" rowspan="3" valign="top" colspan="1">Subcutaneous graft tumor model</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">4&#8211;6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">LLC</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> cells in 200&#8201;&#956;L PBS, pnjected cells subcutaneously in the dorsal side of mice</td><td align="left" valign="top" rowspan="1" colspan="1">1, 2, and 5</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0028" ref-type="bibr">28</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">LLC</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;&#215;&#8201;10<sup>6</sup> cells/mouse, pnject cell suspension right armpit of the mice</td><td align="left" valign="top" rowspan="1" colspan="1">1, 2, 6, and 11</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0029" ref-type="bibr">29</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BALB/c nude mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8211;6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">A549</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> to 1&#8201;&#215;&#8201;10<sup>7</sup> cells/mL, s.c.</td><td align="left" valign="top" rowspan="1" colspan="1">1, 6, and 11</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0030" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">Kidney capsule engraftment</td><td align="left" valign="top" rowspan="1" colspan="1">Nude mice</td><td align="left" valign="top" rowspan="1" colspan="1">3&#8211;5&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">Cancerous tissues samples of patients with NSCLC</td><td align="left" valign="top" rowspan="1" colspan="1">Insert 2&#8211;3 tumor pieces (2&#8201;&#215;&#8201;3&#8201;&#215;&#8201;3&#8201;mm) into the surface of the kidney</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 2</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0031" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD1 athymic mice</td><td align="left" valign="top" rowspan="1" colspan="1">6&#8211;8&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">Tissues silces from primary human lung tumors</td><td align="left" valign="top" rowspan="1" colspan="1">Tissue fragments (3&#8201;&#215;&#8201;3&#8201;mm) were grafted under the renal capsule</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0032" ref-type="bibr">32</xref>]</td></tr><tr><td align="left" colspan="7" valign="top" rowspan="1">Metastasis models</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">Tail vein injection</td><td align="left" valign="top" rowspan="1" colspan="1">SCID mice</td><td align="left" valign="top" rowspan="1" colspan="1">12&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">A549, NCI&#8208;H3122</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>5</sup> A549 cells or 1&#8201;&#215;&#8201;10<sup>5</sup> NCI&#8208;H3122 cells suspended in 100&#8201;&#956;L of PBS, IV</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 2</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0033" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BALB/c nude mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">A549</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>7</sup> cells/mouse, IV</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 2</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0034" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">Left ventricular injection</td><td align="left" valign="top" rowspan="1" colspan="1">BALB/c nude mice</td><td align="left" valign="top" rowspan="1" colspan="1">4&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">A549</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;&#215;&#8201;10<sup>5</sup> cells/mouse, left ventriclar injection</td><td align="left" valign="top" rowspan="1" colspan="1">1, 2, and 10</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0035" ref-type="bibr">35</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BALB/c nude mice</td><td align="left" valign="top" rowspan="1" colspan="1">4&#8211;6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H661</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> cells were resuspended in 200&#8201;&#956;L of PBS, left ventricular injection</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 2</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0036" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">Internal carotid artery injection</td><td align="left" valign="top" rowspan="1" colspan="1">SCID mice</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8211;7&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H1915&#8208;luc</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>5</sup> cells/mouse, internal carotid artery injection</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 2</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0037" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6NCrj mice</td><td align="left" valign="top" rowspan="1" colspan="1">6&#8201;weeks</td><td align="left" valign="top" rowspan="1" colspan="1">A549</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>3</sup> cells/mouse, internal carotid artery injection</td><td align="left" valign="top" rowspan="1" colspan="1">1 and 2</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0038" ref-type="bibr">38</xref>]</td></tr></tbody></table><table-wrap-foot id="ame270028-ntgp-0002"><fn id="ame270028-note-0002"><p>
<italic toggle="yes">Note</italic>: Phenotypes: 1, cell proliferation; 2, tissue invasion and metastasis; 3, oxidative stress; 4, inflammation; 5, immune escape; 6, cell apoptosis; 7, signal path; 8, gene instability and mutation; 9, cell cycle; 10, EMT; 11, immunoinfiltration.</p></fn><fn id="ame270028-note-0003"><p>Abbreviations: i.p., intraperitoneal injection; IN, intranasal instillation; ITLI, intratracheal instillation; IV, tail vein injection; s.c., subcutaneous injection.</p></fn></table-wrap-foot></table-wrap></sec><sec id="ame270028-sec-0002"><label>2</label><title>ANIMAL MODELS OF CHEMICALLY INDUCED LUNG CANCER</title><p>Chemically induced lung cancer models represent a critical approach to understanding the disease's pathology by utilizing various agents that mimic the characteristics of lung cancer in animal subjects (Figure&#160;<xref rid="ame270028-fig-0001" ref-type="fig">1</xref>). Commonly employed chemicals include polycyclic aromatic hydrocarbons (PAHs) and nitrosamines, which are effective in replicating the tumorigenesis associated with lung cancer. In parallel, tobacco smoke models serve as a significant representation of tumor development seen in human smokers, albeit with a potentially prolonged timeline for tumor formation. Within the spectrum of endocrine&#8208;related lung cancers, compounds such as TT&#8208;DDE have been identified as effective in modeling small cell lung cancer and neuroendocrine non&#8208;small cell lung cancer. Urethane also plays a pivotal role, particularly in modeling Kras&#8208;driven lung cancers. Moreover, the contributions of methylation and DNA adduct formation induced by agents like MNU are critical in tumor progression, reflecting various pathological features typical of lung cancers, including adenocarcinoma and squamous cell carcinoma. The interplay between inflammation and lung cancer advancement is further elucidated through the use of agents such as Bap and LPS. Bap primarily induces tumors via mechanisms related to oxidative stress and DNA damage, while LPS often acts in synergy with other carcinogens to elicit immune responses and inflammation that promote tumorigenesis. Lastly, the combination of MCA and DEN in induction models may yield a more nuanced portrayal of the complex tumor microenvironment found in human lung cancer, capturing the intricate nature of tumor development and progression. Wide variety of induction agents enhance our ability to study lung cancer and develop potential therapeutic strategies.</p><fig position="float" fig-type="FIGURE" id="ame270028-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Animal models of chemically induced lung cancer. Bap, benzo[a]pyrene; DEN, diethylnitrosamine; LPS, lipopolysaccharide; MCA, 3&#8208;methylcholanthrene; MNU, <italic toggle="yes">N</italic>&#8208;methyl&#8208;<italic toggle="yes">N</italic>&#8208;nitroxyurea; TT&#8208;DDE, trans&#8208;2,4&#8208;sebacedienal.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="AME2-8-1229-g002.jpg"/></fig><sec id="ame270028-sec-0003"><label>2.1</label><title>Tobacco smoke induction</title><p>Tobacco smoke contains various carcinogens, including benzo[a]pyrene (BaP) and nitroso compounds like 4&#8208;(methylnitrosaminyl)&#8208;1&#8208;(3&#8208;pyridine)&#8208;1&#8208;butanone (NNK). This model simulates the carcinogenic environment of tobacco smoke by either directly exposing animals to the smoke for 2&#8201;weeks or injecting them with specific chemicals. BaP is one of the major carcinogenic components. It promotes tumorigenesis by activating intracellular aromatic hydrocarbon receptors (AhR), which in turn triggers inflammation and affects lipid metabolism.<xref rid="ame270028-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> NNK induces lung cancer through several mechanisms, such as DNA methylation<xref rid="ame270028-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="ame270028-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> and oxidative stress.<xref rid="ame270028-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="ame270028-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> These processes result in DNA adduct formation, leading to genomic instability in cells.<xref rid="ame270028-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="ame270028-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> A/J mice and other sensitive strains show a clear carcinogenic response to NNK.<xref rid="ame270028-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref>, <xref rid="ame270028-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref>
</p><sec id="ame270028-sec-0004"><label>2.1.1</label><title>Phenotypes</title><p>Tobacco smoke often leads to tumors such as adenocarcinoma or squamous cell carcinoma. These tumors show significantly increased proliferation and metastasis potential.<xref rid="ame270028-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> Tobacco smoke can activate immune escape mechanisms through oxidative stress and chronic inflammation. NNK can activate several carcinogenic pathways, including PPAR&#947; /NF&#8208;&#954;B<xref rid="ame270028-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>, <xref rid="ame270028-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> and Wnt /&#946;&#8208;catenin<xref rid="ame270028-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> signaling pathways, which enhance cell proliferation and migration. NNK can inhibit apoptosis<xref rid="ame270028-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> and change the metabolites of intestinal microorganisms, impacting both the immune response and the host's metabolic state.<xref rid="ame270028-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> Changes in the tumor microenvironment, including the release of pro&#8208;inflammatory factors, increased cell proliferation, structural remodeling, and other pathological alterations, have been observed.<xref rid="ame270028-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>, <xref rid="ame270028-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>
</p></sec><sec id="ame270028-sec-0005"><label>2.1.2</label><title>Applicabilities and limitations</title><p>Tobacco smoke&#8208;induced lung cancer models closely mimic human smoking&#8208;related lung cancer. However, this modeling method is time&#8208;consuming, and the exposure duration affects tumor incidence and type. In addition, varying experimental conditions can lead to inconsistent results, limiting the extrapolation of research findings.<xref rid="ame270028-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref>
</p></sec></sec><sec id="ame270028-sec-0006"><label>2.2</label><title>Urethane induction</title><p>Urethane is a widely used chemical inducer that creates a lung cancer model through intraperitoneal injection in experimental animals, typically at a dose of 1&#8201;g/kg, administered three times a week for 12&#8201;weeks.<xref rid="ame270028-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref>, <xref rid="ame270028-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> Urethane induces lung cancer primarily by inhibiting DNA repair mechanisms<xref rid="ame270028-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="ame270028-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> and promoting apoptosis.<xref rid="ame270028-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="ame270028-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref> Furthermore, its metabolites bind to intracellular biomacromolecules, which contributes to cell dysfunction and genomic instability.<xref rid="ame270028-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>
</p><sec id="ame270028-sec-0007"><label>2.2.1</label><title>Phenotypes</title><p>Lung cancer cells in this model often show abnormal shapes and changes in their nuclei, as well as signs of growth. Studies<xref rid="ame270028-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref>, <xref rid="ame270028-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> have noted mutations in genes related to tumors, such as p53 and Kras. These mutations are somewhat similar to those found in human lung cancer, as noted in references.<xref rid="ame270028-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref>
</p></sec><sec id="ame270028-sec-0008"><label>2.2.2</label><title>Applicabilities and limitations</title><p>This model is easy to operate and commonly linked to mutations in the Kras gene, making it a useful tool for simulating KRAS&#8208;driven lung cancer. The ethyl carbamate&#8208;induced lung cancer models may exhibit resistance to certain chemotherapy drugs. This characteristic provides a valuable experimental basis for investigating the mechanisms of drug resistance in lung cancer.<xref rid="ame270028-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref>, <xref rid="ame270028-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref> Nonetheless, the varying sensitivities of different animal strains to ethyl carbamate may influence the model's consistency and reproducibility.</p></sec></sec><sec id="ame270028-sec-0009"><label>2.3</label><title>Bap induction</title><p>BaP is a polycyclic aromatic hydrocarbon commonly found in the environment, particularly in tobacco smoke and automobile exhaust. In this model, researchers exposed animals to BaP either through intraperitoneal injection (1&#8201;mg once a week for 4&#8201;weeks) or by adding it to their drinking water (50&#8201;mg/kg, two times a week for 4&#8201;weeks).<xref rid="ame270028-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref> BaP can cause mutations and tumors. It does this by triggering intracellular oxidative stress and leading to the formation of DNA adducts.<xref rid="ame270028-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref>, <xref rid="ame270028-bib-0064" ref-type="bibr">
<sup>64</sup>
</xref>
</p><sec id="ame270028-sec-0010"><label>2.3.1</label><title>Phenotypes</title><p>Bap is involved in cell cycle regulation, particularly in the G1 and G2/M phases, where it can inhibit apoptosis and promote cell proliferation, accelerating tumor progression.<xref rid="ame270028-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="ame270028-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="ame270028-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref> Exposure to Bap typically impacts the function and structure of various organs, including the liver and lungs, resulting in pathological features such as inflammation, fibrosis, and tumor formation.<xref rid="ame270028-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref> Bap also alters the body's immune response, affecting both the immune system and the tumor microenvironment, which promotes tumor development.<xref rid="ame270028-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref>, <xref rid="ame270028-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref> Lung cancer cells induced by benzopyrene frequently exhibit increased proliferation, reduced apoptosis, and enhanced metastatic potential.<xref rid="ame270028-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref>, <xref rid="ame270028-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref>, <xref rid="ame270028-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref>
</p></sec><sec id="ame270028-sec-0011"><label>2.3.2</label><title>Applicabilities and limitations</title><p>The BAP&#8208;induced lung cancer model is user&#8208;friendly, allows for effective dose and timing control, and is well&#8208;suited for large&#8208;scale screening tests. The inflammatory response activated in lung tissue after benzopyrene exposure is closely linked to tumorigenesis, underscoring its significant role in lung cancer development.<xref rid="ame270028-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref>
</p></sec></sec><sec id="ame270028-sec-0012"><label>2.4</label><title>
<italic toggle="no">N</italic>&#8208;methyl&#8208;<italic toggle="no">N</italic>&#8208;nitroxyurea (<styled-content style="fixed-case" toggle="no">MNU</styled-content>) induction</title><p>MNU is a chemical that attaches a methyl group to DNA, resulting in the formation of DNA adducts. This process causes gene mutations and can lead to tumor formation.<xref rid="ame270028-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> In this model, lung cancer is primarily induced by either intraperitoneal (50&#8201;mg/kg for 20&#8211;26&#8201;weeks) or intravenous injection of MNU solvent, allowing control over the timing of tumor formation through dose and injection frequency. The incidence of lung cancer increases significantly at doses of 50&#8201;mg/kg or more.<xref rid="ame270028-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref>
</p><sec id="ame270028-sec-0013"><label>2.4.1</label><title>Phenotypes</title><p>MNU causes lung cancer by inducing Kras mutations. It also increases the tumor mutation burden, enhances the immune response, and may affect the effectiveness of immune checkpoint inhibitors.<xref rid="ame270028-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref>, <xref rid="ame270028-bib-0075" ref-type="bibr">
<sup>75</sup>
</xref>
</p></sec><sec id="ame270028-sec-0014"><label>2.4.2</label><title>Applicabilities and limitations</title><p>The MNU&#8208;induced lung cancer model has a high tumor incidence and can simulate multiple pathological features of human lung cancer, including adenocarcinoma and squamous cell carcinoma.<xref rid="ame270028-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> MNU treatment in FVB&#8208;Trp53 heterozygote mice effectively induced lung tumor development, with genetic characteristics resembling those of human lung cancer.<xref rid="ame270028-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref>
</p></sec></sec><sec id="ame270028-sec-0015"><label>2.5</label><title>Trans&#8208;2,4&#8208;sebacedienal (<styled-content style="fixed-case" toggle="no">TT</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">DDE</styled-content>) induction</title><p>TT&#8208;DDE, often present in cooking smoke, is recognized for its tendency to accumulate in living organisms and its ability to disrupt hormonal functions.<xref rid="ame270028-bib-0076" ref-type="bibr">
<sup>76</sup>
</xref> This substance can induce lung cancer when administered via intratracheal instillation (24&#8201;mg/kg for 8&#8201;weeks).<xref rid="ame270028-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref> Additionally, TT&#8208;DDE can enhance inflammation and trigger cancer&#8208;related signaling pathways inside cells.<xref rid="ame270028-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="ame270028-bib-0078" ref-type="bibr">
<sup>78</sup>
</xref>
</p><sec id="ame270028-sec-0016"><label>2.5.1</label><title>Phenotypes</title><p>The lung cancer model induced by TT&#8208;DDE primarily demonstrates its effects on the endocrine and immune systems. In&#160;vivo, TT&#8208;DDE metabolites can disrupt the endocrine system, cause an imbalance in cell proliferation and apoptosis,<xref rid="ame270028-bib-0078" ref-type="bibr">
<sup>78</sup>
</xref>, <xref rid="ame270028-bib-0079" ref-type="bibr">
<sup>79</sup>
</xref> elevate oxidative stress markers in lung tissue, suppress immunity, and ultimately result in cell damage and gene mutations.<xref rid="ame270028-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref>, <xref rid="ame270028-bib-0080" ref-type="bibr">
<sup>80</sup>
</xref> Mice that are exposed to prolonged TT&#8208;DDE show an increase in alveolar macrophages, epithelial overgrowth, and the formation of granulomatous nodules, which may also aid in the growth and spread of tumor cells by altering JNK signaling pathways.<xref rid="ame270028-bib-0081" ref-type="bibr">
<sup>81</sup>
</xref>
</p></sec><sec id="ame270028-sec-0017"><label>2.5.2</label><title>Applicabilities and limitations</title><p>The TT&#8208;DDE model is effective for evaluating the efficacy of anti&#8208;tumor drugs, especially those targeting endocrine&#8208;related tumors. Long&#8208;term exposure to TT&#8208;DDE should be studied further, as most existing research only examines short&#8208;term effects. Because TT&#8208;DDE is bioaccumulative, individual differences among animals may affect the experimental results.</p></sec></sec><sec id="ame270028-sec-0018"><label>2.6</label><title>3&#8208;Methylcholanthrene (<styled-content style="fixed-case" toggle="no">MCA</styled-content>) combined with diethylnitrosamine (<styled-content style="fixed-case" toggle="no">DEN</styled-content>) induction</title><p>The combined induction model of MCA and DEN for lung cancer simulates the effects of multiple carcinogens. This model induces lung cancer by instilling a suspension of iodized oil containing MCA and DEN into the tracheas of animals.<xref rid="ame270028-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="ame270028-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Specifically, 10&#8201;mg of MCA and 10&#8201;&#956;L of DEN are instilled into the left lobe on days 15, 35, 55, 65, and 75. MCA is a known carcinogen that forms DNA adducts, disrupting key regulatory genes involved in cell cycle regulation and apoptosis. When paired with promoters like butylated hydroxytoluene (BHT), it significantly increases the risk of tumorigenicity.<xref rid="ame270028-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> DEN causes tumor formation through its metabolites, which damage DNA and promote oxidative stress in lung tissue.<xref rid="ame270028-bib-0082" ref-type="bibr">
<sup>82</sup>
</xref>, <xref rid="ame270028-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref> The combination of these two chemicals significantly enhances DNA damage and inhibits cell repair, increasing the frequency of tumor occurrence.</p><sec id="ame270028-sec-0019"><label>2.6.1</label><title>Phenotypes</title><p>This model represents the process of changing normal bronchial tissue into squamous tissue, which is then followed by abnormal cell growth, localized cancer, and invasive cancer.<xref rid="ame270028-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Throughout this process, immune cell infiltration and the expression of immune factors are observed. Additionally, the positive expression rates of p27, p57, and other proteins increase as cancer progresses.<xref rid="ame270028-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> The combination of MCA and DEN induces significant lung inflammation and promotes neutrophil recruitment, which is essential for tumor development.<xref rid="ame270028-bib-0082" ref-type="bibr">
<sup>82</sup>
</xref>
</p></sec><sec id="ame270028-sec-0020"><label>2.6.2</label><title>Applicabilities and limitations</title><p>When MCA is combined with DEN, it significantly increases lung cancer incidence and provides a better representation of the multifactorial carcinogenic mechanisms in humans. The tumor occurrence in the combined treatment group was significantly higher than in the single treatment group, indicating that the synergistic effect of chemical carcinogens plays a crucial role in lung cancer development.<xref rid="ame270028-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref> However, the modeling cycle is lengthy,<xref rid="ame270028-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref> and there is a high reliance on animal models.</p></sec></sec><sec id="ame270028-sec-0021"><label>2.7</label><title>Lipopolysaccharide (<styled-content style="fixed-case" toggle="no">LPS</styled-content>) induction</title><p>LPS, which is a component of the outer membrane found in gram&#8208;negative bacteria, acts as an effective inflammatory agent.<xref rid="ame270028-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref> The common modeling methods used to induce a chronic inflammatory response have included intraperitoneal injection,<xref rid="ame270028-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="ame270028-bib-0086" ref-type="bibr">
<sup>86</sup>
</xref> caudal vein injection,<xref rid="ame270028-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="ame270028-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref> and tracheal injection or infusion,<xref rid="ame270028-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="ame270028-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> which in turn have promoted tumor occurrence. In experiments, LPS was often combined with NNK, typically at a dosage of 3&#8201;mg of NNK and 5&#8201;&#956;g of LPS for a duration of 10&#8201;weeks. Tumor proliferation and immune escape were then observed.<xref rid="ame270028-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</p><sec id="ame270028-sec-0022"><label>2.7.1</label><title>Phenotypes</title><p>LPS&#8208;mediated chronic inflammatory environments contain proinflammatory factors that can cause genomic instability in cells, increasing the likelihood of mutations.<xref rid="ame270028-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Inflammatory cell infiltration and activation release various growth factors and cytokines that promote tumor cell growth and metastasis. Inflammation also affects the tumor microenvironment and modifies immune cell function, facilitating tumor evasion and progression.<xref rid="ame270028-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="ame270028-bib-0088" ref-type="bibr">
<sup>88</sup>
</xref> Chronic inflammation mediated by LPS can induce T cell failure by regulating the PD&#8208;1/PD&#8208;L1 immune checkpoint axis, impairing the immune system's ability to recognize and eliminate tumor cells.<xref rid="ame270028-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref>
</p></sec><sec id="ame270028-sec-0023"><label>2.7.2</label><title>Applicabilities and limitations</title><p>LPS effectively simulates the impact of chronic inflammation on tumorigenesis, serving as a valuable experimental platform for studying inflammation&#8208;related lung cancer. However, differences may exist between the inflammatory response induced by LPS and the pathogenesis of human lung cancer. Therefore, the biological relevance of this model requires further verification.<xref rid="ame270028-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref> Furthermore, how LPS is administered, including the method and dosage, may impact the reproducibility of the experimental results. Moreover, the LPS&#8208;induced model primarily investigates the relationship between inflammation and tumorigenesis, which may overshadow the impact of other environmental factors, like smoking and pollution, on lung cancer.</p></sec></sec></sec><sec id="ame270028-sec-0024"><label>3</label><title>LUNG CANCER TRANSPLANTATION MODELS</title><p>There are three primary methods for creating animal models of lung cancer transplantation: orthotopic transplantation, heterotopic transplantation, and metastasis models. These models originate from three primary sources: grafts derived from patient tissues, grafts from cell lines, and grafts from circulating blood tumor cells. Each of these models, derived from different sources, can address a wide range of research needs.</p><sec id="ame270028-sec-0025"><label>3.1</label><title>Orthotopic transplantation of lung cancer animal models</title><p>Lung cancer modeling methods are crucial for understanding tumor growth and development, and they typically encompass intrapulmonary, intranasal, and intratracheal injection techniques (Figure&#160;<xref rid="ame270028-fig-0002" ref-type="fig">2</xref>). Intrapulmonary injection involves administering lung cancer cell lines or chemicals directly into the lungs, allowing for better control over tumor localization and growth rates. The endotracheal injection model, on the other hand, entails injecting carcinogens directly into the trachea, thereby significantly influencing the physiological state of the lungs, which is advantageous for accurately reflecting the metastasis and diffusion characteristics of tumor cells within the airways. However, it presents complexities in replicating the tumor microenvironment, which must be accurately replicated in order to investigate mechanisms of tumor immune escape. Furthermore, the intranasal injection model serves to simulate tumor spread in the upper respiratory tract and its effects on adjacent tissues via nasal administration. That is vital for elucidating the early pathogenesis of lung cancer and developing effective prevention strategies. Additionally, the intranasal injection model opens new avenues for researching inhaled drug delivery in relation to tumors. Overall, these modeling methods are integral to advancing our understanding of lung cancer dynamics and therapeutic strategies.</p><fig position="float" fig-type="FIGURE" id="ame270028-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Orthotopic transplantation of lung cancer animal models.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="AME2-8-1229-g008.jpg"/></fig><sec id="ame270028-sec-0026"><label>3.1.1</label><title>Intrapulmonary injection</title><p>In this model, researchers inject lung cancer cells into the lung parenchyma of experimental animals.<xref rid="ame270028-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref> Alternatively, they use a direct percutaneous injection<xref rid="ame270028-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="ame270028-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> after surgically separating the tissue to allow for in&#160;situ growth. Subsequently, after the injection of luciferase&#8208;labeled cells, researchers can monitor tumor growth and metastasis in real time using in&#160;vivo imaging.</p><sec id="ame270028-sec-0027"><title>Phenotypes</title><p>Intrapulmonary injection&#8208;induced lung cancer models typically exhibit rapid tumor growth and are highly aggressive.<xref rid="ame270028-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref> The levels of biomarkers such as IL&#8208;6 and TNF&#8208;&#945; are significantly elevated and strongly associated with the inflammatory microenvironment of tumors.<xref rid="ame270028-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref>
</p></sec><sec id="ame270028-sec-0028"><title>Applicabilities and limitations</title><p>The intrapulmonary injection model effectively assesses how various treatment regimens influence the tumor microenvironment, particularly in immunotherapy and targeted therapy studies. Additionally, this model can be used to study how the tumor microenvironment affects tumor growth, including the interactions between tumor cells and host cells, as well as the role of tumor&#8208;associated fibroblasts, which is crucial for understanding tumor aggressiveness and metastasis.<xref rid="ame270028-bib-0093" ref-type="bibr">
<sup>93</sup>
</xref>, <xref rid="ame270028-bib-0094" ref-type="bibr">
<sup>94</sup>
</xref> However, this modeling method is more complex to perform. Unlike subcutaneous tumors, which can be directly observed for growth, tumors grow within the lung in this model. Injecting tumor cells into the lung can lead to tumor spread and metastasis to the pleura, resulting in multifocal growth. This complicates the study of individual tumors<xref rid="ame270028-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref> and places high technical demands on surgeons.</p></sec></sec><sec id="ame270028-sec-0029"><label>3.1.2</label><title>Intranasal injection</title><p>In this model, lung cancer cells, such as Lewis Lung Carcinoma (LLC) cells (1&#8201;&#215;&#8201;10<sup>5</sup> to 1&#8201;&#215;&#8201;10<sup>7</sup> cells in 100&#8201;&#956;L PBS) or NCI&#8208;H460 cells (1&#8201;&#215;&#8201;10<sup>5</sup> cells in 100&#8201;&#956;L PBS), are injected intranasally into mouse lungs to establish a lung cancer model that effectively simulates the natural progression of cancer in&#160;vivo, with tumor proliferation evident in both the left and right lungs.<xref rid="ame270028-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>
</p><sec id="ame270028-sec-0030"><title>Phenotypes</title><p>The model effectively simulates key pathological features of human lung cancer, such as tumor growth, spread, and changes in the microenvironment. Histological analysis revealed that the tumor cells appeared abnormal, while the surrounding tissues exhibited a marked inflammatory response, indicating changes in the tumor microenvironment.<xref rid="ame270028-bib-0096" ref-type="bibr">
<sup>96</sup>
</xref>
</p></sec><sec id="ame270028-sec-0031"><title>Applicabilities and limitations</title><p>Compared to direct pulmonary injection, intranasal injection better mimics the natural progression of cancer in the body, leading to a more complete pathological formation of lung cancer. Consequently, this model can evaluate the effectiveness of anticancer drugs more accurately.<xref rid="ame270028-bib-0097" ref-type="bibr">
<sup>97</sup>
</xref>, <xref rid="ame270028-bib-0098" ref-type="bibr">
<sup>98</sup>
</xref> However, although the procedure is relatively simple, individual differences in the nasal cavity and lung structure of mice may affect the model's consistency and repeatability. Additionally, intranasal injection has limitations compared to the orthotopic transplantation model when evaluating the tumor microenvironment and local aggressiveness.<xref rid="ame270028-bib-0099" ref-type="bibr">
<sup>99</sup>
</xref>
</p></sec></sec><sec id="ame270028-sec-0032"><label>3.1.3</label><title>Intratracheal injection</title><p>In this model, a syringe is inserted into the trachea through a bronchofiberscope or tracheal intubation. Tumor cell suspensions, specifically Lewis Lung Carcinoma&#8208;luciferase (LLC&#8208;luc) containing 3&#8201;&#215;&#8201;10<sup>5</sup> cells in 200&#8201;&#956;L PBS, were injected into the tail vein. In addition, 200&#8201;&#956;g of particulate matter was administered to induce lung cancer.<xref rid="ame270028-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="ame270028-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>
</p><sec id="ame270028-sec-0033"><title>Phenotypes</title><p>After the endotracheal injection, tumor cells quickly multiply in the lung tissue, resulting in distinct tumor nodules characteristic of either lung adenocarcinoma or squamous cell carcinoma.<xref rid="ame270028-bib-0100" ref-type="bibr">
<sup>100</sup>
</xref> Following the injection, the physiological indicators of the animals&#8212;including body weight, mobility, and respiratory function&#8212;may show changes, reflecting physiological stress.<xref rid="ame270028-bib-0099" ref-type="bibr">
<sup>99</sup>
</xref> Furthermore, the establishment of the model is accompanied by inflammatory reactions, particularly in the tissues surrounding the tumor, where a high density of immune cells is observed.<xref rid="ame270028-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref>, <xref rid="ame270028-bib-0102" ref-type="bibr">
<sup>102</sup>
</xref>, <xref rid="ame270028-bib-0103" ref-type="bibr">
<sup>103</sup>
</xref>
</p></sec><sec id="ame270028-sec-0034"><title>Applicabilities and limitations</title><p>This model better simulates the natural process of cancer progression in the body, with tumor proliferation clearly visible in the lungs. While intratracheal injection offers advantages, it has a significant limitation due to its high technical requirements, making the procedure challenging. Intratracheal injection results in lower tumor formation and metastasis rates compared to other cancer models.<xref rid="ame270028-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref>, <xref rid="ame270028-bib-0105" ref-type="bibr">
<sup>105</sup>
</xref>
</p></sec></sec></sec><sec id="ame270028-sec-0035"><label>3.2</label><title>Heterotopic transplantation of lung cancer animal models</title><p>The heterotopic lung cancer model serves as a valuable platform for investigating tumor dynamics by implanting lung cancer cells or tumor tissues into non&#8208;pulmonary sites, like subcutaneous or subcapsular kidney regions (Figure&#160;<xref rid="ame270028-fig-0003" ref-type="fig">3</xref>). Among these, subcutaneous graft models are particularly notable for exhibiting accelerated tumor growth and improved survival rates. This is attributed to the subcutaneous tissue's abundant blood supply and less immunosuppressive nature, which facilitate the proliferation and spread of the implanted cancerous tissues. Conversely, while the renal subcapsular transplantation model offers a supportive environment for tumor development, its anatomical closeness to the kidney may invoke heightened immune surveillance. This can complicate tumor growth and metastasis due to the increased immune response, leading to slower progression compared to subcutaneous models. Overall, these modeling methods are integral to advancing our understanding of lung cancer dynamics and therapeutic strategies.</p><fig position="float" fig-type="FIGURE" id="ame270028-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Heterotopic transplantation of lung cancer animal models.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="AME2-8-1229-g009.jpg"/></fig><sec id="ame270028-sec-0036"><label>3.2.1</label><title>Subcutaneous transplantation of lung cancer animal models</title><p>In this model, fresh samples or lung cancer cells from patients were implanted directly under the skin of animals. Commonly used cell lines include the Lewis and A549 cell lines. The inoculation sites included the armpit,<xref rid="ame270028-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="ame270028-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> back,<xref rid="ame270028-bib-0106" ref-type="bibr">
<sup>106</sup>
</xref>, <xref rid="ame270028-bib-0107" ref-type="bibr">
<sup>107</sup>
</xref> hip,<xref rid="ame270028-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> foot pad,<xref rid="ame270028-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref> and others. To accurately reflect the tumor's growth and metastasis characteristics, researchers often vary injection doses and cell sources.<xref rid="ame270028-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref> Additionally, various immunodeficient mouse strains, such as nude, NOD/SCID, and transgenic mice, effectively accept human lung cancer cell lines and simulate the disease's biological characteristics.<xref rid="ame270028-bib-0110" ref-type="bibr">
<sup>110</sup>
</xref>
</p><sec id="ame270028-sec-0037"><title>Phenotypes</title><p>Subcutaneously transplanted tumor cells can form large tumor masses in mice and exhibit a notable growth rate over time. The tumor may metastasize to other organs. Pathologically, the tumor tissue is characterized by high cell atypia and increased nuclear division, which indicate its malignancy.<xref rid="ame270028-bib-0111" ref-type="bibr">
<sup>111</sup>
</xref>, <xref rid="ame270028-bib-0112" ref-type="bibr">
<sup>112</sup>
</xref>
</p></sec><sec id="ame270028-sec-0038"><title>Applicabilities and limitations</title><p>Subcutaneous transplantation of lung cancer tumor models offers several advantages, including ease of operation, low cost, rapid tumor model establishment, and the ability to directly observe tumor growth and drug responses, providing a solid platform for new drug development and efficacy evaluation. However, the inoculation occurs beneath the skin, which lacks the lung's microenvironment and blood supply, leading to potential differences in the tumor's biological characteristics compared to primary lung cancer tumors.<xref rid="ame270028-bib-0113" ref-type="bibr">
<sup>113</sup>
</xref>, <xref rid="ame270028-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref> Furthermore, while the use of immunodeficient mice helps eliminate interference from immune responses, it also restricts the model's ability to accurately replicate the immune microenvironment of human tumors. Lastly, the metastatic properties of subcutaneous tumors may be less pronounced than those of in&#160;situ tumors, limiting their applicability in metastasis studies.</p></sec></sec><sec id="ame270028-sec-0039"><label>3.2.2</label><title>Renal subcapsular transplantation of lung cancer animal models</title><p>To simulate tumor growth and metastasis, researchers transplant lung cancer tissue samples from patients with non&#8208;small cell lung cancer (NSCLC), measuring 2&#8201;&#215;&#8201;3&#8201;&#215;&#8201;3&#8201;mm, or cells from beneath the kidney capsule of experimental animals.<xref rid="ame270028-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="ame270028-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>
</p><sec id="ame270028-sec-0040"><title>Phenotypes</title><p>In a model of lung cancer transplanted under the renal capsule, tumor growth is rapid and aggressive. A few weeks after implantation, the tumor expands rapidly and may metastasize to other organs, including the lungs, liver, and bones, via the blood or lymphatic system.<xref rid="ame270028-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref> The ability of tumor cells to metastasize is closely linked to their aggressiveness, the remodeling of the extracellular matrix, and alterations in the tumor microenvironment. Tumor cells secrete cytokines that modify the function of nearby immune cells, which in turn inhibits the anti&#8208;tumor immune response. Additionally, the acidic and hypoxic conditions of the tumor microenvironment can impair immune cell activity, thereby promoting tumor progression and metastasis.<xref rid="ame270028-bib-0116" ref-type="bibr">
<sup>116</sup>
</xref>
</p></sec><sec id="ame270028-sec-0041"><title>Applicabilities and limitations</title><p>This model typically requires surgical intervention. The subcapsular transplantation model has a higher tumor formation rate than subcutaneous transplantation and more accurately reflects the tumor's biological characteristics and therapeutic response. The subcapsular renal transplantation model has limitations due to its procedural complexity and potential effects on the animal's survival and health post&#8208;surgery. Additionally, the kidney's physiological functions may restrict tumor cell growth due to local blood flow and oxygen supply, leading to different growth characteristics compared to tumors in other body parts.<xref rid="ame270028-bib-0117" ref-type="bibr">
<sup>117</sup>
</xref>
</p></sec></sec></sec><sec id="ame270028-sec-0042"><label>3.3</label><title>Animal models of lung cancer metastasis</title><p>Lung cancer metastasis significantly exacerbates patients' conditions, leading to decreased therapeutic effectiveness and survival rates, making it a major contributor to poor prognoses. Various models have been developed to simulate the middle and late stages of lung cancer metastasis, utilizing fluorescent&#8208;labeled lung cancer cell lines and different injection methods, including tail vein, left ventricular, and internal carotid artery injections (Figure&#160;<xref rid="ame270028-fig-0004" ref-type="fig">4</xref>). The caudal vein model is noted for increasing metastasis rates, particularly in common sites such as the liver and bones. This heightened rate may be attributed to the direct connection between the tail vein and the liver, facilitating rapid entry of cancer cells into liver circulation and thereby increasing the likelihood of liver metastasis. Conversely, left ventricular injection tends to induce metastasis primarily in the lungs and heart, although its overall effectiveness is relatively low due to the dilution of cancer cells by the widespread blood flow from the heart before they can reach target organs. In addition, internal carotid artery injection has been associated with a specific increase in brain metastasis, aligning with the blood flow path that directly supplies the brain. Metastatic tumor formation occurs as tumor cells disseminate via the blood and lymphatic systems to various body parts. Common critical organs affected include lymph nodes, bones, brain, and liver, underscoring the importance of selecting appropriate models for studying lung cancer metastasis. While the caudal vein model demonstrates high rates of metastasis, it is essential to evaluate its impact on patient survival in conjunction with the specific metastatic sites and therapeutic approaches employed.</p><fig position="float" fig-type="FIGURE" id="ame270028-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Metastasis models of lung cancer.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="AME2-8-1229-g004.jpg"/></fig><sec id="ame270028-sec-0043"><label>3.3.1</label><title>Lung cancer metastasis models induced by tail vein injection</title><p>This model simulates lung cancer metastasis by injecting lung cancer cells into the tail vein of mice. Researchers can then observe the spread of these cells in the lungs and other distant organs through blood circulation. This provides an excellent platform for studying the mechanisms of lung cancer blood metastasis.<xref rid="ame270028-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="ame270028-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Surveillance typically involves a combination of imaging techniques, such as CT and MRI, along with histological analysis. It may also include detecting specific markers in blood or tissue to assess lung cancer progression and treatment effectiveness.<xref rid="ame270028-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref>, <xref rid="ame270028-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref>
</p><sec id="ame270028-sec-0044"><title>Phenotypes</title><p>Tumor cell metastasis is closely linked to surface markers,<xref rid="ame270028-bib-0119" ref-type="bibr">
<sup>119</sup>
</xref> cell&#8211;cell interactions,<xref rid="ame270028-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref>, <xref rid="ame270028-bib-0121" ref-type="bibr">
<sup>121</sup>
</xref> and microenvironmental factors.<xref rid="ame270028-bib-0122" ref-type="bibr">
<sup>122</sup>
</xref> The histological features of metastatic lung cancer are characterized by tumor cell heterogeneity, invasion, and angiogenesis.<xref rid="ame270028-bib-0123" ref-type="bibr">
<sup>123</sup>
</xref>, <xref rid="ame270028-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref> Immune and stromal cells within the tumor microenvironment play a crucial role in regulating metastasis. Pathological studies indicate that the histological features of metastatic lung cancer often include tumor cell heterogeneity, invasion, and angiogenesis.</p></sec><sec id="ame270028-sec-0045"><title>Applicabilities and limitations</title><p>The tail vein injection model of lung cancer metastasis effectively simulates how tumor cells spread from the primary site to the lungs via the bloodstream. This process is closely linked to the type and quantity of tumor cells, as well as the genetic background of the mice.<xref rid="ame270028-bib-0125" ref-type="bibr">
<sup>125</sup>
</xref>, <xref rid="ame270028-bib-0126" ref-type="bibr">
<sup>126</sup>
</xref> Additionally, tail vein injection is easy to perform and highly repeatable. Compared to other invasive modeling methods, tail vein injection exerts less physiological stress on mice, making it suitable for large&#8208;scale drug testing and screening. However, this model has specific limitations. Variations in the biological characteristics of different cell lines can affect the model's repeatability and accuracy.</p></sec></sec><sec id="ame270028-sec-0046"><label>3.3.2</label><title>Lung cancer metastasis models induced by left ventricular injection</title><p>This model is more complex for inducing lung cancer metastasis and more accurately simulates how tumor cells enter the systemic circulation through the heart. Additionally, the metastasis rate increases with the number of injected cells.<xref rid="ame270028-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref>
</p><sec id="ame270028-sec-0047"><title>Phenotypes</title><p>Metastasis involves several complex physiological mechanisms, including heart pumping capacity, hemodynamics, and the interaction between tumor cells and vascular endothelial cells. Once in the bloodstream, tumor cells can colonize and grow in target organs by adhering to and penetrating endothelial cells. Tumor cells can increase their metastatic ability in the bloodstream through epithelial&#8208;mesenchymal transition (EMT) and degradation of the extracellular matrix.<xref rid="ame270028-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> The high&#8208;pressure environment of the left ventricle may affect cell survival and metastasis, while the heart's systolic function and blood flow rate play key regulatory roles in tumor cell metastasis.<xref rid="ame270028-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref> Pathologically, metastases typically exhibit adenocarcinoma structures along with significant necrosis and inflammatory responses. The expression levels of common markers such as Ki&#8208;67 and CD31 are significantly increased in immunohistochemical staining.<xref rid="ame270028-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref>
</p></sec><sec id="ame270028-sec-0048"><title>Applicabilities and limitations</title><p>This model can investigate how lung cancer metastasizes and the heart's role in this process. The metastasis patterns observed in lung cancer patients closely match those seen in experimental animal models, indicating that this model has significant practical applications in both basic research and the clinical management of lung cancer.<xref rid="ame270028-bib-0128" ref-type="bibr">
<sup>128</sup>
</xref>, <xref rid="ame270028-bib-0129" ref-type="bibr">
<sup>129</sup>
</xref> However, the cardiac microenvironment may influence the growth and metastatic behavior of tumor cells.<xref rid="ame270028-bib-0130" ref-type="bibr">
<sup>130</sup>
</xref>
</p></sec></sec><sec id="ame270028-sec-0049"><label>3.3.3</label><title>Lung cancer metastasis models induced by internal carotid artery injection</title><p>In this model, ultrasound or X&#8208;ray guidance was employed to locate the target artery accurately. A catheter was then inserted through a small incision, or a micro&#8208;syringe was used to inject a suspension of lung cancer cells. Regular imaging examinations, including small animal imaging, CT, and MRI, were performed after surgery to monitor the tumor's growth and metastasis.<xref rid="ame270028-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref>
</p><sec id="ame270028-sec-0050"><title>Phenotypes</title><p>The ability of tumor cells to survive in the bloodstream, interact with vascular endothelial cells, and adapt to their microenvironment are crucial factors that influence metastasis success. Tumor cells increase their metastatic potential by secreting specific cytokines, including transforming growth factor &#946; (TGF&#8208;&#946;) and matrix metalloproteinases (MMPs), which promote both angiogenesis and cell migration.<xref rid="ame270028-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref> Additionally, the unique traits of tumor cells significantly influence the metastasis process, with stem&#8208;like cells demonstrating greater survival and metastatic potential.<xref rid="ame270028-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> Pathologically, metastases are characterized by tumor cell heterogeneity and the remodeling of the microenvironment. These changes are often accompanied by inflammatory responses and immunosuppression, which create new targets for the early diagnosis and treatment of lung cancer.<xref rid="ame270028-bib-0128" ref-type="bibr">
<sup>128</sup>
</xref>
</p></sec><sec id="ame270028-sec-0051"><title>Applicabilities and limitations</title><p>Internal carotid artery injection can be employed to induce lung cancer metastasis for studying metastasis to the brain.<xref rid="ame270028-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> The internal carotid artery injection mimics the actual process of cancer cell accumulation, adhesion, invasion, and penetration through the blood&#8211;brain barrier, leading to metastasis in the brain's terminal capillary bed. This approach allows for a more realistic investigation of lung cancer's blood&#8208;transport metastasis mechanism.<xref rid="ame270028-bib-0131" ref-type="bibr">
<sup>131</sup>
</xref> However, the procedure demands a high level of skill from the operator, and there is a risk of inducing non&#8208;specific metastasis.</p></sec></sec><sec id="ame270028-sec-0052"><label>3.3.4</label><title>Other lung cancer metastasis models</title><p>Lymphatic and bone metastasis are among the most common and severe complications of lung cancer. Lymphatic metastasis can occur by injecting lung cancer cell lines either into the bloodstream or directly into lung. Tumor cells enhance their metastatic potential by secreting specific growth factors like VEGF&#8208;C, which promote the formation of lymphatic vessels.<xref rid="ame270028-bib-0132" ref-type="bibr">
<sup>132</sup>
</xref> Immune and stromal cells in the tumor microenvironment also play a crucial role in metastasis. Some immune cells can promote the migration and invasion of tumor cells, resulting in the occurrence of lymphatic metastasis. Lung cancer with lymphatic metastasis typically shows pathological features such as lymph node enlargement and invasion of lymphatic vessels. These features can be confirmed through imaging and histological examinations.<xref rid="ame270028-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref>
</p><p>The lung cancer bone metastasis model is created by injecting a lung cancer cell suspension either through the tail vein or directly into the bone marrow cavity. Imaging technologies like PET&#8208;CT are then used to monitor the progression of metastasis and bone injury in real time, allowing for the evaluation of the model's effectiveness. The intravenous injection method has a higher success rate than direct injection, with a metastasis rate exceeding 80%. A successful bone metastasis model should accurately reflect the growth and metastatic characteristics of tumor cells in bone tissue. The evaluation criteria mainly include the formation of metastases, the change of tumor load, the degree of bone injury, and the survival time of mice. Lung cancer cells can release a variety of growth factors in bone tissue, such as transforming growth factor &#946; (TGF&#8208;&#946;) and bone morphogenetic protein (BMP), which promote the occurrence of bone metastasis. Biologically, lung cancer bone metastases often consist of more aggressive and drug&#8208;resistant cells that can adapt to and survive in the bone microenvironment. Pathologically, lung cancer bone metastases typically result in bone destruction and an inflammatory response in the bone marrow, which can lead to pain and other clinical symptoms. In addition, lung cancer bone metastasis may also affect bone metabolism, leading to complications such as osteoporosis.</p></sec></sec><sec id="ame270028-sec-0053"><label>3.4</label><title>Lung metastasis models of tumor</title><p>Various tumor types, such as melanoma, kidney cancer, breast cancer, and liver cancer, frequently metastasize to the lungs in clinical settings. Lung metastasis models for tumors include tail vein injection, in&#160;situ inoculation, genetically engineered mice, and exosome induction. Among these, melanoma and liver cancer lung metastasis models are mainly created using tail vein injection, a straightforward method with a high metastasis rate that is suitable for large&#8208;scale experiments. However, the method fails to accurately mimic the natural metastasis process. Orthotopic transplantation is the primary method for constructing lung metastasis models of soft tissue sarcoma, kidney cancer, and breast cancer. This approach better simulates the natural metastasis process and is ideal for studying metastasis mechanisms and drug screening. However, this method is technically challenging, requiring high skill levels and extended observation time.</p><sec id="ame270028-sec-0054"><label>3.4.1</label><title>Melanoma lung metastasis models</title><p>Establishing a melanoma lung metastasis model typically involves tail vein injection or subcutaneous implantation. Tail vein injection directly introduces melanoma cells into the bloodstream, simulating the tumor cell metastasis process. The injection of 5&#8201;&#215;&#8201;10<sup>5</sup> B16&#8208;F10 cells in 200&#8201;&#956;L of PBS into the tail vein effectively establishes a lung metastasis model, with observable lung metastasis appearing after 2&#8201;weeks.<xref rid="ame270028-bib-0134" ref-type="bibr">
<sup>134</sup>
</xref> Once the model is established, imaging and histological analysis are used to measure the number and size of lung metastases, allowing for an assessment of tumor growth and metastasis.</p><sec id="ame270028-sec-0055"><title>Phenotypes</title><p>After injection, melanoma cells enter the pulmonary microvessels via the bloodstream. By the second week, a few metastases appeared and increased rapidly. By the fourth week, some mice had lung surfaces covered with metastases.<xref rid="ame270028-bib-0135" ref-type="bibr">
<sup>135</sup>
</xref> Histological analysis using H&amp;E and Bouin's fixed staining revealed that the lung metastases exhibited a typical focal or clumpy distribution. Over time, new metastases continued to emerge, leading to a significant increase in tumor volume. In lung metastases, melanoma cells showed high proliferative activity, and the positive rate of Ki67 was also high, indicating that tumor cells have strong proliferation and invasion ability.<xref rid="ame270028-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref> Tumor cell metastasis alters the lung microenvironment, mainly through the recruitment and polarization of tumor&#8208;associated macrophages (TAMs). These macrophages enhance the aggressiveness and metastasis of melanoma cells by secreting cancer&#8208;promoting factors and cytokines.<xref rid="ame270028-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref> Melanoma cells interact with surrounding cells through exosomes to regulate the tumor microenvironment and promote the occurrence of metastasis.<xref rid="ame270028-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref>, <xref rid="ame270028-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref>
</p></sec><sec id="ame270028-sec-0056"><title>Applicabilities and limitations</title><p>This model effectively simulates how melanoma cells colonize and spread within pulmonary microvessels. The metastases formed in this model closely resemble clinical melanoma lung metastases, characterized by a focus&#8208;like or clumpy distribution. This similarity provides a crucial foundation for further investigation into the mechanisms of metastasis.</p></sec></sec><sec id="ame270028-sec-0057"><label>3.4.2</label><title>Renal carcinoma lung metastasis models</title><p>Common methods to create lung metastasis models of renal cancer include tail vein injection, orthotopic transplantation, and genetically engineered mouse models. Human renal cancer cells were either injected into the tail vein at a concentration of 5&#8201;&#215;&#8201;10<sup>5</sup> cells in 100&#8201;&#956;L of PBS or injected into the subcapsular space of the kidneys at a concentration of 5&#8201;&#215;&#8201;10<sup>4</sup> cells per mouse in either nude or immunocompromised mice.<xref rid="ame270028-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref> Frequently utilized renal cancer cell lines include SN12&#8208;PM6 and 786&#8208;O. Genetically engineered models employing CRISPR/Cas9 technology to modify genes associated with kidney cancer metastasis can induce the disease and its spread in mice. This approach more accurately mimics the process of kidney cancer cell metastasis to the lungs.<xref rid="ame270028-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref> Extracellular vesicles from renal carcinoma cells significantly contribute to the formation of pre&#8208;metastatic niches.<xref rid="ame270028-bib-0141" ref-type="bibr">
<sup>141</sup>
</xref> Consequently, researchers created a new metastasis model by extracting and analyzing the composition of extracellular vesicles secreted by kidney cancer cells. These vesicles were then injected into mice to observe their effects on the lung microenvironment.</p><sec id="ame270028-sec-0058"><title>Phenotypes</title><p>Renal cancer cells exhibit a strong tendency to metastasize to the lungs. They also create a pulmonary immunosuppressive microenvironment by secreting complement protein C3 in extracellular vesicles (EVs) and attracting tumor&#8208;associated macrophages (TAMs) and polymorphonuclear myeloid immunosuppressor cells (PMN&#8208;MDSCs), further facilitating metastasis.<xref rid="ame270028-bib-0142" ref-type="bibr">
<sup>142</sup>
</xref> There are sex differences in the lung metastasis of renal carcinoma, with high expression of the androgen receptor (AR) closely linked to this process. In nude mouse models, increased AR expression significantly enhances lung metastasis of renal cancer.<xref rid="ame270028-bib-0143" ref-type="bibr">
<sup>143</sup>
</xref> The expression of the LAPTM5 gene in renal cancer cells is crucial for lung metastasis. LAPTM5 maintains the stem cell characteristics of renal cancer cells by inhibiting the function of pulmonary bone morphogenetic protein (BMP), thereby promoting lung&#8208;specific metastasis.<xref rid="ame270028-bib-0144" ref-type="bibr">
<sup>144</sup>
</xref>
</p></sec><sec id="ame270028-sec-0059"><title>Applicabilities and limitations</title><p>The animal model for lung metastasis in renal cancer effectively simulates the clinical lung metastasis process and exhibits a high rate of tumor formation and metastasis. However, many models rely on immunodeficient mice, such as nude mice, which cannot fully replicate the human immune response due to their incomplete immune systems. Additionally, genetically modified mice are unsuitable for large&#8208;scale experiments because of high costs and technical challenges.</p></sec></sec><sec id="ame270028-sec-0060"><label>3.4.3</label><title>Breast cancer lung metastasis models</title><p>Breast cancer lung metastasis models include the spontaneous lung metastasis model, the tail vein injection model, the exosome induction model, and genetically engineered mice. Commonly used cell lines, such as MDA&#8208;MB&#8208;231 and 4&#8201;T1, use a viral vector system to select cells that stably express green fluorescent protein (GFP). 2&#8201;&#215;&#8201;10<sup>5</sup> Luciferase&#8208;labeled MDA&#8208;MB&#8208;231 cells were injected into mice through the caudal vein.<xref rid="ame270028-bib-0145" ref-type="bibr">
<sup>145</sup>
</xref> The spontaneous metastasis model mimics natural tumor growth and distant metastasis by inoculating breast cancer cells either into the mammary fat pad or subcutaneously in immunodeficient mice.<xref rid="ame270028-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref> In the exosome&#8208;induced model, 4&#8201;T1 tumor&#8208;bearing mice, which have 5&#8201;&#215;&#8201;10<sup>5</sup> cells seeded into breast pads, are placed in a chronic stress environment to stimulate the secretion of exosomes rich in proteins such as SP1, promoting lung metastasis of breast cancer.<xref rid="ame270028-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref>
</p><sec id="ame270028-sec-0061"><title>Phenotypes</title><p>In the lung metastasis model of breast cancer, tumor cells migrate to the lungs via the bloodstream, forming tiny metastases. Over time, these metastases increase in size and eventually form distinct pulmonary nodules. Chronic stress significantly promotes lung metastasis of breast cancer through exosomes (TDEs) secreted by tumor cells. These exosomes induce immunosuppressive microenvironments by activating the TLR4&#8208;NF&#954;B&#8208;IL&#8208;1&#946; pathway in pulmonary neutrophils.<xref rid="ame270028-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref> In the 4&#8201;T1 breast cancer model, the number and volume of lung metastases increased with time, and the size distribution of metastases showed dynamic changes.<xref rid="ame270028-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref>, This change can be quantitatively described by mathematical models. During metastasis, the pulmonary immune microenvironment undergoes significant changes, characterized by an increase in neutrophils and monocytes and a decrease in alveolar macrophages.<xref rid="ame270028-bib-0149" ref-type="bibr">
<sup>149</sup>
</xref>
</p></sec><sec id="ame270028-sec-0062"><title>Applicabilities and limitations</title><p>The lung metastasis animal model for breast cancer effectively simulates how breast cancer cells spread to the lungs via the bloodstream, aiding the study of metastatic mechanisms. Researchers can successfully create lung metastasis models of 4&#8201;T1 breast cancer cell lines using either tail vein injection or subcutaneous injection. This model can study the formation of pre&#8208;metastatic niches and analyze dynamic changes in the migratory microenvironment. Chronic stress changes the composition of exosomes released by tumor cells, thereby fostering the development of a pulmonary immunosuppressive microenvironment. However, investigating the role of exosomes in metastasis necessitates advanced experimental equipment and techniques, such as isolating and identifying exosome components and analyzing their effects on immune cells.</p></sec></sec><sec id="ame270028-sec-0063"><label>3.4.4</label><title>Liver cancer lung metastasis models</title><p>Common methods to create lung metastasis models for hepatocellular carcinoma include in&#160;situ injection, tail&#8208;vein injection, exosome induction, and genetically engineered mouse models. Commonly used cell lines are HepG2, H22, and others. Hep3B and Huh&#8208;7 cells, consisting of 2&#8201;&#215;&#8201;10<sup>6</sup> cells in 50&#8201;&#956;L of serum&#8208;free DMEM, were cultured in&#160;vitro and then injected into the left liver lobe.<xref rid="ame270028-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref> Genetic engineering techniques can be employed to investigate the roles of SENP3 and other specific genes in the progression and metastasis of liver cancer.<xref rid="ame270028-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref>
</p><sec id="ame270028-sec-0064"><title>Phenotypes</title><p>In a liver cancer lung metastasis model, liver cancer cells circulate through the bloodstream to the lungs, forming small metastases. After injecting H22 liver cancer cells into the tail vein, small metastases appeared in the lungs of mice within 7&#8201;days. The number of metastases gradually increased at 14 and 21&#8201;days.<xref rid="ame270028-bib-0152" ref-type="bibr">
<sup>152</sup>
</xref> The increase of matrix stiffness regulates the formation of pre&#8208;metastatic lung niche through miRNAs such as let&#8208;7d&#8208;5p and miR&#8208;365a&#8208;5p in exosomes.<xref rid="ame270028-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref> These exosomes enhance glucose metabolism by targeting metabolic pathways in lung fibroblasts, creating favorable conditions for tumor cell colonization and growth. Liver cancer cells recruit tumor&#8208;associated macrophages (TAMs) by secreting specific factors, such as CCL20, which reshapes the pulmonary immune microenvironment and suppresses the anti&#8208;tumor immune response.<xref rid="ame270028-bib-0154" ref-type="bibr">
<sup>154</sup>
</xref> A large number of immune cells infiltrated the metastatic site, including TAMs, CD8+ T cells and NK cells. The expression of SENP3 and other genes regulates the infiltration of these immune cells, thereby influencing tumor progression.<xref rid="ame270028-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref> Liver cancer cells showed strong proliferation and invasion ability after colonization in the lung, and immunohistochemical results showed positive expression of AFP and GPC&#8208;3 markers in metastatic lesions.<xref rid="ame270028-bib-0155" ref-type="bibr">
<sup>155</sup>
</xref> The miR&#8208;7/TGF&#8208;&#946;2 axis was found to be closely related to lung cancer metastasis induced by acidic tumor microenvironment, suggesting that liver cancer cells may depend on acidic changes in the microenvironment during metastasis.<xref rid="ame270028-bib-0156" ref-type="bibr">
<sup>156</sup>
</xref>
</p></sec><sec id="ame270028-sec-0065"><title>Applicabilities and limitations</title><p>Caudal vein injection can effectively create a liver cancer lung metastasis model that has a high tumor formation rate and is easy to perform, In the high&#8208;concentration cell injection group (2&#8201;&#215;&#8201;10<sup>5</sup> cells in 200&#8201;&#956;L PBS), the lung tumor formation rate reached 70% within 14&#8201;days after the injection.<xref rid="ame270028-bib-0152" ref-type="bibr">
<sup>152</sup>
</xref> This model can also be utilized to study the formation of the pre&#8208;metastatic niche, the dynamic changes in the metastatic microenvironment, and to evaluate the therapeutic effects of anti&#8208;metastatic drugs. However, in genetically engineered mouse models, the DNA mutation profile may differ from that of human liver cancer, which could compromise the validity of the findings for clinical use.</p></sec></sec><sec id="ame270028-sec-0066"><label>3.4.5</label><title>Other models of lung metastasis from tumors</title><p>Besides the cancers mentioned earlier, colorectal cancer, thyroid cancer, and head and neck squamous cell carcinoma frequently metastasize to the lungs. When colorectal cancer cells are injected into the tail vein, they first travel to the liver via the portal vein and then to the lungs through systemic circulation. Lung metastases typically present as multiple nodules and are often associated with significantly elevated CEA levels. Approximately 10&#8211;15% of differentiated thyroid cancers metastasize to the lungs, primarily via hematogenous routes and partially through lymphatic diffusion.<xref rid="ame270028-bib-0157" ref-type="bibr">
<sup>157</sup>
</xref> Nasopharyngeal carcinoma and laryngeal carcinoma may also have lung metastasis, lymphatic metastasis and hematologic metastasis. Nasopharyngeal carcinoma associated with the Epstein&#8211;Barr virus has a higher likelihood of metastasizing, and lung metastases frequently occur alongside lymph node enlargement.<xref rid="ame270028-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref>
</p></sec></sec><sec id="ame270028-sec-0067"><label>3.5</label><title>Lung cancer grafts</title><p>Lung cancer grafts can be divided into three categories based on their tissue source: patient tumor tissue, immortalized cell lines from tumor tissue, and circulating tumor cells.</p><sec id="ame270028-sec-0068"><label>3.5.1</label><title>Patient tumor tissue&#8208;derived xenotransplantation models (<styled-content style="fixed-case" toggle="no">PDX</styled-content>)</title><p>This model involves grafting surgically removed or biopsied tumor tissue or cell suspension into the skin or lung of highly immunodeficient mice, such as NSG, NOD/SCID, and NSFG mice, to create a tumor model.<xref rid="ame270028-bib-0159" ref-type="bibr">
<sup>159</sup>
</xref> The primary graft tumor is typically removed once it has grown to 500&#8211;1000&#8201;mm<sup>3</sup>. This tumor is subsequently retransplanted into a new generation of mice to create a PDX model that exhibits stable growth<xref rid="ame270028-bib-0160" ref-type="bibr">
<sup>160</sup>
</xref> (Figure&#160;<xref rid="ame270028-fig-0005" ref-type="fig">5</xref>). Cells derived from lung cancer tissue of patients can be cultured into three&#8208;dimensional organoids in the lab. These organoids can subsequently be transplanted into mice to create the patient&#8208;derived organoids&#8208;based xenograft (PDOX).</p><fig position="float" fig-type="FIGURE" id="ame270028-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Patient&#8208;derived xenograft models.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-11" orientation="portrait" xlink:href="AME2-8-1229-g003.jpg"/></fig><sec id="ame270028-sec-0069"><title>Phenotypes</title><p>PDX models consistently mimic primary tumors, particularly in tissue structure, differentiation level, and marker expression. They exhibit similar growth patterns, such as acinar and solid forms, and express markers like TTF&#8208;1 and Ki&#8208;67.<xref rid="ame270028-bib-0161" ref-type="bibr">
<sup>161</sup>
</xref>, <xref rid="ame270028-bib-0162" ref-type="bibr">
<sup>162</sup>
</xref> Furthermore, PDX models preserve essential drivers of primary tumors, including EGFR, ALK, and KRAS, while showing a lower rate of genomic variation during passage.<xref rid="ame270028-bib-0163" ref-type="bibr">
<sup>163</sup>
</xref>, <xref rid="ame270028-bib-0164" ref-type="bibr">
<sup>164</sup>
</xref> They also accurately reproduce the microenvironmental characteristics, angiogenesis, and intercellular interactions of primary tumors, which are crucial for studying tumor biology. PDOX, when combined with circulating tumor cells (CTCs), can be used to study how CTC clusters relate to organs during tumor metastasis.</p></sec><sec id="ame270028-sec-0070"><title>Applicabilities and limitations</title><p>The PDX model preserves the original tumor's genomic features, mechanisms of drug resistance, and sensitivity to drugs. This allows it to more truly reflect the biology of a patient's tumor and the response to treatment. Additionally, the PDX model is useful for studying metastasis, drug resistance, and tumor stem cells. It can also be used to screen for treatment options tailored to individual patients. However, constructing the PDX model is time&#8208;consuming and costly, and the primary tumor's heterogeneity can affect transplantation success rates.<xref rid="ame270028-bib-0165" ref-type="bibr">
<sup>165</sup>
</xref> To enhance the simulation of the primary tumor's characteristics, comprehensive sampling is essential.<xref rid="ame270028-bib-0166" ref-type="bibr">
<sup>166</sup>
</xref> Mouse stroma can influence tumor behavior, and angiogenesis depends on mouse endothelial cells. This dependence complicates the realistic simulation of responses to immunotherapies, including immune checkpoint inhibitors. During tumor growth, murine&#8208;derived fibroblasts and blood vessels gradually replace human matrix, which may affect drug permeability and microenvironment interactions.<xref rid="ame270028-bib-0167" ref-type="bibr">
<sup>167</sup>
</xref>, <xref rid="ame270028-bib-0168" ref-type="bibr">
<sup>168</sup>
</xref> The PDX models demonstrate their&#160;potential in drug screening.<xref rid="ame270028-bib-0164" ref-type="bibr">
<sup>164</sup>
</xref>
</p></sec></sec><sec id="ame270028-sec-0071"><label>3.5.2</label><title>Cell line derived xenotransplantation models (<styled-content style="fixed-case" toggle="no">CDX</styled-content>)</title><p>This model enables experimental studies by cultivating either human or mouse lung cancer cell lines (Figure&#160;<xref rid="ame270028-fig-0006" ref-type="fig">6</xref>). Cells are prompted to develop lung cancer through either orthotopic transplantation or ectopic inoculation in animals. Lung cancer cell lines can be categorized into two types: small cell lung cancer and non&#8208;small cell lung cancer (Table&#160;<xref rid="ame270028-tbl-0001" ref-type="table">1</xref>). Human lung cancer cell lines are often implanted into nude mice, severely immunodeficient mice, or genetically engineered mice.</p><fig position="float" fig-type="FIGURE" id="ame270028-fig-0006" orientation="portrait"><label>FIGURE 6</label><caption><p>Cell line&#8208;derived xenotransplantation models.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-13" orientation="portrait" xlink:href="AME2-8-1229-g005.jpg"/></fig><sec id="ame270028-sec-0072"><title>Phenotypes</title><p>Lung cancer cell lines vary in genomic characteristics and phenotypes. Small cell lung cancer cell line NCI&#8208;H446 cells are characterized by PTEN deletion and TP53 inactivation.<xref rid="ame270028-bib-0169" ref-type="bibr">
<sup>169</sup>
</xref>, <xref rid="ame270028-bib-0170" ref-type="bibr">
<sup>170</sup>
</xref> BCL&#8208;2 is highly expressed in NCI&#8208;H209 cells and is often used to evaluate the efficacy of BCL&#8208;2 inhibitors.<xref rid="ame270028-bib-0171" ref-type="bibr">
<sup>171</sup>
</xref>, <xref rid="ame270028-bib-0172" ref-type="bibr">
<sup>172</sup>
</xref> NCI&#8208;H82 cells are suitable for constructing genetic engineering models because of MYC amplification.<xref rid="ame270028-bib-0173" ref-type="bibr">
<sup>173</sup>
</xref>, <xref rid="ame270028-bib-0174" ref-type="bibr">
<sup>174</sup>
</xref> DMS&#8208;114 cells, which exhibit a high tumorigenic rate and double deletion of TP53 and RB1, are ideal for studying the transformation mechanisms of SCLC subtypes.<xref rid="ame270028-bib-0175" ref-type="bibr">
<sup>175</sup>
</xref> NCI&#8208;H1688 and A549 cells are sensitive to radiotherapy.<xref rid="ame270028-bib-0176" ref-type="bibr">
<sup>176</sup>
</xref>, <xref rid="ame270028-bib-0177" ref-type="bibr">
<sup>177</sup>
</xref>, <xref rid="ame270028-bib-0178" ref-type="bibr">
<sup>178</sup>
</xref>, <xref rid="ame270028-bib-0179" ref-type="bibr">
<sup>179</sup>
</xref> Calu&#8208;3 cells are characterized by high expression of EGFR and amplification of HER2, and are often used to evaluate the efficacy of antibody&#8208;coupled drugs.<xref rid="ame270028-bib-0180" ref-type="bibr">
<sup>180</sup>
</xref>, <xref rid="ame270028-bib-0181" ref-type="bibr">
<sup>181</sup>
</xref> EGFR mutations in HCC827, NCI&#8208;H1650, and PC&#8208;9 cells are useful for studying EGFR mutation&#8208;related lung cancer.<xref rid="ame270028-bib-0182" ref-type="bibr">
<sup>182</sup>
</xref>, <xref rid="ame270028-bib-0183" ref-type="bibr">
<sup>183</sup>
</xref>, <xref rid="ame270028-bib-0184" ref-type="bibr">
<sup>184</sup>
</xref>, <xref rid="ame270028-bib-0185" ref-type="bibr">
<sup>185</sup>
</xref> Kras mutations in NCI&#8208;H23, NCI&#8208;H358 and NCI&#8208;H460 cells are suitable for screening Kras targeted drugs.<xref rid="ame270028-bib-0184" ref-type="bibr">
<sup>184</sup>
</xref>, <xref rid="ame270028-bib-0186" ref-type="bibr">
<sup>186</sup>
</xref>, <xref rid="ame270028-bib-0187" ref-type="bibr">
<sup>187</sup>
</xref>, <xref rid="ame270028-bib-0188" ref-type="bibr">
<sup>188</sup>
</xref>, <xref rid="ame270028-bib-0189" ref-type="bibr">
<sup>189</sup>
</xref> LLC frequently express pro&#8208;angiogenic factors like MMP9 and VEGF, making them suitable for studying the EMT mechanisms in lung cancer.<xref rid="ame270028-bib-0190" ref-type="bibr">
<sup>190</sup>
</xref>, <xref rid="ame270028-bib-0191" ref-type="bibr">
<sup>191</sup>
</xref>, <xref rid="ame270028-bib-0192" ref-type="bibr">
<sup>192</sup>
</xref> TC&#8208;1 cells, after co&#8208;transfection with HPV16 E6 and E7 genes and the ras gene, acquire tumorigenic properties.<xref rid="ame270028-bib-0193" ref-type="bibr">
<sup>193</sup>
</xref> TC&#8208;1 and SK&#8208;MES&#8208;1 cells are suitable for evaluating immunotherapy.<xref rid="ame270028-bib-0194" ref-type="bibr">
<sup>194</sup>
</xref>, <xref rid="ame270028-bib-0195" ref-type="bibr">
<sup>195</sup>
</xref>
</p></sec><sec id="ame270028-sec-0073"><title>Applicabilities and limitations</title><p>Cell transplant&#8208;induced lung cancer models are reproducible and straightforward to use. Researchers can manipulate the cells in controlled conditions to observe their responses to various drugs. This model has been widely used in drug screening, gene function studies, and mechanistic studies. Through gene editing and transfection of cell lines, researchers explored the roles of specific genes in lung cancer development. In addition, tumor cell lines also provide an important platform for studying tumor microenvironment, cell&#8211;cell interactions, and immune escape mechanisms. However, the genomic and transcriptomic profiles of cell lines significantly differ from those of primary tumors, potentially impacting drug response predictions.</p></sec></sec><sec id="ame270028-sec-0074"><label>3.5.3</label><title>Xenotransplantation models derived from circulating tumor cells (<styled-content style="fixed-case" toggle="no">CTCs</styled-content>)</title><p>In this model, CTCs were isolated from the peripheral blood of lung cancer patients. Cells with high purity and activity were selected and transplanted into highly immunodeficient mice after proper identification and enrichment.<xref rid="ame270028-bib-0196" ref-type="bibr">
<sup>196</sup>
</xref> Subsequently, CTCs are labeled with fluorescence or bioluminescence to track the transfer process in real time (Figure&#160;<xref rid="ame270028-fig-0007" ref-type="fig">7</xref>).</p><fig position="float" fig-type="FIGURE" id="ame270028-fig-0007" orientation="portrait"><label>FIGURE 7</label><caption><p>Xenotransplantation models derived from circulating tumor cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-15" orientation="portrait" xlink:href="AME2-8-1229-g006.jpg"/></fig><sec id="ame270028-sec-0075"><title>Phenotypes</title><p>Models created from CTCs isolated from patients with either chemotherapy&#8208;sensitive or drug&#8208;resistant small cell lung cancer (SCLC) can develop palpable tumors at the injection site. In some cases, micro&#8208;metastases are also detectable, indicating that the CTCs retain their ability to proliferate. Notably, tumor growth can be observed within 4&#8201;months following transplantation.<xref rid="ame270028-bib-0197" ref-type="bibr">
<sup>197</sup>
</xref> CTCs growth in animals mimics the lung cancer microenvironment, showcasing features such as angiogenesis, cell&#8211;cell interactions, and immune cell infiltration. Metastases resemble the primary tumor but may display lower levels of differentiation.<xref rid="ame270028-bib-0198" ref-type="bibr">
<sup>198</sup>
</xref> The CTCs model exhibited activation of the PI3K/AKT pathway while maintaining ALK fusion, TP53 mutation, EGFR T790M, and high expression of metastasis&#8208;related genes, including MMP9 and VEGF.</p></sec><sec id="ame270028-sec-0076"><title>Applicabilities and limitations</title><p>The lung cancer model created from CTCs closely resembles the primary tumor in histology. Additionally, CTCs represent aggressive tumor subgroups with high metastatic potential. This model is more likely to develop multi&#8208;organ metastases, making it suitable for studying metastasis mechanisms. Proliferating CTCs after transplantation may indicate the evolution of drug&#8208;resistant clones under treatment pressure.<xref rid="ame270028-bib-0199" ref-type="bibr">
<sup>199</sup>
</xref> Researchers can directly investigate hematogenous metastasis, organ colonization, and the development of drug resistance. CTCs cloning changes were tracked by liquid biopsy to guide treatment strategy adjustment, and models were constructed using patient CTCs to predict metastasis risk and drug sensitivity. However, the limited number of CTCs and the complex separation and enrichment processes require high&#8208;precision equipment and technical support. This increases the costs of model construction and maintenance and prolongs the experimental period.</p></sec></sec></sec></sec><sec id="ame270028-sec-0077"><label>4</label><title>GENETICALLY ENGINEERED MOUSE MODELS (<styled-content style="fixed-case" toggle="no">GEMMs</styled-content>)</title><p>This model utilizes CRISPR/Cas9 gene editing or transgenic technology to deliver sgRNAs and Cre recombinase into mice using adenovirus or AAV vectors (Figure&#160;<xref rid="ame270028-fig-0008" ref-type="fig">8</xref>). This process facilitates specific gene knockout or activation in the mouse genome, leading to the development of genetically engineered mouse models. Additionally, a mouse lung cancer model was created through orthotopic transplantation and tail vein injection, followed by the transplantation of tumor tissue to a new host.<xref rid="ame270028-bib-0200" ref-type="bibr">
<sup>200</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="ame270028-fig-0008" orientation="portrait"><label>FIGURE 8</label><caption><p>Genetically engineered mouse models.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-17" orientation="portrait" xlink:href="AME2-8-1229-g007.jpg"/></fig><sec id="ame270028-sec-0078"><label>4.1</label><title>Phenotypes</title><p>The tumor tissue in the model closely resembles the original tumor morphology, exhibiting features such as cell atypia, tissue structure, and aggressiveness. The AAV&#8208;Cre virus&#8208;induced Kras&#8208;LSL&#8208;G12D model allows for significant lung tumor formation to occur within 3&#8201;months.<xref rid="ame270028-bib-0201" ref-type="bibr">
<sup>201</sup>
</xref> The genetically engineered mouse model retains the mutational features of the original tumor, including KRAS and TP53, along with the corresponding phenotypic features. The Stk11/EGFP/KRAS&#8208;LSL&#8208;G12D model preserves the features of the KRAS mutant gene and STK11 protein deletion, making it useful for studying the multi&#8208;gene driving mechanisms of tumors.<xref rid="ame270028-bib-0202" ref-type="bibr">
<sup>202</sup>
</xref> Retaining these features makes the model valuable for investigating the genetic driving mechanisms of tumors and developing targeted therapies. This model was able to simulate the metastatic capacity of the original tumor, including transmission through the blood circulation and colonization in the lung.<xref rid="ame270028-bib-0203" ref-type="bibr">
<sup>203</sup>
</xref> PC&#8208;Cre transgenic mouse models can specifically induce mutations in Kras or EGFR in alveolar cells to trigger the development of lung cancer, and better simulate the microenvironment and tumor heterogeneity of human lung cancer.</p></sec><sec id="ame270028-sec-0079"><label>4.2</label><title>Applicabilities and limitations</title><p>GEMM can simulate the development of lung cancer caused by specific gene mutations, including Kras, TP53, and EGFR, and closely matches the genetic features of human lung cancer. The tumors in the model show histopathological similarities in cell atypia, tissue structure, and aggressiveness compared to human lung cancer. Gene modification through the introduction of various genes is valuable for studying the pathogenesis, metastasis, and drug resistance mechanisms of lung cancer, as well as for evaluating the efficacy of targeted therapies like EGFR and KRAS inhibitors. GEMM also preserves the host's immune system. It can be used to study the regulatory mechanisms of the tumor immune microenvironment, including immune cell infiltration, immune escape, and angiogenesis.<xref rid="ame270028-bib-0204" ref-type="bibr">
<sup>204</sup>
</xref> However, transitioning from building the model to tumorigenesis can be time&#8208;consuming and requires specialized gene editing techniques, such as CRISPR/Cas9 and Cre&#8208;LoxP systems, along with complex genetic manipulation. In some therapeutic contexts, GEMM may not only fail to inhibit tumors but also disrupt the function of normal cells.<xref rid="ame270028-bib-0205" ref-type="bibr">
<sup>205</sup>
</xref>
</p></sec></sec><sec sec-type="conclusions" id="ame270028-sec-0080"><label>5</label><title>CONCLUSION</title><p>Animal models of lung cancer play an important role in lung cancer research. These models allow researchers to simulate the development of human lung cancer. They also help evaluate drug efficacy and explore new treatment methods. Chemically induced models create lung cancer using specific chemicals (such as tobacco smoke, ethyl carbamate, and benzopyrene). These models effectively simulate tumor development and are suitable for studying tumorigenesis and evaluating new drugs (Table&#160;<xref rid="ame270028-tbl-0002" ref-type="table">2</xref>). The orthotopic transplantation model directly implants lung cancer cells into animals. This method accurately reflects tumor growth and metastasis in their natural microenvironment, providing a solid foundation for drug screening and treatment research. The ectopic transplantation model involves transplanting lung cancer cells or tumor tissue into non&#8208;lung tissue. This creates a controlled environment for studying tumor growth and metastasis, making it useful for evaluating new drug efficacy. The lung metastasis model has been used to investigate the impact of different injection routes, specifically the caudal vein, left ventricle, and internal carotid artery, on tumor cell metastasis, revealing significant effects on both the rate and location of metastasis. Lung metastasis models for melanoma, kidney, breast, and liver cancers are typically created using either caudal vein injection or orthotopic transplantation. These methods effectively simulate the spread of tumor cells to the lungs. Different models differ in their metastasis rates, tumor formation rates, and operational complexities. Caudal vein injection is a straightforward method that is well suited for large&#8208;scale experiments, but it does not include a primary site. Alternatively, orthotopic transplantation provides a more accurate simulation of the natural metastasis process and is more appropriate for mechanism research and drug screening. Lung cancer modeling can be conducted using patient&#8208;derived xenografts (PDX), genetically engineered mouse models (GEMM), and cell line transplantation models. The PDX model maintains the genomic features of the primary tumor, making it suitable for personalized treatment. GEMM simulates lung cancer caused by specific gene mutations. This model is ideal for investigating genetic mechanisms and targeted therapies. The cell line transplantation model is highly reproducible and commonly used for drug screening and mechanism research. However, its genomic characteristics differ significantly from those of primary tumors. The circulating tumor cell model is particularly useful for studying the mechanisms of metastasis, although it requires invasive procedures to obtain samples.</p><table-wrap position="float" id="ame270028-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Cell strains of lung cancer.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Source</th><th align="left" valign="bottom" rowspan="1" colspan="1">Types of lung cancer</th><th align="left" valign="bottom" rowspan="1" colspan="1">Cell Strain</th><th align="left" valign="bottom" rowspan="1" colspan="1">Methods</th><th align="left" valign="bottom" rowspan="1" colspan="1">Phenotypes</th><th align="left" valign="bottom" rowspan="1" colspan="1">Application</th><th align="left" valign="bottom" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="17" valign="top" colspan="1">Human</td><td align="left" rowspan="5" valign="top" colspan="1">SCLC</td><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H446</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;&#215;&#8201;10<sup>6</sup> cells in 0.1&#8201;mL of PBS mixed with Matrige (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">TP53 inactivation, PTEN deletion, typical neuroendocrine markers (Synaptophysin+, CD56+)</td><td align="left" valign="top" rowspan="1" colspan="1">Sensitivity tests for topoisomerase inhibitors such as irinotecan</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0169" ref-type="bibr">169</xref>, <xref rid="ame270028-bib-0170" ref-type="bibr">170</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H209</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>7</sup> cells/mL in 1:1 ratio of PBS mixed with Matrige (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">It carries high expression of BCL&#8208;2 and is sensitive to apoptosis inducers</td><td align="left" valign="top" rowspan="1" colspan="1">Apoptosis pathway and drug screening targeting BCL&#8208;2</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0171" ref-type="bibr">171</xref>, <xref rid="ame270028-bib-0172" ref-type="bibr">172</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H82</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>5</sup> cells in 300&#8201;&#956;L containing serum&#8208;free RPMI&#8208;1640 and 300&#8201;&#956;L Matrigel (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">Suspension growth, MYC amplification, Etoposide resistance</td><td align="left" valign="top" rowspan="1" colspan="1">Because of MYC amplification, NCI&#8208;H82 is suitable for CRISPR screening research, drug resistance mechanism and MYC targeted therapy research</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0173" ref-type="bibr">173</xref>, <xref rid="ame270028-bib-0174" ref-type="bibr">174</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DMS&#8208;114</td><td align="left" valign="top" rowspan="1" colspan="1">3&#8201;&#215;&#8201;10<sup>6</sup> cells in 250&#8201;&#956;L of PBS (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">Adherent growth, TP53/RB1 double deletion, Low expression of neuroendocrine markers</td><td align="left" valign="top" rowspan="1" colspan="1">Study on the transformation mechanism of SCLC subtype with high tumor formation rate</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0175" ref-type="bibr">175</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H1688</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> cells/mL (i.t.)</td><td align="left" valign="top" rowspan="1" colspan="1">Homozygous loss of Rb1 gene, neuroendocrine differentiation, sensitivity to radiotherapy (G2/M phase block after irradiation is significant)</td><td align="left" valign="top" rowspan="1" colspan="1">DNA damage repair mechanism and radiotherapy sensitization strategy</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0176" ref-type="bibr">176</xref>, <xref rid="ame270028-bib-0177" ref-type="bibr">177</xref>]</td></tr><tr><td align="left" rowspan="12" valign="top" colspan="1">NSCLC</td><td align="left" valign="top" rowspan="1" colspan="1">A549</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> to 1&#8201;&#215;&#8201;10<sup>7</sup> cells/mL (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">Adherent growth, moderate sensitivity to cisplatin, KRAS G12S mutation, TP53 wild type</td><td align="left" valign="top" rowspan="1" colspan="1">Chemotherapy sensitivity, EMT mechanism, KRAS signaling pathway study, subcutaneous tumor formation rate is high</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0178" ref-type="bibr">178</xref>, <xref rid="ame270028-bib-0179" ref-type="bibr">179</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Calu&#8208;3</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;&#215;&#8201;10<sup>5</sup> to 5&#8201;&#215;&#8201;10<sup>6</sup> cells/mouse (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">EGFR was highly expressed and HER2 was amplified</td><td align="left" valign="top" rowspan="1" colspan="1">Evaluation of the efficacy of antibody&#8208;coupling drugs such as T&#8208;DM1</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0180" ref-type="bibr">180</xref>, <xref rid="ame270028-bib-0181" ref-type="bibr">181</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HCC827</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>7</sup> cells/mouse (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">EGFR exon19 deletion, Sensitive to EGFR&#8208;TKI, Used to study EGFR mutation&#8208;associated lung cancer</td><td align="left" valign="top" rowspan="1" colspan="1">It is often used to study EGFR mutation&#8208;associated lung cancer, EGFR&#8208;TKI (gefitinib/ocitinib) sensitivity and mechanism of resistance</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0182" ref-type="bibr">182</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H1299</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> cells/mouse (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">Deletion of p53 gene</td><td align="left" valign="top" rowspan="1" colspan="1">Research on apoptosis mechanisms (e.g. screening of BCL&#8208;2 inhibitors)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0206" ref-type="bibr">206</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H1650</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;&#215;&#8201;10<sup>6</sup> cells in 100&#8201;&#956;L of PBS (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">EGFR exon19 deletion, PTEN deletion, High expression of interstitial markers, Primary resistance to EGFR&#8208;TKI (gefitinib)</td><td align="left" valign="top" rowspan="1" colspan="1">Correlation analysis of EMT (epithelial&#8208;mesenchymal transformation) and targeted therapy, mechanism study of GFR&#8208;TKI resistance (PTEN deletion /MET amplification mediated bypass activation)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0183" ref-type="bibr">183</xref>, <xref rid="ame270028-bib-0184" ref-type="bibr">184</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H1975</td><td align="left" valign="top" rowspan="1" colspan="1">2&#8201;&#215;&#8201;10<sup>6</sup> cells in 0.2&#8201;mL of PBS mixed with 0.2&#8201;mL Matrige (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">EGFR L858R&#8201;+&#8201;T790M double mutation, Constitutive activation of PI3K/AKT pathway (high AKT phosphorylation level), Sensitive to ocitinib (third generation EGFR&#8208;TKI)</td><td align="left" valign="top" rowspan="1" colspan="1">Study on the efficacy and resistance mechanism of the third generation EGFR&#8208;TKI (such as ocitinib)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0185" ref-type="bibr">185</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H23</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;&#215;&#8201;10<sup>6</sup> cells in 100&#8201;&#956;L PBS (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">KRAS mutation</td><td align="left" valign="top" rowspan="1" colspan="1">Evaluation of the efficacy of Pachymic acid</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0186" ref-type="bibr">186</xref>, <xref rid="ame270028-bib-0187" ref-type="bibr">187</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H358</td><td align="left" valign="top" rowspan="1" colspan="1">8&#8201;&#215;&#8201;10<sup>6</sup> to 2&#8201;&#215;&#8201;10<sup>7</sup> cells in 200&#8201;&#956;L of PBS (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">KRAS mutation</td><td align="left" valign="top" rowspan="1" colspan="1">Studies of KRAS G12C&#8208;specific inhibitors such as Sotorasib</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0184" ref-type="bibr">184</xref>, <xref rid="ame270028-bib-0188" ref-type="bibr">188</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H460</td><td align="left" valign="top" rowspan="1" colspan="1">4&#8201;&#215;&#8201;10<sup>6</sup> cells/mL (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">KRAS mutation, Sensitive to mTOR inhibitors</td><td align="left" valign="top" rowspan="1" colspan="1">Studies of metabolic reprogramming (e.g., glutamine dependence) have shown a strong propensity to transfer</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0189" ref-type="bibr">189</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI&#8208;H1975</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> cells in 0.1&#8201;mL PBS (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">EGFR L858R&#8201;+&#8201;T790M double mutation</td><td align="left" valign="top" rowspan="1" colspan="1">Validation of the efficacy of third generation EGFR&#8208;TKI (oxitinib)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0162" ref-type="bibr">162</xref>, <xref rid="ame270028-bib-0207" ref-type="bibr">207</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PC&#8208;9</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> cells in 200&#8201;&#956;L of PBS (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">Expression of EGFR mutation (exon 19 deletion)</td><td align="left" valign="top" rowspan="1" colspan="1">Construction of acquired drug resistance model of T790M</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0208" ref-type="bibr">208</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SK&#8208;MES&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">2&#8201;&#215;&#8201;10<sup>6</sup> cells/mL (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">Expression of PD&#8208;L1</td><td align="left" valign="top" rowspan="1" colspan="1">Regulation of immune checkpoint (PD&#8208;L1) expression</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0194" ref-type="bibr">194</xref>]</td></tr><tr><td align="left" rowspan="3" valign="top" colspan="1">Mouse</td><td align="left" rowspan="2" valign="top" colspan="1">NSCLC</td><td align="left" valign="top" rowspan="1" colspan="1">Lewis Lung Carcinoma (LLC)</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;&#215;&#8201;10<sup>6</sup> to 2&#8201;&#215;&#8201;10<sup>7</sup> cells/mL (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">Expression of VEGF, MMP&#8208;9 and other pro&#8208;angiogenic factors, Sensitive to methotrexate</td><td align="left" valign="top" rowspan="1" colspan="1">Chemotherapy drugs (such as cisplatin), anti&#8208;angiogenesis, metastasis mechanism treatment</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0190" ref-type="bibr">190</xref>, <xref rid="ame270028-bib-0191" ref-type="bibr">191</xref>, <xref rid="ame270028-bib-0192" ref-type="bibr">192</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CMT167</td><td align="left" valign="top" rowspan="1" colspan="1">1&#8201;&#215;&#8201;10<sup>6</sup> cells in 100&#8201;&#956;L of PBS (s.c.)</td><td align="left" valign="top" rowspan="1" colspan="1">Sensitive to MEK inhibitors</td><td align="left" valign="top" rowspan="1" colspan="1">Study on the mechanism of KRAS signaling pathway targeting therapy</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0209" ref-type="bibr">209</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Genetic engineering model</td><td align="left" valign="top" rowspan="1" colspan="1">TC&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">5&#8201;&#215;&#8201;10<sup>5</sup> cells/mouse (IV)</td><td align="left" valign="top" rowspan="1" colspan="1">Expression of HPV16 E7 antigen, Induce immune clearance response</td><td align="left" valign="top" rowspan="1" colspan="1">Used in vaccine research, immunotherapy (such as PD&#8208;1 antibody) efficacy evaluation</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame270028-bib-0195" ref-type="bibr">195</xref>]</td></tr></tbody></table><table-wrap-foot id="ame270028-ntgp-0003"><fn id="ame270028-note-0004"><p>Abbreviations: i.t., intratracheal instillation; IV, tail vein injection; s.c., subcutaneous injection.</p></fn></table-wrap-foot></table-wrap><p>The various animal models described are valuable for studying the biological characteristics and mechanisms of lung cancer, However, these models also have limitations. No single model can represent all the characteristics of human lung cancer, Thus, selecting the right model, which can simulate the clinical manifestations of lung cancer, is vital for understanding lung cancer development and treatment options, and laying the groundwork for future diagnosis and treatment of the disease.<xref rid="ame270028-bib-0210" ref-type="bibr">
<sup>210</sup>
</xref>
</p></sec><sec id="ame270028-sec-0084"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Zixuan Yang:</bold> Conceptualization; data curation; investigation; methodology; project administration; writing &#8211; original draft; writing &#8211; review and editing. <bold>Xianbin Zhao:</bold> Conceptualization; formal analysis; investigation; methodology; visualization; writing &#8211; original draft. <bold>Lili Tan:</bold> Investigation; methodology; validation. <bold>Pingxinyi Que:</bold> Data curation; investigation; methodology. <bold>Tong Zhao:</bold> Investigation; methodology; visualization. <bold>Wei Huang:</bold> Conceptualization; formal analysis; supervision; validation. <bold>Dejiao Yao:</bold> Conceptualization; funding acquisition; writing &#8211; review and editing. <bold>Songqi Tang:</bold> Conceptualization; supervision; visualization; writing &#8211; review and editing.</p></sec><sec id="ame270028-sec-0082"><title>FUNDING INFORMATION</title><p>This work was supported by the National Natural Science Foundation of China (grant number 82474436) and the Sichuan Provincial Administration of Traditional Chinese Medicine (grant number 2023MS564).</p></sec><sec id="ame270028-sec-0085"><title>ETHIC STATEMENT</title><p>This review article is grounded in ethical principles, ensuring the accurate and objective presentation of information. All sources are properly credited, and potential biases are carefully minimized to maintain a fair and transparent exploration of the topic.</p></sec><sec sec-type="COI-statement" id="ame270028-sec-0083"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec></body><back><ack id="ame270028-sec-0081"><title>ACKNOWLEDGMENTS</title><p>Figure support was provided by Figdraw.</p></ack><ref-list content-type="cited-references" id="ame270028-bibl-0001"><title>REFERENCES</title><ref id="ame270028-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ame270028-cit-0001"><string-name name-style="western"><surname>Debnath</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Shahjahan</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Debnath</surname><given-names>MR</given-names></string-name>, et&#160;al. <article-title>Parotid gland metastasis &#8208; an unusual presentation of adenocarcinoma of lung</article-title>. <source>Mymensingh Med J</source>. <year>2015</year>;<volume>24</volume>(<issue>1</issue>):<fpage>175</fpage>&#8208;<lpage>177</lpage>.<pub-id pub-id-type="pmid">25725686</pub-id></mixed-citation></ref><ref id="ame270028-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ame270028-cit-0002"><string-name name-style="western"><surname>Bray</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Laversanne</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sung</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J Clin</source>. <year>2024</year>;<volume>74</volume>(<issue>3</issue>):<fpage>229</fpage>&#8208;<lpage>263</lpage>.<pub-id pub-id-type="pmid">38572751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21834</pub-id></mixed-citation></ref><ref id="ame270028-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ame270028-cit-0003"><string-name name-style="western"><surname>Malhotra</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Malvezzi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Negri</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>La Vecchia</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Boffetta</surname><given-names>P</given-names></string-name>. <article-title>Risk factors for lung cancer worldwide</article-title>. <source>Eur Respir J</source>. <year>2016</year>;<volume>48</volume>(<issue>3</issue>):<fpage>889</fpage>&#8208;<lpage>902</lpage>.<pub-id pub-id-type="pmid">27174888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.00359-2016</pub-id></mixed-citation></ref><ref id="ame270028-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ame270028-cit-0004"><string-name name-style="western"><surname>Nishida</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Yatera</surname><given-names>K</given-names></string-name>. <article-title>The impact of ambient environmental and occupational pollution on respiratory diseases</article-title>. <source>Int J Environ Res Public Health</source>. <year>2022</year>;<volume>19</volume>(<issue>5</issue>):<fpage>2788</fpage>.<pub-id pub-id-type="pmid">35270479</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijerph19052788</pub-id><pub-id pub-id-type="pmcid">PMC8910713</pub-id></mixed-citation></ref><ref id="ame270028-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ame270028-cit-0005"><string-name name-style="western"><surname>Salehiniya</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Bahadori</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ghanizadeh</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Raei</surname><given-names>M</given-names></string-name>. <article-title>Epidemiological study of lung cancer in Iran: a systematic review</article-title>. <source>Iran J Public Health</source>. <year>2022</year>;<volume>51</volume>(<issue>2</issue>):<fpage>306</fpage>&#8208;<lpage>317</lpage>.<pub-id pub-id-type="pmid">35866136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18502/ijph.v51i2.8683</pub-id><pub-id pub-id-type="pmcid">PMC9273489</pub-id></mixed-citation></ref><ref id="ame270028-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ame270028-cit-0006"><string-name name-style="western"><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Upregulated DNMT3a coupling with inhibiting p62&#8208;dependent autophagy contributes to NNK tumorigenicity in human bronchial epithelial cells</article-title>. <source>Ecotoxicol Environ Saf</source>. <year>2024</year>;<volume>286</volume>(<issue>Nov 1</issue>):<fpage>117157</fpage>.<pub-id pub-id-type="pmid">39393198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ecoenv.2024.117157</pub-id></mixed-citation></ref><ref id="ame270028-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ame270028-cit-0007"><string-name name-style="western"><surname>Hartog</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>QY</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>X</given-names></string-name>. <article-title>Role of mouse cytochrome P450 enzymes of the Cyp2abfgs subfamilies in the induction of lung inflammation by cigarette smoke exposure</article-title>. <source>Toxicol Sci</source>. <year>2019</year>;<volume>172</volume>(<issue>1</issue>):<fpage>123</fpage>&#8208;<lpage>131</lpage>.<pub-id pub-id-type="pmid">31388674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfz171</pub-id><pub-id pub-id-type="pmcid">PMC6813748</pub-id></mixed-citation></ref><ref id="ame270028-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ame270028-cit-0008"><string-name name-style="western"><surname>Ali</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Elsayed</surname><given-names>GH</given-names></string-name>, <string-name name-style="western"><surname>Mohamed</surname><given-names>SH</given-names></string-name>, et&#160;al. <article-title>Chia seed (Salvia hispanica) attenuates chemically induced lung carcinomas in rats through suppression of proliferation and angiogenesis</article-title>. <source>Pharmaceuticals (Basel)</source>. <year>2024</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1129</fpage>.<pub-id pub-id-type="pmid">39338293</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ph17091129</pub-id><pub-id pub-id-type="pmcid">PMC11435337</pub-id></mixed-citation></ref><ref id="ame270028-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ame270028-cit-0009"><string-name name-style="western"><surname>Chikara</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mamidi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sreedasyam</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Flaxseed consumption inhibits chemically induced lung tumorigenesis and modulates expression of phase II enzymes and inflammatory cytokines in a/J mice</article-title>. <source>Cancer Prev Res (Phila)</source>. <year>2018</year>;<volume>11</volume>(<issue>1</issue>):<fpage>27</fpage>&#8208;<lpage>37</lpage>.<pub-id pub-id-type="pmid">29074535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1940-6207.CAPR-17-0119</pub-id><pub-id pub-id-type="pmcid">PMC5754250</pub-id></mixed-citation></ref><ref id="ame270028-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ame270028-cit-0010"><string-name name-style="western"><surname>Sonkar</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Verma</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Yadav</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Antiproliferative, apoptotic and anti&#8208;inflammatory potential of 5H&#8208;benzo[h]thiazolo[2,3&#8208;b]quinazoline analogues: novel series of anticancer compounds</article-title>. <source>Int Immunopharmacol</source>. <year>2024</year>;<volume>137</volume>:<elocation-id>112496</elocation-id>.<pub-id pub-id-type="pmid">38901240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2024.112496</pub-id></mixed-citation></ref><ref id="ame270028-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ame270028-cit-0011"><string-name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Qin</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Qian</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>FFAR2 expressing myeloid&#8208;derived suppressor cells drive cancer immunoevasion</article-title>. <source>J Hematol Oncol</source>. <year>2024</year>;<volume>17</volume>(<issue>1</issue>):<fpage>9</fpage>.<pub-id pub-id-type="pmid">38402237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13045-024-01529-6</pub-id><pub-id pub-id-type="pmcid">PMC10894476</pub-id></mixed-citation></ref><ref id="ame270028-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ame270028-cit-0012"><string-name name-style="western"><surname>Benedetti</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Silvestri</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Denaro</surname><given-names>F</given-names></string-name>, et&#160;al. <article-title>Mycoplasma DnaK expression increases cancer development in&#160;vivo upon DNA damage</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2024</year>;<volume>121</volume>(<issue>10</issue>):<elocation-id>e2320859121</elocation-id>.<pub-id pub-id-type="pmid">38412130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2320859121</pub-id><pub-id pub-id-type="pmcid">PMC10927570</pub-id></mixed-citation></ref><ref id="ame270028-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ame270028-cit-0013"><string-name name-style="western"><surname>Fan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Z</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>C</given-names></string-name>. <article-title>BPDE induces apoptosis while melatonin protects in spermatogonial GC&#8208;1 cells</article-title>. <source>J Third Mil Med Univ</source>. <year>2017</year>;<volume>39</volume>(<issue>23</issue>):<fpage>2323</fpage>&#8208;<lpage>2328</lpage>.</mixed-citation></ref><ref id="ame270028-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ame270028-cit-0014"><string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ouyang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mao</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Inhibition of RNF182 mediated by bap promotes non&#8208;small cell lung cancer progression</article-title>. <source>Front Oncol</source>. <year>2023</year>;<volume>12</volume>:<elocation-id>1009508</elocation-id>.<pub-id pub-id-type="pmid">36686776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.1009508</pub-id><pub-id pub-id-type="pmcid">PMC9853554</pub-id></mixed-citation></ref><ref id="ame270028-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="ame270028-cit-0015"><string-name name-style="western"><surname>Thongararm</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Fedeles</surname><given-names>BI</given-names></string-name>, <string-name name-style="western"><surname>Khumsubdee</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Modulation of N&#8208;methyl&#8208;N&#8208;nitrosourea mutagenesis in mouse embryo fibroblasts derived from the gpt Delta mouse by an inhibitor of the O6&#8208;methylguanine methyltransferase, MGMT</article-title>. <source>Chem Res Toxicol</source>. <year>2020</year>;<volume>33</volume>(<issue>2</issue>):<fpage>625</fpage>&#8208;<lpage>633</lpage>.<pub-id pub-id-type="pmid">31841318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.chemrestox.9b00444</pub-id><pub-id pub-id-type="pmcid">PMC7033946</pub-id></mixed-citation></ref><ref id="ame270028-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ame270028-cit-0016"><string-name name-style="western"><surname>Westcott</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Halliwill</surname><given-names>KD</given-names></string-name>, <collab collab-type="authors">To, MD</collab>
, et&#160;al. <article-title>The mutational landscapes of genetic and chemical models of Kras&#8208;driven lung cancer</article-title>. <source>Nature</source>. <year>2015</year>;<volume>517</volume>(<issue>7535</issue>):<fpage>489</fpage>&#8208;<lpage>492</lpage>.<pub-id pub-id-type="pmid">25363767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature13898</pub-id><pub-id pub-id-type="pmcid">PMC4304785</pub-id></mixed-citation></ref><ref id="ame270028-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ame270028-cit-0017"><string-name name-style="western"><surname>Hu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Trans, trans&#8208;2,4&#8208;decadienal impairs vascular endothelial function by inducing oxidative/nitrative stress and apoptosis</article-title>. <source>Redox Biol</source>. <year>2020</year>;<volume>34</volume>:<elocation-id>101577</elocation-id>.<pub-id pub-id-type="pmid">32446174</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.redox.2020.101577</pub-id><pub-id pub-id-type="pmcid">PMC7243189</pub-id></mixed-citation></ref><ref id="ame270028-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ame270028-cit-0018"><string-name name-style="western"><surname>Liu</surname><given-names>WB</given-names></string-name>, <string-name name-style="western"><surname>Ao</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>ZY</given-names></string-name>, et&#160;al. <article-title>CpG Island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3&#8208;methylcholanthrene and diethylnitrosamine</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2010</year>;<volume>402</volume>(<issue>3</issue>):<fpage>507</fpage>&#8208;<lpage>514</lpage>.<pub-id pub-id-type="pmid">20970405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2010.10.061</pub-id></mixed-citation></ref><ref id="ame270028-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ame270028-cit-0019"><string-name name-style="western"><surname>Liu</surname><given-names>WB</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname><given-names>ZH</given-names></string-name>, <string-name name-style="western"><surname>Ao</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Aberrant methylation accounts for cell adhesion&#8208;related gene silencing during 3&#8208;methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2011</year>;<volume>251</volume>(<issue>1</issue>):<fpage>70</fpage>&#8208;<lpage>78</lpage>.<pub-id pub-id-type="pmid">21163286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2010.12.002</pub-id></mixed-citation></ref><ref id="ame270028-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ame270028-cit-0020"><string-name name-style="western"><surname>Liu</surname><given-names>WB</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Ao</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Epigenetic silencing of cell cycle regulatory genes during 3&#8208;methylcholanthrene and diethylnitrosamine&#8208;induced multistep rat lung cancer</article-title>. <source>Mol Carcinog</source>. <year>2010</year>;<volume>49</volume>(<issue>6</issue>):<fpage>556</fpage>&#8208;<lpage>565</lpage>.<pub-id pub-id-type="pmid">20512841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mc.20621</pub-id></mixed-citation></ref><ref id="ame270028-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ame270028-cit-0021"><string-name name-style="western"><surname>Liu</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>Lipopolysaccharide&#8208;mediated chronic inflammation promotes tobacco carcinogen&#8208;induced lung cancer and determines the efficacy of immunotherapy</article-title>. <source>Cancer Res</source>. <year>2021</year>;<volume>81</volume>(<issue>1</issue>):<fpage>144</fpage>&#8208;<lpage>157</lpage>.<pub-id pub-id-type="pmid">33122306</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-20-1994</pub-id><pub-id pub-id-type="pmcid">PMC7878420</pub-id></mixed-citation></ref><ref id="ame270028-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ame270028-cit-0022"><string-name name-style="western"><surname>Gao</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Is NLRP3 or NLRP6 inflammasome activation associated with inflammation&#8208;related lung tumorigenesis induced by benzo(a)pyrene and lipopolysaccharide?</article-title><source>Ecotoxicol Environ Saf</source>. <year>2019</year>;<volume>185</volume>:<elocation-id>109687</elocation-id>.<pub-id pub-id-type="pmid">31561077</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ecoenv.2019.109687</pub-id></mixed-citation></ref><ref id="ame270028-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ame270028-cit-0023"><string-name name-style="western"><surname>Gu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Qu</surname><given-names>J</given-names></string-name>. <article-title>A comparison between lung carcinoma and a subcutaneous malignant tumor induced in rats by a 3,4&#8208;benzopyrene injection</article-title>. <source>Int J Clin Exp Pathol</source>. <year>2018</year>;<volume>11</volume>(<issue>8</issue>):<fpage>3934</fpage>&#8208;<lpage>3942</lpage>.<pub-id pub-id-type="pmid">31949781</pub-id><pub-id pub-id-type="pmcid">PMC6962791</pub-id></mixed-citation></ref><ref id="ame270028-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="ame270028-cit-0024"><string-name name-style="western"><surname>Su</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>MX</given-names></string-name>, et&#160;al. <article-title>The Tian&#8208;men&#8208;Dong decoction suppresses the tumour&#8208;infiltrating G&#8208;MDSCs via IL&#8208;1&#946;&#8208;mediated signalling in lung cancer</article-title>. <source>J Ethnopharmacol</source>. <year>2023</year>;<volume>313</volume>:<elocation-id>116491</elocation-id>.<pub-id pub-id-type="pmid">37072091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2023.116491</pub-id></mixed-citation></ref><ref id="ame270028-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="ame270028-cit-0025"><string-name name-style="western"><surname>Tanaka</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Yoshinouchi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Karouji</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology</article-title>. <source>FEBS Open Bio</source>. <year>2023</year>;<volume>13</volume>(<issue>1</issue>):<fpage>51</fpage>&#8208;<lpage>59</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/2211-5463.13486</pub-id><pub-id pub-id-type="pmcid">PMC9810119</pub-id><pub-id pub-id-type="pmid">36102619</pub-id></mixed-citation></ref><ref id="ame270028-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="ame270028-cit-0026"><string-name name-style="western"><surname>Park</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Yoon</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Particulate matter promotes cancer metastasis through increased HBEGF expression in macrophages</article-title>. <source>Exp Mol Med</source>. <year>2022</year>;<volume>54</volume>(<issue>11</issue>):<fpage>1901</fpage>&#8208;<lpage>1912</lpage>.<pub-id pub-id-type="pmid">36352257</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s12276-022-00886-x</pub-id><pub-id pub-id-type="pmcid">PMC9722902</pub-id></mixed-citation></ref><ref id="ame270028-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="ame270028-cit-0027"><string-name name-style="western"><surname>Mottaghitalab</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Kiani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Farokhi</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Targeted delivery system based on gemcitabine&#8208;loaded silk fibroin nanoparticles for lung cancer therapy</article-title>. <source>ACS Appl Mater Interfaces</source>. <year>2017</year>;<volume>9</volume>(<issue>37</issue>):<fpage>31600</fpage>&#8208;<lpage>31611</lpage>.<pub-id pub-id-type="pmid">28836425</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsami.7b10408</pub-id></mixed-citation></ref><ref id="ame270028-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="ame270028-cit-0028"><string-name name-style="western"><surname>Lin</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>PPAR&#8208;&#947;/NF&#8208;kB/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL&#8208;6</article-title>. <source>Cell Death Dis</source>. <year>2024</year>;<volume>15</volume>(<issue>7</issue>):<fpage>532</fpage>.<pub-id pub-id-type="pmid">39060229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-024-06919-9</pub-id><pub-id pub-id-type="pmcid">PMC11282095</pub-id></mixed-citation></ref><ref id="ame270028-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="ame270028-cit-0029"><string-name name-style="western"><surname>Yin</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Predicting the mechanism of action of YQYYJD prescription in the treatment of non&#8208;small cell lung cancer using transcriptomics analysis</article-title>. <source>J Ethnopharmacol</source>. <year>2024</year>;<volume>326</volume>:<elocation-id>117984</elocation-id>.<pub-id pub-id-type="pmid">38428661</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2024.117984</pub-id></mixed-citation></ref><ref id="ame270028-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="ame270028-cit-0030"><string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>Influence of the vaccinating density of A549 cells on tumorigenesis and distant organ metastasis in a lung cancer mice model</article-title>. <source>Cell Mol Biol (Noisy&#8208;le&#8208;Grand)</source>. <year>2018</year>;<volume>64</volume>(<issue>6</issue>):<fpage>53</fpage>&#8208;<lpage>57</lpage>.<pub-id pub-id-type="pmid">29808801</pub-id></mixed-citation></ref><ref id="ame270028-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="ame270028-cit-0031"><string-name name-style="western"><surname>Tang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Pan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>. <article-title>Expression of GOLPH3 in patients with non&#8208;small cell lung cancer and xenografts models</article-title>. <source>Oncol Lett</source>. <year>2018</year>;<volume>15</volume>(<issue>5</issue>):<fpage>7555</fpage>&#8208;<lpage>7562</lpage>.<pub-id pub-id-type="pmid">29849795</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/ol.2018.8340</pub-id><pub-id pub-id-type="pmcid">PMC5962867</pub-id></mixed-citation></ref><ref id="ame270028-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="ame270028-cit-0032"><string-name name-style="western"><surname>Russo</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Faversani</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gatti</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>A new mouse avatar model of non&#8208;small cell lung cancer</article-title>. <source>Front Oncol</source>. <year>2015</year>;<volume>5</volume>:<elocation-id>52</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fonc.2015.00052</pub-id><pub-id pub-id-type="pmid">25785245</pub-id><pub-id pub-id-type="pmcid">PMC4347595</pub-id></mixed-citation></ref><ref id="ame270028-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="ame270028-cit-0033"><string-name name-style="western"><surname>Shrestha</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Lateef</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Martey</surname><given-names>O</given-names></string-name>, et&#160;al. <article-title>Does the mouse tail vein injection method provide a good model of lung cancer?</article-title><source>F1000Res</source>. <year>2019</year>;<volume>8</volume>:<fpage>190</fpage>.<pub-id pub-id-type="pmid">31448098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12688/f1000research.17964.1</pub-id><pub-id pub-id-type="pmcid">PMC6668049</pub-id></mixed-citation></ref><ref id="ame270028-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="ame270028-cit-0034"><string-name name-style="western"><surname>Cheng</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ji</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>J</given-names></string-name>. <article-title>TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS&#8208;STING signalling pathway</article-title>. <source>BMC Cancer</source>. <year>2023</year>;<volume>23</volume>(<issue>1</issue>):<fpage>825</fpage>.<pub-id pub-id-type="pmid">37667220</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-023-11343-x</pub-id><pub-id pub-id-type="pmcid">PMC10478367</pub-id></mixed-citation></ref><ref id="ame270028-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="ame270028-cit-0035"><string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Lei</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Bone&#8208;metastatic lung adenocarcinoma cells bearing CD74&#8208;ROS1 fusion interact with macrophages to promote their dissemination</article-title>. <source>Oncogene</source>. <year>2024</year>;<volume>43</volume>(<issue>28</issue>):<fpage>2215</fpage>&#8208;<lpage>2227</lpage>.<pub-id pub-id-type="pmid">38802647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41388-024-03072-7</pub-id></mixed-citation></ref><ref id="ame270028-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="ame270028-cit-0036"><string-name name-style="western"><surname>Zhang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ying</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Jin</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>GAP43, a novel metastasis promoter in non&#8208;small cell lung cancer</article-title>. <source>J Transl Med</source>. <year>2018</year>;<volume>16</volume>(<issue>1</issue>):<fpage>310</fpage>.<pub-id pub-id-type="pmid">30419922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-018-1682-5</pub-id><pub-id pub-id-type="pmcid">PMC6233536</pub-id></mixed-citation></ref><ref id="ame270028-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="ame270028-cit-0037"><string-name name-style="western"><surname>Masuda</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Morinaga</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wakita</surname><given-names>D</given-names></string-name>, et&#160;al. <article-title>PD&#8208;L1 blockade exhibits anti&#8208;tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion</article-title>. <source>Clin Exp Metastasis</source>. <year>2022</year>;<volume>39</volume>(<issue>2</issue>):<fpage>335</fpage>&#8208;<lpage>344</lpage>.<pub-id pub-id-type="pmid">34797455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10585-021-10135-6</pub-id><pub-id pub-id-type="pmcid">PMC8971192</pub-id></mixed-citation></ref><ref id="ame270028-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="ame270028-cit-0038"><string-name name-style="western"><surname>Lee</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>EJ</given-names></string-name>, et&#160;al. <article-title>Noggin contributes to brain metastatic colonization of lung cancer cells</article-title>. <source>Cancer Cell Int</source>. <year>2023</year>;<volume>23</volume>(<issue>1</issue>):<fpage>299</fpage>.<pub-id pub-id-type="pmid">38012621</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12935-023-03155-7</pub-id><pub-id pub-id-type="pmcid">PMC10683317</pub-id></mixed-citation></ref><ref id="ame270028-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="ame270028-cit-0039"><string-name name-style="western"><surname>Lou</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Q</given-names></string-name>, et&#160;al. <article-title>Molecular mechanism of benzo [a] pyrene regulating lipid metabolism via aryl hydrocarbon receptor</article-title>. <source>Lipids Health Dis</source>. <year>2022</year>;<volume>21</volume>(<issue>1</issue>):<fpage>13</fpage>.<pub-id pub-id-type="pmid">35057794</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12944-022-01627-9</pub-id><pub-id pub-id-type="pmcid">PMC8772151</pub-id></mixed-citation></ref><ref id="ame270028-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="ame270028-cit-0040"><string-name name-style="western"><surname>Sheinin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jeong</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Paidi</surname><given-names>RK</given-names></string-name>, <string-name name-style="western"><surname>Pahan</surname><given-names>K</given-names></string-name>. <article-title>Regression of lung cancer in mice by intranasal administration of SARS&#8208;CoV&#8208;2 spike S1</article-title>. <source>Cancers (Basel)</source>. <year>2022</year>;<volume>14</volume>(<issue>22</issue>):<fpage>5648</fpage>.<pub-id pub-id-type="pmid">36428739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers14225648</pub-id><pub-id pub-id-type="pmcid">PMC9688283</pub-id></mixed-citation></ref><ref id="ame270028-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="ame270028-cit-0041"><string-name name-style="western"><surname>Zhou</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Xiong</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas&#8208;2B cells induced by tobacco carcinogen NNK</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2022</year>;<volume>436</volume>:<elocation-id>115849</elocation-id>.<pub-id pub-id-type="pmid">34974052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2021.115849</pub-id></mixed-citation></ref><ref id="ame270028-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="ame270028-cit-0042"><string-name name-style="western"><surname>Razani&#8208;Boroujerdi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sopori</surname><given-names>ML</given-names></string-name>. <article-title>Early manifestations of NNK&#8208;induced lung cancer: role of lung immunity in tumor susceptibility</article-title>. <source>Am J Respir Cell Mol Biol</source>. <year>2007</year>;<volume>36</volume>(<issue>1</issue>):<fpage>13</fpage>&#8208;<lpage>19</lpage>.<pub-id pub-id-type="pmid">16873770</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2005-0330OC</pub-id><pub-id pub-id-type="pmcid">PMC1899301</pub-id></mixed-citation></ref><ref id="ame270028-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="ame270028-cit-0043"><string-name name-style="western"><surname>Narayanapillai</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Leitzman</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Upadhyaya</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Baglole</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Xing</surname><given-names>C</given-names></string-name>. <article-title>Dihydromethysticin (DHM) blocks tobacco carcinogen 4&#8208;(Methylnitrosamino)&#8208;1&#8208;(3&#8208;pyridyl)&#8208;1&#8208;butanone (NNK)&#8208;induced O6&#8208;methylguanine in a manner independent of the aryl hydrocarbon receptor (AhR) pathway in C57BL/6 female mice</article-title>. <source>Chem Res Toxicol</source>. <year>2016</year>;<volume>29</volume>(<issue>11</issue>):<fpage>1828</fpage>&#8208;<lpage>1834</lpage>.<pub-id pub-id-type="pmid">27728767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.chemrestox.6b00203</pub-id><pub-id pub-id-type="pmcid">PMC6532060</pub-id></mixed-citation></ref><ref id="ame270028-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="ame270028-cit-0044"><string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ning</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Wan</surname><given-names>X</given-names></string-name>. <article-title>Analysis of the associations of indoor air pollution and tobacco use with morbidity of lung cancer in Xuanwei, China</article-title>. <source>Sci Total Environ</source>. <year>2020</year>;<volume>717</volume>:<elocation-id>135232</elocation-id>.<pub-id pub-id-type="pmid">31839320</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scitotenv.2019.135232</pub-id></mixed-citation></ref><ref id="ame270028-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="ame270028-cit-0045"><string-name name-style="western"><surname>Qu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Tian</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Diallyl trisulfide inhibits 4&#8208;(methylnitrosamino)&#8208;1&#8208;(3&#8208;pyridyl)&#8208;1&#8208;butanone&#8208;induced lung cancer via modulating gut microbiota and the PPAR&#947;/NF&#8208;&#954;B pathway</article-title>. <source>Food Funct</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>158</fpage>&#8208;<lpage>171</lpage>.<pub-id pub-id-type="pmid">38086660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d3fo03914e</pub-id></mixed-citation></ref><ref id="ame270028-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="ame270028-cit-0046"><string-name name-style="western"><surname>Min</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Boo</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>HJ</given-names></string-name>, et&#160;al. <article-title>Smoking&#8208;associated lung cancer prevention by blockade of the beta&#8208;adrenergic receptor&#8208;mediated insulin&#8208;like growth factor receptor activation</article-title>. <source>Oncotarget</source>. <year>2016</year>;<volume>7</volume>(<issue>43</issue>):<fpage>70936</fpage>&#8208;<lpage>70947</lpage>.<pub-id pub-id-type="pmid">27708216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.12342</pub-id><pub-id pub-id-type="pmcid">PMC5342599</pub-id></mixed-citation></ref><ref id="ame270028-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="ame270028-cit-0047"><string-name name-style="western"><surname>Song</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Upadhyaya</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Kassie</surname><given-names>F</given-names></string-name>. <article-title>Nitric oxide&#8208;donating aspirin (NO&#8208;aspirin) suppresses lung tumorigenesis in&#160;vitro and in&#160;vivo and these effects are associated with modulation of the EGFR signaling pathway</article-title>. <source>Carcinogenesis</source>. <year>2018</year>;<volume>39</volume>(<issue>7</issue>):<fpage>911</fpage>&#8208;<lpage>920</lpage>.<pub-id pub-id-type="pmid">29982425</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/carcin/bgy049</pub-id></mixed-citation></ref><ref id="ame270028-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="ame270028-cit-0048"><string-name name-style="western"><surname>Ou</surname><given-names>WT</given-names></string-name>, <string-name name-style="western"><surname>Wan</surname><given-names>QX</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>YB</given-names></string-name>, et&#160;al. <article-title>Long noncoding RNA PSMB8&#8208;AS1 mediates the tobacco&#8208;carcinogen&#8208;induced transformation of a human bronchial epithelial cell line by regulating cell cycle</article-title>. <source>Chem Res Toxicol</source>. <year>2024</year>;<volume>37</volume>(<issue>6</issue>):<fpage>957</fpage>&#8208;<lpage>967</lpage>.<pub-id pub-id-type="pmid">38771128</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.chemrestox.4c00025</pub-id></mixed-citation></ref><ref id="ame270028-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="ame270028-cit-0049"><string-name name-style="western"><surname>Hudlikar</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Pai</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>Dose&#8208;related modulatory effects of polymeric black tea polyphenols (PBPs) on initiation and promotion events in B(a)P and NNK&#8208;induced lung carcinogenesis</article-title>. <source>Nutr Cancer</source>. <year>2019</year>;<volume>71</volume>(<issue>3</issue>):<fpage>508</fpage>&#8208;<lpage>523</lpage>.<pub-id pub-id-type="pmid">30857437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/01635581.2019.1578389</pub-id></mixed-citation></ref><ref id="ame270028-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="ame270028-cit-0050"><string-name name-style="western"><surname>Tackett</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Dai</surname><given-names>HD</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>DH</given-names></string-name>, et&#160;al. <article-title>Appeal of e&#8208;cigarette flavors: differences between never and ever use of combustible cigarettes</article-title>. <source>Drug Alcohol Depend</source>. <year>2023</year>;<volume>246</volume>:<elocation-id>109849</elocation-id>.<pub-id pub-id-type="pmid">37028103</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2023.109849</pub-id><pub-id pub-id-type="pmcid">PMC10161874</pub-id></mixed-citation></ref><ref id="ame270028-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="ame270028-cit-0051"><string-name name-style="western"><surname>Duko</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Pereira</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Tait</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Nyadanu</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Betts</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Alati</surname><given-names>R</given-names></string-name>. <article-title>Prenatal tobacco exposure and the risk of tobacco smoking and dependence in offspring: a systematic review and meta&#8208;analysis</article-title>. <source>Drug Alcohol Depend</source>. <year>2021</year>;<volume>227</volume>:<elocation-id>108993</elocation-id>.<pub-id pub-id-type="pmid">34482031</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2021.108993</pub-id></mixed-citation></ref><ref id="ame270028-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="ame270028-cit-0052"><string-name name-style="western"><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jin</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Construction and validation of a nomogram of risk factors for new&#8208;onset atrial fibrillation in advanced lung cancer patients after non&#8208;surgical therapy</article-title>. <source>Front Oncol</source>. <year>2023</year>;<volume>13</volume>:<elocation-id>1125592</elocation-id>.<pub-id pub-id-type="pmid">37519821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2023.1125592</pub-id><pub-id pub-id-type="pmcid">PMC10374250</pub-id></mixed-citation></ref><ref id="ame270028-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="ame270028-cit-0053"><string-name name-style="western"><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Rao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Yi&#8208;Fei&#8208;san&#8208;Jie Chinese medicine formula reverses immune escape by regulating deoxycholic acid metabolism to inhibit TGR5/STAT3/PD&#8208;L1 axis in lung cancer</article-title>. <source>Phytomedicine</source>. <year>2024</year>;<volume>135</volume>:<elocation-id>156175</elocation-id>.<pub-id pub-id-type="pmid">39515098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.156175</pub-id></mixed-citation></ref><ref id="ame270028-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="ame270028-cit-0054"><string-name name-style="western"><surname>Abdallah</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Ghoneim</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Abd&#8208;Alhaseeb</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Abdel&#8208;Raheem</surname><given-names>IT</given-names></string-name>, <string-name name-style="western"><surname>Helmy</surname><given-names>MW</given-names></string-name>. <article-title>Unveiling the antitumor synergy between pazopanib and metformin on lung cancer through suppressing p&#8208;Akt/ NF&#8208;&#954;B/ STAT3/ PD&#8208;L1 signal pathway</article-title>. <source>Biomed Pharmacother</source>. <year>2024</year>;<volume>180</volume>:<fpage>117468</fpage>.<pub-id pub-id-type="pmid">39332188</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2024.117468</pub-id></mixed-citation></ref><ref id="ame270028-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="ame270028-cit-0055"><string-name name-style="western"><surname>Satoh</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Arai</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Furukawa</surname><given-names>E</given-names></string-name>, et&#160;al. <article-title>Genomic landscape of chemical&#8208;induced lung tumors under Nrf2 different expression levels</article-title>. <source>Carcinogenesis</source>. <year>2022</year>;<volume>43</volume>(<issue>7</issue>):<fpage>613</fpage>&#8208;<lpage>623</lpage>.<pub-id pub-id-type="pmid">35561328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/carcin/bgac041</pub-id></mixed-citation></ref><ref id="ame270028-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="ame270028-cit-0056"><string-name name-style="western"><surname>Zhou</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Saliba</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sandusky</surname><given-names>GE</given-names></string-name>, <string-name name-style="western"><surname>Sears</surname><given-names>CR</given-names></string-name>. <article-title>XPC protects against smoking&#8208; and carcinogen&#8208;induced lung adenocarcinoma</article-title>. <source>Carcinogenesis</source>. <year>2019</year>;<volume>40</volume>(<issue>3</issue>):<fpage>403</fpage>&#8208;<lpage>411</lpage>.<pub-id pub-id-type="pmid">30624620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/carcin/bgz003</pub-id><pub-id pub-id-type="pmcid">PMC6514449</pub-id></mixed-citation></ref><ref id="ame270028-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="ame270028-cit-0057"><string-name name-style="western"><surname>Parra</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Bielecki</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Ribeiro</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Andrade Balsalobre</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Teodoro</surname><given-names>WR</given-names></string-name>, <string-name name-style="western"><surname>Capelozzi</surname><given-names>VL</given-names></string-name>. <article-title>Association between decreases in type V collagen and apoptosis in mouse lung chemical carcinogenesis: a preliminary model to study cancer cell behavior</article-title>. <source>Clinics (Sao Paulo)</source>. <year>2010</year>;<volume>65</volume>(<issue>4</issue>):<fpage>425</fpage>&#8208;<lpage>432</lpage>.<pub-id pub-id-type="pmid">20454501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/S1807-59322010000400012</pub-id><pub-id pub-id-type="pmcid">PMC2862677</pub-id></mixed-citation></ref><ref id="ame270028-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="ame270028-cit-0058"><string-name name-style="western"><surname>Zerbe</surname><given-names>LK</given-names></string-name>, <string-name name-style="western"><surname>Dwyer&#8208;Nield</surname><given-names>LD</given-names></string-name>, <string-name name-style="western"><surname>Fritz</surname><given-names>JM</given-names></string-name>, et&#160;al. <article-title>Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice</article-title>. <source>Cancer Chemother Pharmacol</source>. <year>2008</year>;<volume>62</volume>(<issue>4</issue>):<fpage>605</fpage>&#8208;<lpage>620</lpage>.<pub-id pub-id-type="pmid">18030469</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00280-007-0644-z</pub-id></mixed-citation></ref><ref id="ame270028-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="ame270028-cit-0059"><string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Counter</surname><given-names>CM</given-names></string-name>. <article-title>Non&#8208;canonical genomic driver mutations of urethane carcinogenesis</article-title>. <source>PLoS One</source>. <year>2022</year>;<volume>17</volume>(<issue>4</issue>):<elocation-id>e0267147</elocation-id>.<pub-id pub-id-type="pmid">35482806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0267147</pub-id><pub-id pub-id-type="pmcid">PMC9049545</pub-id></mixed-citation></ref><ref id="ame270028-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="ame270028-cit-0060"><string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>MacAlpine</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Counter</surname><given-names>CM</given-names></string-name>. <article-title>Capturing the primordial Kras mutation initiating urethane carcinogenesis</article-title>. <source>Nat Commun</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>1800</fpage>.<pub-id pub-id-type="pmid">32286309</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-020-15660-8</pub-id><pub-id pub-id-type="pmcid">PMC7156420</pub-id></mixed-citation></ref><ref id="ame270028-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="ame270028-cit-0061"><string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>W</given-names></string-name>, et&#160;al. <article-title>Mutant p53 in cancer: from molecular mechanism to therapeutic modulation</article-title>. <source>Cell Death Dis</source>. <year>2022</year>;<volume>13</volume>(<issue>11</issue>):<fpage>974</fpage>.<pub-id pub-id-type="pmid">36400749</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-022-05408-1</pub-id><pub-id pub-id-type="pmcid">PMC9674619</pub-id></mixed-citation></ref><ref id="ame270028-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="ame270028-cit-0062"><string-name name-style="western"><surname>Simanullang</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>Ilyas</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hutahaean</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rosidah.</surname></string-name><article-title>Effect of Andaliman (Zanthoxylum acanthopodium DC.) methanol extract on rat's kidney and liver histology induced by Benzopyrene</article-title>. <source>Pak J Biol Sci</source>. <year>2021</year>;<volume>24</volume>:<fpage>274</fpage>&#8208;<lpage>281</lpage>.<pub-id pub-id-type="pmid">33683058</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3923/pjbs.2021.274.281</pub-id></mixed-citation></ref><ref id="ame270028-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="ame270028-cit-0063"><string-name name-style="western"><surname>Bukowska</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Duchnowicz</surname><given-names>P</given-names></string-name>. <article-title>Molecular mechanisms of action of selected substances involved in the reduction of benzo[a]pyrene&#8208;induced oxidative stress</article-title>. <source>Molecules</source>. <year>2022</year>;<volume>27</volume>(<issue>4</issue>):<fpage>1379</fpage>.<pub-id pub-id-type="pmid">35209168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules27041379</pub-id><pub-id pub-id-type="pmcid">PMC8878767</pub-id></mixed-citation></ref><ref id="ame270028-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="ame270028-cit-0064"><string-name name-style="western"><surname>Zhou</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>J</given-names></string-name>. <article-title>Research progress in cancer epigenetics mechanisms of benzo (a) pyrene</article-title>. <source>Chin J Pharmacol Toxicol</source>. <year>2017</year>;<volume>31</volume>(<issue>5</issue>):<fpage>375</fpage>&#8208;<lpage>384</lpage>.</mixed-citation></ref><ref id="ame270028-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="ame270028-cit-0065"><string-name name-style="western"><surname>Dang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Hussain</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>D</given-names></string-name>. <article-title>Protective effect of avicularin against lung cancer via inhibiting inflammation, oxidative stress, and induction of apoptosis: an in&#160;vitro and in&#160;vivo study</article-title>. <source>In Vitro Cell Dev Biol Anim</source>. <year>2024</year>;<volume>60</volume>(<issue>4</issue>):<fpage>374</fpage>&#8208;<lpage>381</lpage>.<pub-id pub-id-type="pmid">38592596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11626-024-00854-x</pub-id></mixed-citation></ref><ref id="ame270028-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="ame270028-cit-0066"><string-name name-style="western"><surname>Khan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Alhumaydhi</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Alwashmi</surname><given-names>ASS</given-names></string-name>, et&#160;al. <article-title>Diallyl sulfide&#8208;mediated modulation of the fatty acid synthase (FASN) leads to cancer cell death in BaP&#8208;induced lung carcinogenesis in swiss mice</article-title>. <source>J Inflamm Res</source>. <year>2020</year>;<volume>13</volume>:<fpage>1075</fpage>&#8208;<lpage>1087</lpage>.<pub-id pub-id-type="pmid">33324084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/JIR.S284279</pub-id><pub-id pub-id-type="pmcid">PMC7733419</pub-id></mixed-citation></ref><ref id="ame270028-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="ame270028-cit-0067"><string-name name-style="western"><surname>Qiu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>B</given-names></string-name>, et&#160;al. <article-title>Unraveling the protective role of Nrf2 in molluscs: insights into mitochondrial and apoptosis pathways in the defense against bap&#8208;induced oxidative stress</article-title>. <source>Aquat Toxicol</source>. <year>2023</year>;<volume>264</volume>:<elocation-id>106728</elocation-id>.<pub-id pub-id-type="pmid">37837868</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aquatox.2023.106728</pub-id></mixed-citation></ref><ref id="ame270028-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="ame270028-cit-0068"><string-name name-style="western"><surname>Kohli</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Pillarisetty</surname><given-names>VG</given-names></string-name>. <article-title>Dendritic cells in the tumor microenvironment</article-title>. <source>Adv Exp Med Biol</source>. <year>2020</year>;<volume>1273</volume>:<fpage>29</fpage>&#8208;<lpage>38</lpage>.<pub-id pub-id-type="pmid">33119874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-030-49270-0_2</pub-id></mixed-citation></ref><ref id="ame270028-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="ame270028-cit-0069"><string-name name-style="western"><surname>Abd El&#8208;Fattah</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Abdelhamid</surname><given-names>AM</given-names></string-name>. <article-title>Benzo[a]pyrene immunogenetics and immune archetype reprogramming of lung</article-title>. <source>Toxicology</source>. <year>2021</year>;<volume>463</volume>:<elocation-id>152994</elocation-id>.<pub-id pub-id-type="pmid">34678320</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tox.2021.152994</pub-id></mixed-citation></ref><ref id="ame270028-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="ame270028-cit-0070"><string-name name-style="western"><surname>Du</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Chemoprotective effect of atorvastatin against benzo(a)pyrene&#8208;induced lung cancer via the inhibition of oxidative stress and inflammatory parameters</article-title>. <source>Ann Transl Med</source>. <year>2021</year>;<volume>9</volume>(<issue>4</issue>):<fpage>355</fpage>. doi:<pub-id pub-id-type="doi">10.21037/atm-20-7770</pub-id><pub-id pub-id-type="pmid">33708982</pub-id><pub-id pub-id-type="pmcid">PMC7944302</pub-id></mixed-citation></ref><ref id="ame270028-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="ame270028-cit-0071"><string-name name-style="western"><surname>Mu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Exposure of benzo[a]pyrene induces HCC exosome&#8208;circular RNA to activate lung fibroblasts and trigger organotropic metastasis</article-title>. <source>Cancer Commun (Lond)</source>. <year>2024</year>;<volume>44</volume>(<issue>7</issue>):<fpage>718</fpage>&#8208;<lpage>738</lpage>.<pub-id pub-id-type="pmid">38840551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cac2.12574</pub-id><pub-id pub-id-type="pmcid">PMC11260768</pub-id></mixed-citation></ref><ref id="ame270028-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="ame270028-cit-0072"><string-name name-style="western"><surname>Adachi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ishizawa</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Uno</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Oral benzo[a]pyrene administration attenuates dextran sulfate sodium&#8208;induced colitis in mice</article-title>. <source>Chem Biol Interact</source>. <year>2022</year>;<volume>353</volume>:<elocation-id>109802</elocation-id>.<pub-id pub-id-type="pmid">34998820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2022.109802</pub-id></mixed-citation></ref><ref id="ame270028-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="ame270028-cit-0073"><string-name name-style="western"><surname>Kim</surname><given-names>NW</given-names></string-name>, <string-name name-style="western"><surname>Seo</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Yoo</surname><given-names>ES</given-names></string-name>, et&#160;al. <article-title>Short&#8208;term carcinogenicity study of N&#8208;methyl&#8208;N&#8208;nitrosourea in FVB&#8208;Trp53 heterozygous mice</article-title>. <source>PLoS One</source>. <year>2023</year>;<volume>18</volume>(<issue>1</issue>):<elocation-id>e0280214</elocation-id>.<pub-id pub-id-type="pmid">36608059</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0280214</pub-id><pub-id pub-id-type="pmcid">PMC9821506</pub-id></mixed-citation></ref><ref id="ame270028-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="ame270028-cit-0074"><string-name name-style="western"><surname>Salehi&#8208;Rad</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Tran</surname><given-names>LM</given-names></string-name>, et&#160;al. <article-title>Novel Kras&#8208;mutant murine models of non&#8208;small cell lung cancer possessing co&#8208;occurring oncogenic mutations and increased tumor mutational burden</article-title>. <source>Cancer Immunol Immunother</source>. <year>2021</year>;<volume>70</volume>(<issue>8</issue>):<fpage>2389</fpage>&#8208;<lpage>2400</lpage>.<pub-id pub-id-type="pmid">33507343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00262-020-02837-9</pub-id><pub-id pub-id-type="pmcid">PMC8289771</pub-id></mixed-citation></ref><ref id="ame270028-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="ame270028-cit-0075"><string-name name-style="western"><surname>Saggese</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Martinez</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Tran</surname><given-names>LM</given-names></string-name>, et&#160;al. <article-title>Genotoxic treatment enhances immune response in a genetic model of lung cancer</article-title>. <source>Cancers (Basel)</source>. <year>2021</year>;<volume>13</volume>(<issue>14</issue>):<fpage>3595</fpage>.<pub-id pub-id-type="pmid">34298808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers13143595</pub-id><pub-id pub-id-type="pmcid">PMC8307650</pub-id></mixed-citation></ref><ref id="ame270028-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="ame270028-cit-0076"><string-name name-style="western"><surname>Lin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>HI</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>HJ</given-names></string-name>. <article-title>Metabolomic profiling of mice urine and serum associated with trans&#8208;trans 2, 4&#8208;decadienal induced lung lesions by liquid chromatography&#8208;mass spectrometry</article-title>. <source>Anal Bioanal Chem</source>. <year>2014</year>;<volume>406</volume>(<issue>17</issue>):<fpage>4287</fpage>&#8208;<lpage>4297</lpage>.<pub-id pub-id-type="pmid">24577578</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00216-014-7681-3</pub-id></mixed-citation></ref><ref id="ame270028-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="ame270028-cit-0077"><string-name name-style="western"><surname>Hu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Qin</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Trans,trans&#8208;2,4&#8208;decadienal induces endothelial cell injury by impairing mitochondrial function and autophagic flux</article-title>. <source>Food Funct</source>. <year>2021</year>;<volume>12</volume>(<issue>12</issue>):<fpage>5488</fpage>&#8208;<lpage>5500</lpage>.<pub-id pub-id-type="pmid">33998634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d1fo00372k</pub-id></mixed-citation></ref><ref id="ame270028-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="ame270028-cit-0078"><string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Dattmore</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>W</given-names></string-name>, et&#160;al. <article-title>Trans, trans&#8208;2,4&#8208;decadienal, a lipid peroxidation product, induces inflammatory responses via Hsp90&#8208; or 14&#8208;3&#8208;3&#950;&#8208;dependent mechanisms</article-title>. <source>J Nutr Biochem</source>. <year>2020</year>;<volume>76</volume>:<elocation-id>108286</elocation-id>.<pub-id pub-id-type="pmid">31918337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jnutbio.2019.108286</pub-id><pub-id pub-id-type="pmcid">PMC7003550</pub-id></mixed-citation></ref><ref id="ame270028-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="ame270028-cit-0079"><string-name name-style="western"><surname>Wang</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>LW</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Pulmonary changes induced by trans,trans&#8208;2,4&#8208;decadienal, a component of cooking oil fumes</article-title>. <source>Eur Respir J</source>. <year>2010</year>;<volume>35</volume>(<issue>3</issue>):<fpage>667</fpage>&#8208;<lpage>675</lpage>.<pub-id pub-id-type="pmid">19797125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.00140508</pub-id></mixed-citation></ref><ref id="ame270028-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="ame270028-cit-0080"><string-name name-style="western"><surname>Sudakov</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Klimenkov</surname><given-names>IV</given-names></string-name>, <string-name name-style="western"><surname>Bedoshvili</surname><given-names>YD</given-names></string-name>, et&#160;al. <article-title>Early structural and functional changes in Baikal sculpin gills exposed to suspended soot microparticles in experiment</article-title>. <source>Chemosphere</source>. <year>2022</year>;<volume>290</volume>:<elocation-id>133241</elocation-id>.<pub-id pub-id-type="pmid">34896428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2021.133241</pub-id></mixed-citation></ref><ref id="ame270028-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="ame270028-cit-0081"><string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Dang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Jiao</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>W</given-names></string-name>. <article-title>Silencing PPAP2C inhibits lung adenocarcinoma migration and invasion via the ERK/JNK pathway</article-title>. <source>Mol Med Rep</source>. <year>2025</year>;<volume>31</volume>(<issue>1</issue>):<fpage>27</fpage>.<pub-id pub-id-type="pmid">39540350</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2024.13392</pub-id><pub-id pub-id-type="pmcid">PMC11579831</pub-id></mixed-citation></ref><ref id="ame270028-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="ame270028-cit-0082"><string-name name-style="western"><surname>Huang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>T</given-names></string-name>, et&#160;al. <article-title>Single&#8208;cell RNA sequencing uncovered the involvement of an endothelial subset in neutrophil recruitment in chemically induced rat pulmonary inflammation</article-title>. <source>Int J Med Sci</source>. <year>2022</year>;<volume>19</volume>(<issue>4</issue>):<fpage>669</fpage>&#8208;<lpage>680</lpage>.<pub-id pub-id-type="pmid">35582423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/ijms.67806</pub-id><pub-id pub-id-type="pmcid">PMC9108403</pub-id></mixed-citation></ref><ref id="ame270028-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="ame270028-cit-0083"><string-name name-style="western"><surname>Ohnishi</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Fukamachi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ohshima</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Possible application of human c&#8208;Ha&#8208;ras proto&#8208;oncogene transgenic rats in a medium&#8208;term bioassay model for carcinogens</article-title>. <source>Toxicol Pathol</source>. <year>2007</year>;<volume>35</volume>(<issue>3</issue>):<fpage>436</fpage>&#8208;<lpage>443</lpage>.<pub-id pub-id-type="pmid">17474063</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/01926230701302541</pub-id></mixed-citation></ref><ref id="ame270028-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="ame270028-cit-0084"><string-name name-style="western"><surname>Sotty</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bablon</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Weiss</surname><given-names>PH</given-names></string-name>, <string-name name-style="western"><surname>Soussan</surname><given-names>P</given-names></string-name>. <article-title>Diethylnitrosamine induction of hepatocarcinogenesis in mice</article-title>. <source>Methods Mol Biol</source>. <year>2024</year>;<volume>2769</volume>:<fpage>15</fpage>&#8208;<lpage>25</lpage>.<pub-id pub-id-type="pmid">38315386</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-0716-3694-7_2</pub-id></mixed-citation></ref><ref id="ame270028-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="ame270028-cit-0085"><string-name name-style="western"><surname>Wen</surname><given-names>LX</given-names></string-name>, <string-name name-style="western"><surname>Lv</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Mou</surname><given-names>XJ</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>Y</given-names></string-name>. <article-title>A fluorescent probe composed of quantum dot labeled aptamer and graphene oxide for the determination of the lipopolysaccharide endotoxin</article-title>. <source>Mikrochim Acta</source>. <year>2019</year>;<volume>186</volume>(<issue>2</issue>):<fpage>122</fpage>.<pub-id pub-id-type="pmid">30666423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00604-018-3218-3</pub-id></mixed-citation></ref><ref id="ame270028-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="ame270028-cit-0086"><string-name name-style="western"><surname>Melkamu</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Qian</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Upadhyaya</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>O'Sullivan</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Kassie</surname><given-names>F</given-names></string-name>. <article-title>Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation&#8208;driven lung cancer</article-title>. <source>Vet Pathol</source>. <year>2013</year>;<volume>50</volume>(<issue>5</issue>):<fpage>895</fpage>&#8208;<lpage>902</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0300985813476061</pub-id><pub-id pub-id-type="pmid">23381924</pub-id><pub-id pub-id-type="pmcid">PMC4667800</pub-id></mixed-citation></ref><ref id="ame270028-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="ame270028-cit-0087"><string-name name-style="western"><surname>Hua</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Upregulation of Circ_0035266 contributes to the malignant progression of inflammation&#8208;associated malignant transformed cells induced by tobacco&#8208;specific carcinogen NNK</article-title>. <source>Toxicol Sci</source>. <year>2022</year>;<volume>189</volume>(<issue>2</issue>):<fpage>203</fpage>&#8208;<lpage>215</lpage>.<pub-id pub-id-type="pmid">35866630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfac072</pub-id></mixed-citation></ref><ref id="ame270028-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="ame270028-cit-0088"><string-name name-style="western"><surname>Wang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>W</given-names></string-name>. <article-title>Knockdown of Slfn5 alleviates lipopolysaccharide&#8208;induced pneumonia by regulating Janus kinase/signal transduction and activator of transcription pathway</article-title>. <source>J Thorac Dis</source>. <year>2023</year>;<volume>15</volume>(<issue>12</issue>):<fpage>6708</fpage>&#8208;<lpage>6720</lpage>.<pub-id pub-id-type="pmid">38249884</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/jtd-23-889</pub-id><pub-id pub-id-type="pmcid">PMC10797344</pub-id></mixed-citation></ref><ref id="ame270028-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="ame270028-cit-0089"><string-name name-style="western"><surname>Houel</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Riffard</surname><given-names>C</given-names></string-name>. <article-title>Comparative automated quantification of tertiary lymphoid structures in two distinct mouse models of inflammation</article-title>. <source>Methods Mol Biol</source>. <year>2025</year>;<volume>2864</volume>:<fpage>141</fpage>&#8208;<lpage>157</lpage>.<pub-id pub-id-type="pmid">39527221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-0716-4184-2_8</pub-id></mixed-citation></ref><ref id="ame270028-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="ame270028-cit-0090"><string-name name-style="western"><surname>Li</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>LncRNA XIST knockdown alleviates LPS&#8208;induced acute lung injury by inactivation of XIST/miR&#8208;132&#8208;3p/MAPK14 pathway: XIST promotes ALI via miR&#8208;132&#8208;3p/MAPK14 axis</article-title>. <source>Mol Cell Biochem</source>. <year>2021</year>;<volume>476</volume>(<issue>12</issue>):<fpage>4217</fpage>&#8208;<lpage>4229</lpage>.<pub-id pub-id-type="pmid">34346000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11010-021-04234-x</pub-id><pub-id pub-id-type="pmcid">PMC8330477</pub-id></mixed-citation></ref><ref id="ame270028-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="ame270028-cit-0091"><string-name name-style="western"><surname>Wilson</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Kurie</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name>. <article-title>A method for orthotopic transplantation of lung cancer in mice</article-title>. <source>Methods Mol Biol</source>. <year>2022</year>;<volume>2374</volume>:<fpage>231</fpage>&#8208;<lpage>242</lpage>.<pub-id pub-id-type="pmid">34562257</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-0716-1701-4_20</pub-id><pub-id pub-id-type="pmcid">PMC9262117</pub-id></mixed-citation></ref><ref id="ame270028-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="ame270028-cit-0092"><string-name name-style="western"><surname>Gu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Xia</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>H</given-names></string-name>. <article-title>Development of a rat model by 3,4&#8208;benzopyrene intra&#8208;pulmonary injection and evaluation of the effect of green tea drinking on p53 and bcl&#8208;2 expression in lung carcinoma</article-title>. <source>Cancer Detect Prev</source>. <year>2009</year>;<volume>32</volume>(<issue>5&#8211;6</issue>):<fpage>444</fpage>&#8208;<lpage>451</lpage>.<pub-id pub-id-type="pmid">19588545</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.canep.2009.04.002</pub-id></mixed-citation></ref><ref id="ame270028-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="ame270028-cit-0093"><string-name name-style="western"><surname>Matsui</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Taniguchi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ishii</surname><given-names>M</given-names></string-name>. <article-title>Function of alveolar macrophages in lung cancer microenvironment</article-title>. <source>Inflamm Regen</source>. <year>2024</year>;<volume>44</volume>(<issue>1</issue>):<fpage>23</fpage>.<pub-id pub-id-type="pmid">38720352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s41232-024-00335-4</pub-id><pub-id pub-id-type="pmcid">PMC11077793</pub-id></mixed-citation></ref><ref id="ame270028-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="ame270028-cit-0094"><string-name name-style="western"><surname>Ma</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Inhalable GSH&#8208;triggered nanoparticles to treat commensal bacterial infection in in&#160;situ lung tumors</article-title>. <source>ACS Nano</source>. <year>2023</year>;<volume>17</volume>(<issue>6</issue>):<fpage>5740</fpage>&#8208;<lpage>5756</lpage>.<pub-id pub-id-type="pmid">36884352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.2c12165</pub-id></mixed-citation></ref><ref id="ame270028-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="ame270028-cit-0095"><string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Iguchi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ito</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Blood flow velocity is reduced in a tumor micro&#8208;dissemination in the visceral pleura in anesthetized open&#8208;chest rat lung</article-title>. <source>In Vivo</source>. <year>2009</year>;<volume>23</volume>(<issue>2</issue>):<fpage>291</fpage>&#8208;<lpage>295</lpage>.<pub-id pub-id-type="pmid">19414417</pub-id></mixed-citation></ref><ref id="ame270028-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="ame270028-cit-0096"><string-name name-style="western"><surname>Sozio</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Schioppa</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Sozzani</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Del Prete</surname><given-names>A</given-names></string-name>. <article-title>Urethane&#8208;induced lung carcinogenesis</article-title>. <source>Methods Cell Biol</source>. <year>2021</year>;<volume>163</volume>:<fpage>45</fpage>&#8208;<lpage>57</lpage>.<pub-id pub-id-type="pmid">33785168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/bs.mcb.2020.09.005</pub-id></mixed-citation></ref><ref id="ame270028-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="ame270028-cit-0097"><string-name name-style="western"><surname>Battistoni</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lantier</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>di Tommaso</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Nasal administration of recombinant Neospora caninum secreting IL&#8208;15/IL&#8208;15R&#945; inhibits metastatic melanoma development in lung</article-title>. <source>J Immunother Cancer</source>. <year>2023</year>;<volume>11</volume>(<issue>5</issue>):<elocation-id>e006683</elocation-id>.<pub-id pub-id-type="pmid">37192784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jitc-2023-006683</pub-id><pub-id pub-id-type="pmcid">PMC10193056</pub-id></mixed-citation></ref><ref id="ame270028-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="ame270028-cit-0098"><string-name name-style="western"><surname>Li</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>D</given-names></string-name>, et&#160;al. <article-title>Nasal mRNA Nanovaccine with key activators of dendritic and MAIT cells for effective against lung tumor metastasis in mice model</article-title>. <source>Int J Nanomedicine</source>. <year>2024</year>;<volume>19</volume>:<fpage>11479</fpage>&#8208;<lpage>11497</lpage>.<pub-id pub-id-type="pmid">39534380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S479741</pub-id><pub-id pub-id-type="pmcid">PMC11556332</pub-id></mixed-citation></ref><ref id="ame270028-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="ame270028-cit-0099"><string-name name-style="western"><surname>Mahiswar</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Dubey</surname><given-names>PK</given-names></string-name>, <string-name name-style="western"><surname>Ranjan</surname><given-names>A</given-names></string-name>. <article-title>Comparison between dexmedetomidine and fentanyl bolus in attenuating the stress response to laryngoscopy and tracheal intubation: a randomized double&#8208;blind trial</article-title>. <source>Braz J Anesthesiol</source>. <year>2022</year>;<volume>72</volume>(<issue>1</issue>):<fpage>103</fpage>&#8208;<lpage>109</lpage>.<pub-id pub-id-type="pmid">34000325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bjane.2021.02.060</pub-id><pub-id pub-id-type="pmcid">PMC9373229</pub-id></mixed-citation></ref><ref id="ame270028-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="ame270028-cit-0100"><string-name name-style="western"><surname>Bai</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>A systematical strategy for quality markers screening of different methods processing Platycodonis radix based on phytochemical analysis and the impact on chronic obstructive pulmonary disease</article-title>. <source>J Ethnopharmacol</source>. <year>2024</year>;<volume>319</volume>(<issue>Pt 2</issue>):<elocation-id>117311</elocation-id>.<pub-id pub-id-type="pmid">37827295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2023.117311</pub-id></mixed-citation></ref><ref id="ame270028-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="ame270028-cit-0101"><string-name name-style="western"><surname>Yang</surname><given-names>WK</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Youn</surname><given-names>SH</given-names></string-name>, et&#160;al. <article-title>Respiratory protective effects of Korean red ginseng in a mouse model of particulate matter 4&#8208;induced airway inflammation</article-title>. <source>J Ginseng Res</source>. <year>2023</year>;<volume>47</volume>(<issue>1</issue>):<fpage>81</fpage>&#8208;<lpage>88</lpage>.<pub-id pub-id-type="pmid">36644393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jgr.2022.05.008</pub-id><pub-id pub-id-type="pmcid">PMC9834024</pub-id></mixed-citation></ref><ref id="ame270028-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="ame270028-cit-0102"><string-name name-style="western"><surname>Jiang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>JH</given-names></string-name>, et&#160;al. <article-title>Airway epithelial integrin &#946;4&#8208;deficiency exacerbates lipopolysaccharide&#8208;induced acute lung injury</article-title>. <source>J Cell Physiol</source>. <year>2021</year>;<volume>236</volume>(<issue>11</issue>):<fpage>7711</fpage>&#8208;<lpage>7724</lpage>.<pub-id pub-id-type="pmid">34018612</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcp.30422</pub-id></mixed-citation></ref><ref id="ame270028-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="ame270028-cit-0103"><string-name name-style="western"><surname>Durante</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sgambellone</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lanzi</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Effects of PARP&#8208;1 deficiency and histamine H4 receptor inhibition in an inflammatory model of lung fibrosis in mice</article-title>. <source>Front Pharmacol</source>. <year>2019</year>;<volume>10</volume>:<elocation-id>525</elocation-id>.<pub-id pub-id-type="pmid">31164820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2019.00525</pub-id><pub-id pub-id-type="pmcid">PMC6535496</pub-id></mixed-citation></ref><ref id="ame270028-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="ame270028-cit-0104"><string-name name-style="western"><surname>Lin</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Shen</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>. <article-title>Inhibition of human lung adenocarcinoma growth and metastasis by JC polyomavirus&#8208;like particles packaged with an SP&#8208;B promoter&#8208;driven CD59&#8208;specific shRNA</article-title>. <source>Clin Sci (Lond)</source>. <year>2019</year>;<volume>133</volume>(<issue>21</issue>):<fpage>2159</fpage>&#8208;<lpage>2169</lpage>.<pub-id pub-id-type="pmid">31693732</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/CS20190395</pub-id></mixed-citation></ref><ref id="ame270028-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="ame270028-cit-0105"><string-name name-style="western"><surname>Greenwell</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Torres&#8208;Gonzalez</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Ritzenthaler</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Roman</surname><given-names>J</given-names></string-name>. <article-title>Interplay between aging, lung inflammation/remodeling, and fibronectin EDA in lung cancer progression</article-title>. <source>Cancer Biol Ther</source>. <year>2020</year>;<volume>21</volume>(<issue>12</issue>):<fpage>1109</fpage>&#8208;<lpage>1118</lpage>.<pub-id pub-id-type="pmid">33222614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15384047.2020.1831372</pub-id><pub-id pub-id-type="pmcid">PMC7722795</pub-id></mixed-citation></ref><ref id="ame270028-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="ame270028-cit-0106"><string-name name-style="western"><surname>I&#241;a&#241;ez</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Del Rey&#8208;Vergara</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Quimis</surname><given-names>F</given-names></string-name>, et&#160;al. <article-title>The potential of single&#8208;transcription factor gene expression by RT&#8208;qPCR for subtyping small cell lung cancer</article-title>. <source>Int J Mol Sci</source>. <year>2025</year>;<volume>26</volume>(<issue>3</issue>):<fpage>1293</fpage>.<pub-id pub-id-type="pmid">39941061</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms26031293</pub-id><pub-id pub-id-type="pmcid">PMC11818609</pub-id></mixed-citation></ref><ref id="ame270028-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="ame270028-cit-0107"><string-name name-style="western"><surname>Choi</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>DW</given-names></string-name>, et&#160;al. <article-title>Inoculation of Lewis lung carcinoma cells enhances formalin&#8208;induced pain behavior and spinal Fos expression in mice</article-title>. <source>J Vet Sci</source>. <year>2017</year>;<volume>18</volume>(<issue>3</issue>):<fpage>267</fpage>&#8208;<lpage>272</lpage>.<pub-id pub-id-type="pmid">27586465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4142/jvs.2017.18.3.267</pub-id><pub-id pub-id-type="pmcid">PMC5639078</pub-id></mixed-citation></ref><ref id="ame270028-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="ame270028-cit-0108"><string-name name-style="western"><surname>Hou</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Salvianolic acid F suppresses KRAS&#8208;dependent lung cancer cell growth through the PI3K/AKT signaling pathway</article-title>. <source>Phytomedicine</source>. <year>2023</year>;<volume>121</volume>:<elocation-id>155093</elocation-id>.<pub-id pub-id-type="pmid">37783131</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2023.155093</pub-id></mixed-citation></ref><ref id="ame270028-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="ame270028-cit-0109"><string-name name-style="western"><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Vadlamudi</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Intrapulmonary inoculation of multicellular spheroids to construct an orthotopic lung cancer xenograft model that mimics four clinical stages of non&#8208;small cell lung cancer</article-title>. <source>J Pharmacol Toxicol Methods</source>. <year>2020</year>;<volume>104</volume>:<elocation-id>106885</elocation-id>.<pub-id pub-id-type="pmid">32531198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vascn.2020.106885</pub-id></mixed-citation></ref><ref id="ame270028-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="ame270028-cit-0110"><string-name name-style="western"><surname>Xu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Construction of an orthotopic xenograft model of non&#8208;small cell lung cancer mimicking disease progression and predicting drug activities</article-title>. <source>J Vis Exp</source>. <year>2024</year>;(<issue>207</issue>):<elocation-id>e66787</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3791/66787</pub-id><pub-id pub-id-type="pmid">38801268</pub-id></mixed-citation></ref><ref id="ame270028-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="ame270028-cit-0111"><string-name name-style="western"><surname>Haney</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Konen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Marcus</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Bazhenov</surname><given-names>M</given-names></string-name>. <article-title>The complex ecosystem in non small cell lung cancer invasion</article-title>. <source>PLoS Comput Biol</source>. <year>2018</year>;<volume>14</volume>(<issue>5</issue>):<elocation-id>e1006131</elocation-id>.<pub-id pub-id-type="pmid">29795571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pcbi.1006131</pub-id><pub-id pub-id-type="pmcid">PMC5991406</pub-id></mixed-citation></ref><ref id="ame270028-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="ame270028-cit-0112"><string-name name-style="western"><surname>Shreberk&#8208;Shaked</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dassa</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Sinha</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>A division of labor between YAP and TAZ in non&#8208;small cell lung cancer</article-title>. <source>Cancer Res</source>. <year>2020</year>;<volume>80</volume>(<issue>19</issue>):<fpage>4145</fpage>&#8208;<lpage>4157</lpage>.<pub-id pub-id-type="pmid">32816858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-20-0125</pub-id><pub-id pub-id-type="pmcid">PMC8916161</pub-id></mixed-citation></ref><ref id="ame270028-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="ame270028-cit-0113"><string-name name-style="western"><surname>Miao</surname><given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Chai</surname><given-names>MQ</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>XY</given-names></string-name>, et&#160;al. <article-title>Exercise accelerates recruitment of CD8+ T cell to promotes anti&#8208;tumor immunity in lung cancer via epinephrine</article-title>. <source>BMC Cancer</source>. <year>2024</year>;<volume>24</volume>(<issue>1</issue>):<fpage>474</fpage>.<pub-id pub-id-type="pmid">38622609</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-024-12224-7</pub-id><pub-id pub-id-type="pmcid">PMC11021002</pub-id></mixed-citation></ref><ref id="ame270028-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="ame270028-cit-0114"><string-name name-style="western"><surname>Guan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Bai</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Potential mechanisms underlying inhibition of xenograft lung cancer models by kaempferol: modulation of gut microbiota in activating immune cell function</article-title>. <source>J Cancer</source>. <year>2024</year>;<volume>15</volume>(<issue>5</issue>):<fpage>1314</fpage>&#8208;<lpage>1327</lpage>.<pub-id pub-id-type="pmid">38356724</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/jca.88038</pub-id><pub-id pub-id-type="pmcid">PMC10861830</pub-id></mixed-citation></ref><ref id="ame270028-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="ame270028-cit-0115"><string-name name-style="western"><surname>Mishra</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Creighton</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Thrall</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>MP</given-names></string-name>. <article-title>Ex vivo four&#8208;dimensional lung cancer model mimics metastasis</article-title>. <source>Ann Thorac Surg</source>. <year>2015</year>;<volume>99</volume>(<issue>4</issue>):<fpage>1149</fpage>&#8208;<lpage>1156</lpage>.<pub-id pub-id-type="pmid">25701100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.athoracsur.2014.08.085</pub-id><pub-id pub-id-type="pmcid">PMC4387006</pub-id></mixed-citation></ref><ref id="ame270028-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="ame270028-cit-0116"><string-name name-style="western"><surname>Conway</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Braden</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wilmott</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Scolyer</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Long</surname><given-names>GV</given-names></string-name>, <string-name name-style="western"><surname>da Pires Silva</surname><given-names>I</given-names></string-name>. <article-title>The effect of organ&#8208;specific tumor microenvironments on response patterns to immunotherapy</article-title>. <source>Front Immunol</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>1030147</elocation-id>.<pub-id pub-id-type="pmid">36466910</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2022.1030147</pub-id><pub-id pub-id-type="pmcid">PMC9713699</pub-id></mixed-citation></ref><ref id="ame270028-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="ame270028-cit-0117"><string-name name-style="western"><surname>Masuda</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Maruyama</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hiratsu</surname><given-names>E</given-names></string-name>, et&#160;al. <article-title>Noninvasive and real&#8208;time assessment of reconstructed functional human endometrium in NOD/SCID/gamma c(null) immunodeficient mice</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2007</year>;<volume>104</volume>(<issue>6</issue>):<fpage>1925</fpage>&#8208;<lpage>1930</lpage>.<pub-id pub-id-type="pmid">17261813</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0604310104</pub-id><pub-id pub-id-type="pmcid">PMC1794295</pub-id></mixed-citation></ref><ref id="ame270028-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="ame270028-cit-0118"><string-name name-style="western"><surname>Sun</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Xia</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Yao</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ge</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>F</given-names></string-name>. <article-title>Overexpression of PIK3CG in cancer cells promotes lung cancer cell migration and metastasis through enhanced MMPs expression and neutrophil recruitment and activation</article-title>. <source>Biochem Genet</source>. <year>2025</year>;<volume>63</volume>(<issue>2</issue>):<fpage>1647</fpage>&#8208;<lpage>1659</lpage>.<pub-id pub-id-type="pmid">38602596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10528-024-10788-4</pub-id></mixed-citation></ref><ref id="ame270028-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="ame270028-cit-0119"><string-name name-style="western"><surname>Richardson</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>GD</given-names></string-name>, <string-name name-style="western"><surname>Sennello</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>The evaluation of E&#8208;cadherin and vimentin as biomarkers of clinical outcomes among patients with non&#8208;small cell lung cancer treated with erlotinib as second&#8208; or third&#8208;line therapy</article-title>. <source>Anticancer Res</source>. <year>2012</year>;<volume>32</volume>(<issue>2</issue>):<fpage>537</fpage>&#8208;<lpage>552</lpage>.<pub-id pub-id-type="pmid">22287743</pub-id></mixed-citation></ref><ref id="ame270028-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="ame270028-cit-0120"><string-name name-style="western"><surname>de Visser</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Joyce</surname><given-names>JA</given-names></string-name>. <article-title>The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth</article-title>. <source>Cancer Cell</source>. <year>2023</year>;<volume>41</volume>(<issue>3</issue>):<fpage>374</fpage>&#8208;<lpage>403</lpage>.<pub-id pub-id-type="pmid">36917948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccell.2023.02.016</pub-id></mixed-citation></ref><ref id="ame270028-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="ame270028-cit-0121"><string-name name-style="western"><surname>Vergara</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Simeone</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Franck</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Translating epithelial mesenchymal transition markers into the clinic: novel insights from proteomics</article-title>. <source>EuPA Open Proteom</source>. <year>2016</year>;<volume>10</volume>:<fpage>31</fpage>&#8208;<lpage>41</lpage>.<pub-id pub-id-type="pmid">29900098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.euprot.2016.01.003</pub-id><pub-id pub-id-type="pmcid">PMC5988589</pub-id></mixed-citation></ref><ref id="ame270028-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="ame270028-cit-0122"><string-name name-style="western"><surname>Wei</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Z</surname><given-names>TT</given-names></string-name>, <string-name name-style="western"><surname>C</surname><given-names>YZ</given-names></string-name>, et&#160;al. <article-title>Research progress of mechanism of pre&#8208;metastatic niches formation</article-title>. <source>Chin Pharmacol Bull</source>. <year>2018</year>;<volume>34</volume>(<issue>10</issue>):<fpage>1348</fpage>&#8208;<lpage>1351</lpage>.</mixed-citation></ref><ref id="ame270028-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="ame270028-cit-0123"><string-name name-style="western"><surname>Hamidi</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ivaska</surname><given-names>J</given-names></string-name>. <article-title>Author correction: every step of the way: integrins in cancer progression and metastasis</article-title>. <source>Nat Rev Cancer</source>. <year>2019</year>;<volume>19</volume>(<issue>3</issue>):<fpage>179</fpage>.<pub-id pub-id-type="pmid">30705430</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41568-019-0112-1</pub-id></mixed-citation></ref><ref id="ame270028-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="ame270028-cit-0124"><string-name name-style="western"><surname>Yayan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Franke</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Berger</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Windisch</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Rasche</surname><given-names>K</given-names></string-name>. <article-title>Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review</article-title>. <source>Mol Biol Rep</source>. <year>2024</year>;<volume>51</volume>(<issue>1</issue>):<fpage>165</fpage>.<pub-id pub-id-type="pmid">38252369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11033-023-08920-5</pub-id><pub-id pub-id-type="pmcid">PMC10803487</pub-id></mixed-citation></ref><ref id="ame270028-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="ame270028-cit-0125"><string-name name-style="western"><surname>Marcazzan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dadbin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Brachi</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Development of lung metastases in mouse models of tongue squamous cell carcinoma</article-title>. <source>Oral Dis</source>. <year>2021</year>;<volume>27</volume>(<issue>3</issue>):<fpage>494</fpage>&#8208;<lpage>505</lpage>.<pub-id pub-id-type="pmid">32767730</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/odi.13592</pub-id></mixed-citation></ref><ref id="ame270028-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="ame270028-cit-0126"><string-name name-style="western"><surname>Thies</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Steck</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Knoblaugh</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Sizemore</surname><given-names>ST</given-names></string-name>. <article-title>Pathological analysis of lung metastasis following lateral tail&#8208;vein injection of tumor cells</article-title>. <source>J Vis Exp</source>. <year>2020</year>;(<issue>159</issue>):<elocation-id>e61270</elocation-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3791/61270</pub-id><pub-id pub-id-type="pmid">32510518</pub-id></mixed-citation></ref><ref id="ame270028-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="ame270028-cit-0127"><string-name name-style="western"><surname>Xie</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Qi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>X</given-names></string-name>. <article-title>The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges</article-title>. <source>Biomed Pharmacother</source>. <year>2021</year>;<volume>138</volume>:<elocation-id>111450</elocation-id>.<pub-id pub-id-type="pmid">33690088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2021.111450</pub-id></mixed-citation></ref><ref id="ame270028-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="ame270028-cit-0128"><string-name name-style="western"><surname>Lazebnik</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bunimovich&#8208;Mendrazitsky</surname><given-names>S</given-names></string-name>. <article-title>Predicting lung cancer's metastats' locations using bioclinical model</article-title>. <source>Front Med (Lausanne)</source>. <year>2024</year>;<volume>11</volume>:<elocation-id>1388702</elocation-id>.<pub-id pub-id-type="pmid">38846148</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2024.1388702</pub-id><pub-id pub-id-type="pmcid">PMC11153684</pub-id></mixed-citation></ref><ref id="ame270028-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="ame270028-cit-0129"><string-name name-style="western"><surname>Gao</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>D</given-names></string-name>. <article-title>Effect of Qiangxin Huoli decoction on rats with adriamycin&#8208;induced chronic heart failure</article-title>. <source>J Tradit Chin Med</source>. <year>2019</year>;<volume>39</volume>(<issue>1</issue>):<fpage>81</fpage>&#8208;<lpage>88</lpage>.<pub-id pub-id-type="pmid">32186027</pub-id></mixed-citation></ref><ref id="ame270028-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="ame270028-cit-0130"><string-name name-style="western"><surname>Matsumura</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Intramyocardial injection of a fully synthetic hydrogel attenuates left ventricular remodeling post myocardial infarction</article-title>. <source>Biomaterials</source>. <year>2019</year>;<volume>217</volume>:<elocation-id>119289</elocation-id>.<pub-id pub-id-type="pmid">31254935</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2019.119289</pub-id></mixed-citation></ref><ref id="ame270028-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="ame270028-cit-0131"><string-name name-style="western"><surname>Fidler</surname><given-names>IJ</given-names></string-name>. <article-title>The role of the organ microenvironment in brain metastasis</article-title>. <source>Semin Cancer Biol</source>. <year>2011</year>;<volume>21</volume>(<issue>2</issue>):<fpage>107</fpage>&#8208;<lpage>112</lpage>.<pub-id pub-id-type="pmid">21167939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semcancer.2010.12.009</pub-id></mixed-citation></ref><ref id="ame270028-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="ame270028-cit-0132"><string-name name-style="western"><surname>Wu</surname><given-names>YJ</given-names></string-name>, <string-name name-style="western"><surname>Muldoon</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Dickey</surname><given-names>DT</given-names></string-name>, <string-name name-style="western"><surname>Lewin</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Varallyay</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>Neuwelt</surname><given-names>EA</given-names></string-name>. <article-title>Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models</article-title>. <source>Neoplasia</source>. <year>2009</year>;<volume>11</volume>(<issue>2</issue>):<fpage>187</fpage>&#8208;<lpage>195</lpage>.<pub-id pub-id-type="pmid">19177203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1593/neo.81352</pub-id><pub-id pub-id-type="pmcid">PMC2631143</pub-id></mixed-citation></ref><ref id="ame270028-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="ame270028-cit-0133"><string-name name-style="western"><surname>Senchukova</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Kalinin</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Volchenko</surname><given-names>NN</given-names></string-name>. <article-title>Different types of tumor microvessels in stage I&#8208;IIIA squamous cell lung cancer and their clinical significance</article-title>. <source>World J Clin Oncol</source>. <year>2024</year>;<volume>15</volume>(<issue>5</issue>):<fpage>614</fpage>&#8208;<lpage>634</lpage>.<pub-id pub-id-type="pmid">38835849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5306/wjco.v15.i5.614</pub-id><pub-id pub-id-type="pmcid">PMC11145955</pub-id></mixed-citation></ref><ref id="ame270028-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="ame270028-cit-0134"><string-name name-style="western"><surname>Wu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>CD248&#8208;expressing cancer&#8208;associated fibroblasts induce non&#8208;small cell lung cancer metastasis via hippo pathway&#8208;mediated extracellular matrix stiffness</article-title>. <source>J Cell Mol Med</source>. <year>2024</year>;<volume>28</volume>(<issue>16</issue>):<elocation-id>e70025</elocation-id>.<pub-id pub-id-type="pmid">39164826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jcmm.70025</pub-id><pub-id pub-id-type="pmcid">PMC11335579</pub-id></mixed-citation></ref><ref id="ame270028-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="ame270028-cit-0135"><string-name name-style="western"><surname>Hu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Fong</surname><given-names>KO</given-names></string-name>, <string-name name-style="western"><surname>Cheung</surname><given-names>MPL</given-names></string-name>, et&#160;al. <article-title>DEPDC1B promotes melanoma angiogenesis and metastasis through sequestration of ubiquitin ligase CDC16 to stabilize secreted SCUBE3</article-title>. <source>Adv Sci (Weinh)</source>. <year>2022</year>;<volume>9</volume>(<issue>10</issue>):<elocation-id>e2105226</elocation-id>.<pub-id pub-id-type="pmid">35088579</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202105226</pub-id><pub-id pub-id-type="pmcid">PMC8981904</pub-id></mixed-citation></ref><ref id="ame270028-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="ame270028-cit-0136"><string-name name-style="western"><surname>Li</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Qi</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Cryoshocked adipocytes mediated dual&#8208;modal strategy combining photodynamic therapy and triptolide palmitate for pulmonary metastatic melanoma treatment</article-title>. <source>Adv Sci (Weinh)</source>. <year>2025</year>;<volume>12</volume>(<issue>9</issue>):<elocation-id>e2414307</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/advs.202414307</pub-id><pub-id pub-id-type="pmid">39804941</pub-id><pub-id pub-id-type="pmcid">PMC11884613</pub-id></mixed-citation></ref><ref id="ame270028-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="ame270028-cit-0137"><string-name name-style="western"><surname>Alia Moosavian</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hashemi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Etemad</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Daneshmand</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Salmasi</surname><given-names>Z</given-names></string-name>. <article-title>Melanoma&#8208;derived exosomes: versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma</article-title>. <source>Int Immunopharmacol</source>. <year>2022</year>;<volume>113</volume>(<issue>Pt A</issue>):<elocation-id>109320</elocation-id>.<pub-id pub-id-type="pmid">36274482</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2022.109320</pub-id></mixed-citation></ref><ref id="ame270028-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="ame270028-cit-0138"><string-name name-style="western"><surname>Garc&#237;a&#8208;Silva</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Benito&#8208;Mart&#237;n</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nogu&#233;s</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Melanoma&#8208;derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR&#8208;dependent mechanism</article-title>. <source>Nat Cancer</source>. <year>2021</year>;<volume>2</volume>(<issue>12</issue>):<fpage>1387</fpage>&#8208;<lpage>1405</lpage>.<pub-id pub-id-type="pmid">34957415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43018-021-00272-y</pub-id><pub-id pub-id-type="pmcid">PMC8697753</pub-id></mixed-citation></ref><ref id="ame270028-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="ame270028-cit-0139"><string-name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Targeting Siglec&#8208;E facilitates tumor vaccine&#8208;induced antitumor immunity in renal carcinoma</article-title>. <source>J Immunother Cancer</source>. <year>2025</year>;<volume>13</volume>(<issue>1</issue>):<elocation-id>e010521</elocation-id>.<pub-id pub-id-type="pmid">39755580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jitc-2024-010521</pub-id><pub-id pub-id-type="pmcid">PMC11749828</pub-id></mixed-citation></ref><ref id="ame270028-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="ame270028-cit-0140"><string-name name-style="western"><surname>Brodaczewska</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Majewska</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Filipiak&#8208;Duliban</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kieda</surname><given-names>C</given-names></string-name>. <article-title>Pten knockout affects drug resistance differently in melanoma and kidney cancer</article-title>. <source>Pharmacol Rep</source>. <year>2023</year>;<volume>75</volume>(<issue>5</issue>):<fpage>1187</fpage>&#8208;<lpage>1199</lpage>.<pub-id pub-id-type="pmid">37673853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s43440-023-00523-y</pub-id><pub-id pub-id-type="pmcid">PMC10539195</pub-id></mixed-citation></ref><ref id="ame270028-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="ame270028-cit-0141"><string-name name-style="western"><surname>Sharma</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Exosomal long non&#8208;coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor</article-title>. <source>Pediatr Surg Int</source>. <year>2024</year>;<volume>40</volume>(<issue>1</issue>):<fpage>57</fpage>.<pub-id pub-id-type="pmid">38353772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00383-023-05626-4</pub-id></mixed-citation></ref><ref id="ame270028-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="ame270028-cit-0142"><string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Complement C3 of tumor&#8208;derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2025</year>;<volume>122</volume>(<issue>4</issue>):<elocation-id>e2420005122</elocation-id>.<pub-id pub-id-type="pmid">39847320</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2420005122</pub-id><pub-id pub-id-type="pmcid">PMC11789090</pub-id></mixed-citation></ref><ref id="ame270028-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="ame270028-cit-0143"><string-name name-style="western"><surname>Huang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma</article-title>. <source>Nat Commun</source>. <year>2017</year>;<volume>8</volume>(<issue>1</issue>):<fpage>918</fpage>.<pub-id pub-id-type="pmid">29030639</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-017-00701-6</pub-id><pub-id pub-id-type="pmcid">PMC5640635</pub-id></mixed-citation></ref><ref id="ame270028-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="ame270028-cit-0144"><string-name name-style="western"><surname>Jiang</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>W</given-names></string-name>, et&#160;al. <article-title>Lysosomal protein transmembrane 5 promotes lung&#8208;specific metastasis by regulating BMPR1A lysosomal degradation</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>4141</fpage>.<pub-id pub-id-type="pmid">35842443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-022-31783-6</pub-id><pub-id pub-id-type="pmcid">PMC9288479</pub-id></mixed-citation></ref><ref id="ame270028-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="ame270028-cit-0145"><string-name name-style="western"><surname>Tang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Xue</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Breast cancer stem cell&#8208;derived exosomal lnc&#8208;PDGFD induces fibroblast&#8208;niche formation and promotes lung metastasis</article-title>. <source>Oncogene</source>. <year>2025</year>;<volume>44</volume>(<issue>9</issue>):<fpage>601</fpage>&#8208;<lpage>617</lpage>.<pub-id pub-id-type="pmid">39633064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41388-024-03237-4</pub-id><pub-id pub-id-type="pmcid">PMC11850284</pub-id></mixed-citation></ref><ref id="ame270028-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="ame270028-cit-0146"><string-name name-style="western"><surname>Mu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Klinowska</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Dong</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non&#8208;amplified inflammatory breast cancer models</article-title>. <source>J Exp Clin Cancer Res</source>. <year>2014</year>;<volume>33</volume>(<issue>1</issue>):<fpage>47</fpage>.<pub-id pub-id-type="pmid">24886365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1756-9966-33-47</pub-id><pub-id pub-id-type="pmcid">PMC4061513</pub-id></mixed-citation></ref><ref id="ame270028-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="ame270028-cit-0147"><string-name name-style="western"><surname>Shi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Fu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Farhadi Sabet</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Hydrogel&#8208;mediated jamming of exosome communications that Counter tumor adaption in the tumor immune microenvironment</article-title>. <source>ACS Nano</source>. <year>2024</year>;<volume>18</volume>(<issue>48</issue>):<fpage>33042</fpage>&#8208;<lpage>33057</lpage>.<pub-id pub-id-type="pmid">39441690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.4c07603</pub-id></mixed-citation></ref><ref id="ame270028-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="ame270028-cit-0148"><string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Pan</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Chronic stress&#8208;induced and tumor derived SP1+ exosomes polarizing IL&#8208;1&#946;+ neutrophils to increase lung metastasis of breast cancer</article-title>. <source>Adv Sci (Weinh)</source>. <year>2025</year>;<volume>12</volume>(<issue>4</issue>):<elocation-id>e2310266</elocation-id>.<pub-id pub-id-type="pmid">39630109</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202310266</pub-id><pub-id pub-id-type="pmcid">PMC11789585</pub-id></mixed-citation></ref><ref id="ame270028-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="ame270028-cit-0149"><string-name name-style="western"><surname>Jiang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Macrophages promote pre&#8208;metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity</article-title>. <source>Signal Transduct Target Ther</source>. <year>2024</year>;<volume>9</volume>(<issue>1</issue>):<fpage>352</fpage>.<pub-id pub-id-type="pmid">39690159</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-024-02042-5</pub-id><pub-id pub-id-type="pmcid">PMC11652640</pub-id></mixed-citation></ref><ref id="ame270028-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="ame270028-cit-0150"><string-name name-style="western"><surname>Ding</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lei</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>FOXM1 promotes malignant biological behavior and metabolic reprogramming by targeting SPINK1 in hepatocellular carcinoma and affecting the p53 pathway</article-title>. <source>Biochim Biophys Acta Mol basis Dis</source>. <year>2025</year>;<volume>1871</volume>(<issue>3</issue>):<elocation-id>167673</elocation-id>.<pub-id pub-id-type="pmid">39828047</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbadis.2025.167673</pub-id></mixed-citation></ref><ref id="ame270028-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="ame270028-cit-0151"><string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Qiu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Fang</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti&#8208;PD&#8208;1 immunotherapy</article-title>. <source>Cell Death Differ</source>. <year>2025</year>. doi:<pub-id pub-id-type="doi">10.1038/s41418-024-01437-9</pub-id>.<pub-id pub-id-type="pmcid">PMC12089275</pub-id><pub-id pub-id-type="pmid">39755756</pub-id></mixed-citation></ref><ref id="ame270028-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="ame270028-cit-0152"><string-name name-style="western"><surname>Haiying</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Huimei</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Jinghua</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Chao</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Shuang</surname><given-names>L</given-names></string-name>. <article-title>Establishment of lung metastasis model of liver cancer in mice</article-title>. <source>J Med Pest Control</source>. <year>2023</year>;<volume>39</volume>(<issue>6</issue>):<fpage>591</fpage>&#8208;<lpage>593</lpage>.</mixed-citation></ref><ref id="ame270028-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="ame270028-cit-0153"><string-name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>A glucose&#8208;enriched lung pre&#8208;metastatic niche triggered by matrix stiffness&#8208;tuned exosomal miRNAs in hepatocellular carcinoma</article-title>. <source>Nat Commun</source>. <year>2025</year>;<volume>16</volume>(<issue>1</issue>):<fpage>1736</fpage>.<pub-id pub-id-type="pmid">39966385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-025-56878-8</pub-id><pub-id pub-id-type="pmcid">PMC11836368</pub-id></mixed-citation></ref><ref id="ame270028-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="ame270028-cit-0154"><string-name name-style="western"><surname>Yu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Qian</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Galectin&#8208;1&#8208;induced tumor associated macrophages repress antitumor immunity in hepatocellular carcinoma through recruitment of tregs</article-title>. <source>Adv Sci</source>. <year>2025</year>;<volume>12</volume>(<issue>11</issue>):<elocation-id>e2408788</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202408788</pub-id><pub-id pub-id-type="pmcid">PMC11923918</pub-id><pub-id pub-id-type="pmid">39853961</pub-id></mixed-citation></ref><ref id="ame270028-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="ame270028-cit-0155"><string-name name-style="western"><surname>Xun</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Jiao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Shunli</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Huajian</surname><given-names>C</given-names></string-name>. <article-title>HMMR promotes invasion and metastasis of hepatocellular carcinoma via activating MEK/ERK signaling pathway</article-title>. <source>J Army Med Univ</source>. <year>2022</year>;<volume>44</volume>(<issue>17</issue>):<fpage>1720</fpage>&#8208;<lpage>1727</lpage>.</mixed-citation></ref><ref id="ame270028-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="ame270028-cit-0156"><string-name name-style="western"><surname>Su</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>miR&#8208;7/TGF&#8208;&#946;2 axis sustains acidic tumor microenvironment&#8208;induced lung cancer metastasis</article-title>. <source>Acta Pharm Sin B</source>. <year>2022</year>;<volume>12</volume>(<issue>2</issue>):<fpage>821</fpage>&#8208;<lpage>837</lpage>.<pub-id pub-id-type="pmid">35251919</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.apsb.2021.06.009</pub-id><pub-id pub-id-type="pmcid">PMC8896986</pub-id></mixed-citation></ref><ref id="ame270028-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="ame270028-cit-0157"><string-name name-style="western"><surname>Nicholas</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Sughrue</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Battiste</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Algan</surname><given-names>O</given-names></string-name>. <article-title>When evaluating a new thyroid mass and a ring&#8208;enhancing brain lesion (when two presentations collide)</article-title>. <source>Cureus</source>. <year>2016</year>;<volume>8</volume>(<issue>5</issue>):<elocation-id>e600</elocation-id>.<pub-id pub-id-type="pmid">27335712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.600</pub-id><pub-id pub-id-type="pmcid">PMC4895081</pub-id></mixed-citation></ref><ref id="ame270028-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="ame270028-cit-0158"><string-name name-style="western"><surname>Richardo</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Prattapong</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ngernsombat</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Epstein&#8208;Barr virus mediated signaling in nasopharyngeal carcinoma carcinogenesis</article-title>. <source>Cancers (Basel)</source>. <year>2020</year>;<volume>12</volume>(<issue>9</issue>):<fpage>2441</fpage>.<pub-id pub-id-type="pmid">32872147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers12092441</pub-id><pub-id pub-id-type="pmcid">PMC7565514</pub-id></mixed-citation></ref><ref id="ame270028-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="ame270028-cit-0159"><string-name name-style="western"><surname>Miyamoto</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tanaka</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hirosuna</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>Validation of a patient&#8208;derived xenograft model for cervical cancer based on genomic and phenotypic characterization</article-title>. <source>Cancers (Basel)</source>. <year>2022</year>;<volume>14</volume>(<issue>12</issue>):<fpage>2969</fpage>.<pub-id pub-id-type="pmid">35740635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers14122969</pub-id><pub-id pub-id-type="pmcid">PMC9221029</pub-id></mixed-citation></ref><ref id="ame270028-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="ame270028-cit-0160"><string-name name-style="western"><surname>Woo</surname><given-names>XY</given-names></string-name>, <string-name name-style="western"><surname>Srivastava</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mack</surname><given-names>PC</given-names></string-name>, et&#160;al. <article-title>A Genomically and clinically annotated patient&#8208;derived xenograft resource for preclinical research in non&#8208;small cell lung cancer</article-title>. <source>Cancer Res</source>. <year>2022</year>;<volume>82</volume>(<issue>22</issue>):<fpage>4126</fpage>&#8208;<lpage>4138</lpage>.<pub-id pub-id-type="pmid">36069866</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-22-0948</pub-id><pub-id pub-id-type="pmcid">PMC9664138</pub-id></mixed-citation></ref><ref id="ame270028-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="ame270028-cit-0161"><string-name name-style="western"><surname>Fang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>Effects of siRNA silencing of TUG1 and LCAL6 Long non&#8208;coding RNAs on patient&#8208;derived xenograft of non&#8208;small cell lung cancer</article-title>. <source>Anticancer Res</source>. <year>2018</year>;<volume>38</volume>(<issue>1</issue>):<fpage>179</fpage>&#8208;<lpage>186</lpage>.<pub-id pub-id-type="pmid">29277771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21873/anticanres.12206</pub-id></mixed-citation></ref><ref id="ame270028-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="ame270028-cit-0162"><string-name name-style="western"><surname>He</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Discovery and preclinical evaluations of drug candidate DA&#8208;0157 capable of overcoming EGFR drug&#8208;resistant mutation C797S and EGFR/ALK co&#8208;mutations</article-title>. <source>Eur J Med Chem</source>. <year>2025</year>;<volume>287</volume>:<fpage>117323</fpage>.<pub-id pub-id-type="pmid">39892095</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejmech.2025.117323</pub-id></mixed-citation></ref><ref id="ame270028-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="ame270028-cit-0163"><string-name name-style="western"><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Tumor characteristics associated with engraftment of patient&#8208;derived non&#8208;small cell lung cancer xenografts in immunocompromised mice</article-title>. <source>Cancer</source>. <year>2019</year>;<volume>125</volume>(<issue>21</issue>):<fpage>3738</fpage>&#8208;<lpage>3748</lpage>.<pub-id pub-id-type="pmid">31287557</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.32366</pub-id><pub-id pub-id-type="pmcid">PMC7294643</pub-id></mixed-citation></ref><ref id="ame270028-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="ame270028-cit-0164"><string-name name-style="western"><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Shen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>Z</given-names></string-name>, et&#160;al. <article-title>Patient&#8208;derived non&#8208;small cell lung cancer xenograft mirrors complex tumor heterogeneity</article-title>. <source>Cancer Biol Med</source>. <year>2021</year>;<volume>18</volume>(<issue>1</issue>):<fpage>184</fpage>&#8208;<lpage>198</lpage>.<pub-id pub-id-type="pmid">33628593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.20892/j.issn.2095-3941.2020.0012</pub-id><pub-id pub-id-type="pmcid">PMC7877179</pub-id></mixed-citation></ref><ref id="ame270028-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="ame270028-cit-0165"><string-name name-style="western"><surname>Zhuo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Molecular phenotypes reveal heterogeneous engraftments of patient&#8208;derived hepatocellular carcinoma xenografts</article-title>. <source>Chin J Cancer Res</source>. <year>2021</year>;<volume>33</volume>(<issue>4</issue>):<fpage>470</fpage>&#8208;<lpage>479</lpage>.<pub-id pub-id-type="pmid">34584372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21147/j.issn.1000-9604.2021.04.04</pub-id><pub-id pub-id-type="pmcid">PMC8435819</pub-id></mixed-citation></ref><ref id="ame270028-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="ame270028-cit-0166"><string-name name-style="western"><surname>Hynds</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Huebner</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pearce</surname><given-names>DR</given-names></string-name>, et&#160;al. <article-title>Representation of genomic intratumor heterogeneity in multi&#8208;region non&#8208;small cell lung cancer patient&#8208;derived xenograft models</article-title>. <source>Nat Commun</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>4653</fpage>.<pub-id pub-id-type="pmid">38821942</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-47547-3</pub-id><pub-id pub-id-type="pmcid">PMC11143323</pub-id></mixed-citation></ref><ref id="ame270028-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="ame270028-cit-0167"><string-name name-style="western"><surname>Sugimoto</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Takiguchi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kurosu</surname><given-names>K</given-names></string-name>, et&#160;al. <article-title>Growth factor&#8208;mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small&#8208;cell lung cancer</article-title>. <source>Oncol Rep</source>. <year>2005</year>;<volume>14</volume>(<issue>4</issue>):<fpage>823</fpage>&#8208;<lpage>830</lpage>.<pub-id pub-id-type="pmid">16142338</pub-id></mixed-citation></ref><ref id="ame270028-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="ame270028-cit-0168"><string-name name-style="western"><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>CD16+ fibroblasts foster a trastuzumab&#8208;refractory microenvironment that is reversed by VAV2 inhibition</article-title>. <source>Cancer Cell</source>. <year>2022</year>;<volume>40</volume>(<issue>11</issue>):<fpage>1341</fpage>&#8208;<lpage>1357.e13</lpage>.<pub-id pub-id-type="pmid">36379207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccell.2022.10.015</pub-id></mixed-citation></ref><ref id="ame270028-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="ame270028-cit-0169"><string-name name-style="western"><surname>Xu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Kong</surname><given-names>Q</given-names></string-name>, et&#160;al. <article-title>Inhibition of p62/SQSTM1 sensitizes small&#8208;cell lung cancer cells to cisplatin&#8208;induced cytotoxicity by targeting NEDD9 expression</article-title>. <source>Mol Carcinog</source>. <year>2020</year>;<volume>59</volume>(<issue>8</issue>):<fpage>967</fpage>&#8208;<lpage>979</lpage>.<pub-id pub-id-type="pmid">32424979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mc.23215</pub-id></mixed-citation></ref><ref id="ame270028-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="ame270028-cit-0170"><string-name name-style="western"><surname>Li</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xiang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>J</given-names></string-name>. <article-title>Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small&#8208;cell lung cancer</article-title>. <source>Cancer Gene Ther</source>. <year>2013</year>;<volume>20</volume>(<issue>4</issue>):<fpage>251</fpage>&#8208;<lpage>259</lpage>.<pub-id pub-id-type="pmid">23470565</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cgt.2013.14</pub-id></mixed-citation></ref><ref id="ame270028-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="ame270028-cit-0171"><string-name name-style="western"><surname>Hokari</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tamura</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kaneda</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Comparative analysis of TTF&#8208;1 binding DNA regions in small&#8208;cell lung cancer and non&#8208;small&#8208;cell lung cancer</article-title>. <source>Mol Oncol</source>. <year>2020</year>;<volume>14</volume>(<issue>2</issue>):<fpage>277</fpage>&#8208;<lpage>293</lpage>.<pub-id pub-id-type="pmid">31782890</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1878-0261.12608</pub-id><pub-id pub-id-type="pmcid">PMC6998394</pub-id></mixed-citation></ref><ref id="ame270028-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="ame270028-cit-0172"><string-name name-style="western"><surname>Zinn</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Gardner</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Dobromilskaya</surname><given-names>I</given-names></string-name>, et&#160;al. <article-title>Combination treatment with ABT&#8208;737 and chloroquine in preclinical models of small cell lung cancer</article-title>. <source>Mol Cancer</source>. <year>2013</year>;<volume>12</volume>:<fpage>16</fpage>.<pub-id pub-id-type="pmid">23452820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1476-4598-12-16</pub-id><pub-id pub-id-type="pmcid">PMC3599053</pub-id></mixed-citation></ref><ref id="ame270028-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="ame270028-cit-0173"><string-name name-style="western"><surname>Pifano</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Garona</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Capobianco</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Gonzalez</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Alonso</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Ripoll</surname><given-names>GV</given-names></string-name>. <article-title>Peptide agonists of vasopressin V2 receptor reduce expression of neuroendocrine markers and tumor growth in human lung and prostate tumor cells</article-title>. <source>Front Oncol</source>. <year>2017</year>;<volume>7</volume>:<elocation-id>11</elocation-id>.<pub-id pub-id-type="pmid">28194370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2017.00011</pub-id><pub-id pub-id-type="pmcid">PMC5276816</pub-id></mixed-citation></ref><ref id="ame270028-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="ame270028-cit-0174"><string-name name-style="western"><surname>Deniz</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Gedik</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Y&#252;ksel</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Cebeci</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>&#350;ahin</surname><given-names>F</given-names></string-name>. <article-title>Anti&#8208;cancer effect of sodium pentaborate in combination with cisplatin on lung cancer cell lines</article-title>. <source>Mol Biol Rep</source>. <year>2024</year>;<volume>52</volume>(<issue>1</issue>):<fpage>28</fpage>.<pub-id pub-id-type="pmid">39612011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11033-024-10119-1</pub-id></mixed-citation></ref><ref id="ame270028-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="ame270028-cit-0175"><string-name name-style="western"><surname>Cao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>A novel therapeutic target for small&#8208;cell lung cancer: tumor&#8208;associated repair&#8208;like Schwann cells</article-title>. <source>Cancers (Basel)</source>. <year>2022</year>;<volume>14</volume>(<issue>24</issue>):<fpage>6132</fpage>.<pub-id pub-id-type="pmid">36551618</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers14246132</pub-id><pub-id pub-id-type="pmcid">PMC9776631</pub-id></mixed-citation></ref><ref id="ame270028-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="ame270028-cit-0176"><string-name name-style="western"><surname>Liang</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>HL</given-names></string-name>, et&#160;al. <article-title>FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis</article-title>. <source>Oncogene</source>. <year>2021</year>;<volume>40</volume>(<issue>30</issue>):<fpage>4847</fpage>&#8208;<lpage>4858</lpage>. Erratum in: <italic toggle="yes">Oncogene</italic>. 2021;40(49):6705. <pub-id pub-id-type="doi">10.1038/s41388-021-01895-2</pub-id><pub-id pub-id-type="pmid">34155349</pub-id></mixed-citation></ref><ref id="ame270028-bib-0177"><label>177</label><mixed-citation publication-type="journal" id="ame270028-cit-0177"><string-name name-style="western"><surname>Ferguson</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Gerak</surname><given-names>CAN</given-names></string-name>, <string-name name-style="western"><surname>Chow</surname><given-names>CCT</given-names></string-name>, et&#160;al. <article-title>The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418</article-title>. <source>PLoS One</source>. <year>2019</year>;<volume>14</volume>(<issue>5</issue>):<elocation-id>e0216423</elocation-id>.<pub-id pub-id-type="pmid">31120902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0216423</pub-id><pub-id pub-id-type="pmcid">PMC6532957</pub-id></mixed-citation></ref><ref id="ame270028-bib-0178"><label>178</label><mixed-citation publication-type="journal" id="ame270028-cit-0178"><string-name name-style="western"><surname>Mukherjee</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Suresh</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Zambre</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Synergistic inhibition of drug resistant KRAS mutant non&#8208;small cell lung cancer by Co&#8208;targeting AXL and SRC</article-title>. <source>Cancers (Basel)</source>. <year>2025</year>;<volume>17</volume>(<issue>3</issue>):<fpage>490</fpage>.<pub-id pub-id-type="pmid">39941857</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers17030490</pub-id><pub-id pub-id-type="pmcid">PMC11816174</pub-id></mixed-citation></ref><ref id="ame270028-bib-0179"><label>179</label><mixed-citation publication-type="journal" id="ame270028-cit-0179"><string-name name-style="western"><surname>Meraz</surname><given-names>IM</given-names></string-name>, <string-name name-style="western"><surname>Majidi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti&#8208;PD1 resistant metastatic non&#8208;small cell lung cancer (NSCLC) in a humanized mouse model</article-title>. <source>elife</source>. <year>2025</year>;<volume>13</volume>:<elocation-id>RP98258</elocation-id>.<pub-id pub-id-type="pmid">39932765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.98258</pub-id><pub-id pub-id-type="pmcid">PMC11813225</pub-id></mixed-citation></ref><ref id="ame270028-bib-0180"><label>180</label><mixed-citation publication-type="journal" id="ame270028-cit-0180"><string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>The diagnostic value of 68Ga&#8208;NOTA&#8208;MAL&#8208;Cys&#8208;MZHER2:342 PET/CT imaging for HER2&#8208;positive lung adenocarcinoma</article-title>. <source>Front Med</source>. <year>2024</year>;<volume>11</volume>:<elocation-id>1447500</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2024.1447500</pub-id><pub-id pub-id-type="pmcid">PMC11347437</pub-id><pub-id pub-id-type="pmid">39193019</pub-id></mixed-citation></ref><ref id="ame270028-bib-0181"><label>181</label><mixed-citation publication-type="journal" id="ame270028-cit-0181"><string-name name-style="western"><surname>Singh</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Mattheolabakis</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Withers</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dahal</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jois</surname><given-names>S</given-names></string-name>. <article-title>A grafted peptidomimetic for EGFR heterodimerization inhibition: implications in NSCLC models</article-title>. <source>Eur J Med Chem</source>. <year>2021</year>;<volume>216</volume>:<elocation-id>113312</elocation-id>.<pub-id pub-id-type="pmid">33667849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejmech.2021.113312</pub-id><pub-id pub-id-type="pmcid">PMC8044046</pub-id></mixed-citation></ref><ref id="ame270028-bib-0182"><label>182</label><mixed-citation publication-type="journal" id="ame270028-cit-0182"><string-name name-style="western"><surname>Fang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Silica&#8208;based EGFR&#8208;degrading nano&#8208;PROTACs for efficient therapy of non&#8208;small cell lung cancer</article-title>. <source>Eur J Pharm Biopharm</source>. <year>2025</year>;<volume>210</volume>:<elocation-id>114699</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.ejpb.2025.114699</pub-id><pub-id pub-id-type="pmid">40113047</pub-id></mixed-citation></ref><ref id="ame270028-bib-0183"><label>183</label><mixed-citation publication-type="journal" id="ame270028-cit-0183"><string-name name-style="western"><surname>Cho</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>You</surname><given-names>YM</given-names></string-name>, <string-name name-style="western"><surname>Koo</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Yeom</surname><given-names>YI</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>KC</given-names></string-name>. <article-title>LPIN1 induces gefitinib resistance in EGFR inhibitor&#8208;resistant non&#8208;small cell lung cancer cells</article-title>. <source>Cancers (Basel)</source>. <year>2022</year>;<volume>14</volume>(<issue>9</issue>):<fpage>2222</fpage>.<pub-id pub-id-type="pmid">35565351</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers14092222</pub-id><pub-id pub-id-type="pmcid">PMC9102170</pub-id></mixed-citation></ref><ref id="ame270028-bib-0184"><label>184</label><mixed-citation publication-type="journal" id="ame270028-cit-0184"><string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>Discovery of novel quinazoline&#8208;based KRAS G12C inhibitors as potential anticancer agents</article-title>. <source>Bioorg Med Chem</source>. <year>2022</year>;<volume>71</volume>:<elocation-id>116962</elocation-id>.<pub-id pub-id-type="pmid">35987104</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bmc.2022.116962</pub-id></mixed-citation></ref><ref id="ame270028-bib-0185"><label>185</label><mixed-citation publication-type="journal" id="ame270028-cit-0185"><string-name name-style="western"><surname>Han</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>H</given-names></string-name>, et&#160;al. <article-title>Marsdenia tenacissima extract enhances gefitinib efficacy in non&#8208;small cell lung cancer xenografts</article-title>. <source>Phytomedicine</source>. <year>2015</year>;<volume>22</volume>(<issue>5</issue>):<fpage>560</fpage>&#8208;<lpage>567</lpage>.<pub-id pub-id-type="pmid">25981922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2015.03.001</pub-id></mixed-citation></ref><ref id="ame270028-bib-0186"><label>186</label><mixed-citation publication-type="journal" id="ame270028-cit-0186"><string-name name-style="western"><surname>Ma</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname><given-names>D</given-names></string-name>. <article-title>Pachymic acid induces apoptosis via activating ROS&#8208;dependent JNK and ER stress pathways in lung cancer cells</article-title>. <source>Cancer Cell Int</source>. <year>2015</year>;<volume>15</volume>:<fpage>78</fpage>.<pub-id pub-id-type="pmid">26244039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12935-015-0230-0</pub-id><pub-id pub-id-type="pmcid">PMC4524283</pub-id></mixed-citation></ref><ref id="ame270028-bib-0187"><label>187</label><mixed-citation publication-type="journal" id="ame270028-cit-0187"><string-name name-style="western"><surname>Wu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>RASON promotes KRASG12C&#8208;driven tumor progression and immune evasion in non&#8208;small cell lung cancer</article-title>. <source>J Exp Clin Cancer Res</source>. <year>2025</year>;<volume>44</volume>(<issue>1</issue>):<fpage>106</fpage>.<pub-id pub-id-type="pmid">40128846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13046-025-03369-9</pub-id><pub-id pub-id-type="pmcid">PMC11934775</pub-id></mixed-citation></ref><ref id="ame270028-bib-0188"><label>188</label><mixed-citation publication-type="journal" id="ame270028-cit-0188"><string-name name-style="western"><surname>Du</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Qi</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>. <article-title>Novel Camptothecin derivative 9c with enhanced antitumor activity via NSA2&#8208;EGFR&#8208;P53 signaling pathway</article-title>. <source>Int J Mol Sci</source>. <year>2025</year>;<volume>26</volume>(<issue>5</issue>):<fpage>1987</fpage>.<pub-id pub-id-type="pmid">40076615</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms26051987</pub-id><pub-id pub-id-type="pmcid">PMC11900506</pub-id></mixed-citation></ref><ref id="ame270028-bib-0189"><label>189</label><mixed-citation publication-type="journal" id="ame270028-cit-0189"><string-name name-style="western"><surname>Yan</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism</article-title>. <source>Cancer Biol Med</source>. <year>2025</year>;<volume>22</volume>(<issue>2</issue>):<fpage>144</fpage>&#8208;<lpage>165</lpage>.<pub-id pub-id-type="pmid">39995202</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.20892/j.issn.2095-3941.2024.0385</pub-id><pub-id pub-id-type="pmcid">PMC11899589</pub-id></mixed-citation></ref><ref id="ame270028-bib-0190"><label>190</label><mixed-citation publication-type="journal" id="ame270028-cit-0190"><string-name name-style="western"><surname>Ding</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname><given-names>Y</given-names></string-name>, et&#160;al. <article-title>Anti&#8208;angiogenic effect of a chemically sulfated polysaccharide from Phellinus ribis by inhibiting VEGF/VEGFR pathway</article-title>. <source>Int J Biol Macromol</source>. <year>2020</year>;<volume>154</volume>(<issue>1</issue>):<fpage>72</fpage>&#8208;<lpage>81</lpage>.<pub-id pub-id-type="pmid">32171839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijbiomac.2020.03.068</pub-id></mixed-citation></ref><ref id="ame270028-bib-0191"><label>191</label><mixed-citation publication-type="journal" id="ame270028-cit-0191"><string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>. <article-title>Xiaoliu Pingyi Pecipe inhibits lung pre&#8208;metastatic niche formation and prevents myeloid&#8208;derived suppressor cells recruitment</article-title>. <source>Integr Cancer Ther</source>. <year>2023</year>;<volume>22</volume>:<elocation-id>15347354231187000</elocation-id>.<pub-id pub-id-type="pmid">37431869</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/15347354231187000</pub-id><pub-id pub-id-type="pmcid">PMC10338726</pub-id></mixed-citation></ref><ref id="ame270028-bib-0192"><label>192</label><mixed-citation publication-type="journal" id="ame270028-cit-0192"><string-name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>Targeting neddylation inhibits intravascular survival and extravasation of cancer cells to prevent lung&#8208;cancer metastasis</article-title>. <source>Cell Biol Toxicol</source>. <year>2019</year>;<volume>35</volume>(<issue>3</issue>):<fpage>233</fpage>&#8208;<lpage>245</lpage>.<pub-id pub-id-type="pmid">31140025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10565-019-09472-w</pub-id></mixed-citation></ref><ref id="ame270028-bib-0193"><label>193</label><mixed-citation publication-type="journal" id="ame270028-cit-0193"><string-name name-style="western"><surname>Mukherjee</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Debata</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Hussaini</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression</article-title>. <source>Oncotarget</source>. <year>2017</year>;<volume>8</volume>(<issue>37</issue>):<fpage>60904</fpage>&#8208;<lpage>60916</lpage>.<pub-id pub-id-type="pmid">28977833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.16648</pub-id><pub-id pub-id-type="pmcid">PMC5617393</pub-id></mixed-citation></ref><ref id="ame270028-bib-0194"><label>194</label><mixed-citation publication-type="journal" id="ame270028-cit-0194"><string-name name-style="western"><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Xue</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Geng</surname><given-names>Y</given-names></string-name>. <article-title>FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD&#8208;L1</article-title>. <source>Allergol Immunopathol (Madr)</source>. <year>2022</year>;<volume>50</volume>(<issue>5</issue>):<fpage>68</fpage>&#8208;<lpage>74</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.15586/aei.v50i5.659</pub-id><pub-id pub-id-type="pmid">36086966</pub-id></mixed-citation></ref><ref id="ame270028-bib-0195"><label>195</label><mixed-citation publication-type="journal" id="ame270028-cit-0195"><string-name name-style="western"><surname>Kim</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>HJ</given-names></string-name>, et&#160;al. <article-title>Deletion of PD&#8208;1 destabilizes the lineage identity and metabolic fitness of tumor&#8208;infiltrating regulatory T cells</article-title>. <source>Nat Immunol</source>. <year>2023</year>;<volume>24</volume>(<issue>1</issue>):<fpage>148</fpage>&#8208;<lpage>161</lpage>.<pub-id pub-id-type="pmid">36577929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-022-01373-1</pub-id></mixed-citation></ref><ref id="ame270028-bib-0196"><label>196</label><mixed-citation publication-type="journal" id="ame270028-cit-0196"><string-name name-style="western"><surname>Wakefield</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Agarwal</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tanner</surname><given-names>K</given-names></string-name>. <article-title>Preclinical models for drug discovery for metastatic disease</article-title>. <source>Cell</source>. <year>2023</year>;<volume>186</volume>(<issue>8</issue>):<fpage>1792</fpage>&#8208;<lpage>1813</lpage>.<pub-id pub-id-type="pmid">37059072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2023.02.026</pub-id></mixed-citation></ref><ref id="ame270028-bib-0197"><label>197</label><mixed-citation publication-type="journal" id="ame270028-cit-0197"><string-name name-style="western"><surname>Yang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <collab collab-type="authors">To, KKW</collab>
, et&#160;al. <article-title>Circulating tumor cells shielded with extracellular vesicle&#8208;derived CD45 evade T cell attack to enable metastasis</article-title>. <source>Signal Transduct Target Ther</source>. <year>2024</year>;<volume>9</volume>(<issue>1</issue>):<fpage>84</fpage>.<pub-id pub-id-type="pmid">38575583</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-024-01789-1</pub-id><pub-id pub-id-type="pmcid">PMC10995208</pub-id></mixed-citation></ref><ref id="ame270028-bib-0198"><label>198</label><mixed-citation publication-type="journal" id="ame270028-cit-0198"><string-name name-style="western"><surname>Dai</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>XY</given-names></string-name>, <string-name name-style="western"><surname>Xiang</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Gong</surname><given-names>DD</given-names></string-name>, <string-name name-style="western"><surname>Man</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname><given-names>Y</given-names></string-name>. <article-title>Research and application of single&#8208;cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells</article-title>. <source>Biomark Res</source>. <year>2020</year>;<volume>8</volume>(<issue>1</issue>):<fpage>60</fpage>.<pub-id pub-id-type="pmid">33292625</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40364-020-00240-1</pub-id><pub-id pub-id-type="pmcid">PMC7653877</pub-id></mixed-citation></ref><ref id="ame270028-bib-0199"><label>199</label><mixed-citation publication-type="journal" id="ame270028-cit-0199"><string-name name-style="western"><surname>W&#252;rth</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Donato</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Michel</surname><given-names>LL</given-names></string-name>, et&#160;al. <article-title>Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1&#8208;HER3 signaling</article-title>. <source>Nat Cancer</source>. <year>2025</year>;<volume>6</volume>(<issue>1</issue>):<fpage>67</fpage>&#8208;<lpage>85</lpage>.<pub-id pub-id-type="pmid">39753722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43018-024-00882-2</pub-id><pub-id pub-id-type="pmcid">PMC11779641</pub-id></mixed-citation></ref><ref id="ame270028-bib-0200"><label>200</label><mixed-citation publication-type="journal" id="ame270028-cit-0200"><string-name name-style="western"><surname>Deng</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ge</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Dubey</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno&#8208;associated virus vector compatible with biosafety level 1</article-title>. <source>Cancer Immunol Immunother</source>. <year>2023</year>;<volume>72</volume>(<issue>12</issue>):<fpage>4457</fpage>&#8208;<lpage>4470</lpage>.<pub-id pub-id-type="pmid">37796299</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00262-023-03542-z</pub-id><pub-id pub-id-type="pmcid">PMC10700219</pub-id></mixed-citation></ref><ref id="ame270028-bib-0201"><label>201</label><mixed-citation publication-type="journal" id="ame270028-cit-0201"><string-name name-style="western"><surname>Yamakado</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Sato&#8208;Yazawa</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ishii</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Spontaneous transformation from lung adenocarcinoma to MYC&#8208;amplified large cell neuroendocrine carcinoma</article-title>. <source>Pathol Int</source>. <year>2025</year>;<volume>75</volume>(<issue>2</issue>):<fpage>105</fpage>&#8208;<lpage>113</lpage>.<pub-id pub-id-type="pmid">39868963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/pin.13507</pub-id></mixed-citation></ref><ref id="ame270028-bib-0202"><label>202</label><mixed-citation publication-type="journal" id="ame270028-cit-0202"><string-name name-style="western"><surname>Ciampricotti</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Karakousi</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Richards</surname><given-names>AL</given-names></string-name>, et&#160;al. <article-title>Rlf&#8208;Mycl gene fusion drives tumorigenesis and metastasis in a mouse model of small cell lung cancer</article-title>. <source>Cancer Discov</source>. <year>2021</year>;<volume>11</volume>(<issue>12</issue>):<fpage>3214</fpage>&#8208;<lpage>3229</lpage>.<pub-id pub-id-type="pmid">34344693</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2159-8290.CD-21-0441</pub-id><pub-id pub-id-type="pmcid">PMC8810895</pub-id></mixed-citation></ref><ref id="ame270028-bib-0203"><label>203</label><mixed-citation publication-type="journal" id="ame270028-cit-0203"><string-name name-style="western"><surname>Martinez&#8208;Usatorre</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kadioglu</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Boivin</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Overcoming microenvironmental resistance to PD&#8208;1 blockade in genetically engineered lung cancer models</article-title>. <source>Sci Transl Med</source>. <year>2021</year>;<volume>13</volume>(<issue>606</issue>):<elocation-id>eabd1616</elocation-id>.<pub-id pub-id-type="pmid">34380768</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.abd1616</pub-id><pub-id pub-id-type="pmcid">PMC7612153</pub-id></mixed-citation></ref><ref id="ame270028-bib-0204"><label>204</label><mixed-citation publication-type="journal" id="ame270028-cit-0204"><string-name name-style="western"><surname>Oser</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>MacPherson</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Oliver</surname><given-names>TG</given-names></string-name>, <string-name name-style="western"><surname>Sage</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>KS</given-names></string-name>. <article-title>Genetically&#8208;engineered mouse models of small cell lung cancer: the next generation</article-title>. <source>Oncogene</source>. <year>2024</year>;<volume>43</volume>(<issue>7</issue>):<fpage>457</fpage>&#8208;<lpage>469</lpage>.<pub-id pub-id-type="pmid">38191672</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41388-023-02929-7</pub-id><pub-id pub-id-type="pmcid">PMC11180418</pub-id></mixed-citation></ref><ref id="ame270028-bib-0205"><label>205</label><mixed-citation publication-type="journal" id="ame270028-cit-0205"><string-name name-style="western"><surname>Leibowitz</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Papathanasiou</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Doerfler</surname><given-names>PA</given-names></string-name>, et&#160;al. <article-title>Chromothripsis as an on&#8208;target consequence of CRISPR&#8208;Cas9 genome editing</article-title>. <source>Nat Genet</source>. <year>2021</year>;<volume>53</volume>(<issue>6</issue>):<fpage>895</fpage>&#8208;<lpage>905</lpage>.<pub-id pub-id-type="pmid">33846636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-021-00838-7</pub-id><pub-id pub-id-type="pmcid">PMC8192433</pub-id></mixed-citation></ref><ref id="ame270028-bib-0206"><label>206</label><mixed-citation publication-type="journal" id="ame270028-cit-0206"><string-name name-style="western"><surname>Lan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>X</given-names></string-name>, et&#160;al. <article-title>Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. Ex Li leaves triggers ROS&#8208;dependent p53 activation leading to apoptosis in non&#8208;small cell lung cancer cells</article-title>. <source>J Ethnopharmacol</source>. <year>2024</year>;<volume>332</volume>:<elocation-id>118340</elocation-id>.<pub-id pub-id-type="pmid">38762212</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2024.118340</pub-id></mixed-citation></ref><ref id="ame270028-bib-0207"><label>207</label><mixed-citation publication-type="journal" id="ame270028-cit-0207"><string-name name-style="western"><surname>Song</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Lei</surname><given-names>X</given-names></string-name>. <article-title>Synthesis and biological evaluation of the Fluoro analog of Romidepsin with improved selectivity for class I histone deacetylases (HDACs)</article-title>. <source>Bioorg Chem</source>. <year>2025</year>;<volume>159</volume>:<fpage>108348</fpage>.<pub-id pub-id-type="pmid">40090152</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioorg.2025.108348</pub-id></mixed-citation></ref><ref id="ame270028-bib-0208"><label>208</label><mixed-citation publication-type="journal" id="ame270028-cit-0208"><string-name name-style="western"><surname>Wu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Tu</surname><given-names>L</given-names></string-name>, et&#160;al. <article-title>AZD9291 increases sensitivity to radiation in PC&#8208;9&#8208;IR cells by delaying DNA damage repair after irradiation and inducing apoptosis</article-title>. <source>Radiat Res</source>. <year>2018</year>;<volume>189</volume>(<issue>3</issue>):<fpage>283</fpage>&#8208;<lpage>291</lpage>.<pub-id pub-id-type="pmid">29332537</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1667/RR14682.1</pub-id></mixed-citation></ref><ref id="ame270028-bib-0209"><label>209</label><mixed-citation publication-type="journal" id="ame270028-cit-0209"><string-name name-style="western"><surname>Kotani</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Oshima</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Boucher</surname><given-names>JC</given-names></string-name>, et&#160;al. <article-title>Dual inhibition of SUMOylation and MEK conquers MYC&#8208;expressing KRAS&#8208;mutant cancers by accumulating DNA damage</article-title>. <source>J Biomed Sci</source>. <year>2024</year>;<volume>31</volume>(<issue>1</issue>):<fpage>68</fpage>.<pub-id pub-id-type="pmid">38992694</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12929-024-01060-3</pub-id><pub-id pub-id-type="pmcid">PMC11238369</pub-id></mixed-citation></ref><ref id="ame270028-bib-0210"><label>210</label><mixed-citation publication-type="journal" id="ame270028-cit-0210"><string-name name-style="western"><surname>McGinnis</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Miao</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Superville</surname><given-names>D</given-names></string-name>, et&#160;al. <article-title>The temporal progression of lung immune remodeling during breast cancer metastasis</article-title>. <source>Cancer Cell</source>. <year>2024</year>;<volume>42</volume>(<issue>6</issue>):<fpage>1018</fpage>&#8208;<lpage>1031.e6</lpage>.<pub-id pub-id-type="pmid">38821060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccell.2024.05.004</pub-id><pub-id pub-id-type="pmcid">PMC11255555</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>